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ABSTRACT
The adrenergic receptor o f sheep adipose tissue was studied in  
adipose tissue membranes and p a rtia lly -p u rifie d  preparations, to 
determ ine some o f its  basic  stru ctu ra l and pharm acological properties. 
The work in  sheep was complemented w ith  studies on the ^-adrenergic 
receptor o f ra t adipocytes, to  compare the -receptors in  these two 
species. The key findings o f the study can be summarised as follow s:
1) Sheep om ental adipose tissue membranes, rich  in  jg-adrenergic 
receptors (about 150 fm ol/m g membrane protein measured using 10 nM
n  q
[ H jdihydroalprenolol ( [ H ]D H A)), were prepared from  whole tissue by 
d iffe re n tia l centrifugation, w ithout any collagenase digestion o f the 
tissue. ^-A drenerg ic receptors were e ffe c tive ly  solubilised w ith 
d ig iton in , and p a rtia lly  pu rified  by a ffin ity  chromatography on a 
Sepharose 4B-alprenolol column. This resulted in  jg-adrenergic receptor 
preparations w ith a specific a c tiv ity  o f about 35 pmol/mg protein ( > 
300-fold p u rifica tio n ), and an overa ll recovery o f 65%.
2) /S -Adrenergic receptors were photoaffm ity-labe lled w ith
[ ^^]jodocyanopm dolo l-d iaarine ([^^ ijlC Y P D ) and subjected to  SDS PAGE. 
P hotoaffin ity-labe lling  o f the ^-adrenergic receptors o f sheep adipose 
tissue membranes specifica lly labelled a broad protein band o f 
approxim ately 58 kDa in  membranes, and two m inor proteins w ith  m olecular 
weights o f 42.5 and 30 kDa. In  p a rtia lly -p u rifie d  preparations only a 58 
kDa protein was labelled. The m igration o f th is protein on SDS PAGE was 
unaffected by addition o f high concentrations o f reducing agents capable 
o f breaking disulphide bridge. The results were s im ila r fo r both 
om ental and subcutaneous adipose tissue. In  ra t adipocyte membranes, a 
48 kDa protein was specifica lly labelled w ith  [^^ijEC YPD . The
isoe le ctric  po int o f photoaffim ty-labe lled jg -adrenergic receptor was 
6.15-6.25 in  sheep adipose tissue membranes. Two dimensional-PAGE o f 
photoaffinity-labelLed partialLy-purifi.ed jg-adrenergic receptors revealed 
nine apparently d iffe re n t proteins, a ll w ith  a molecular weight o f 58 
kDa. Studies were also perform ed w ith  benzyldim e th y l-n -
hexadecylam monium chloride PAGE (16-BAC PAGE), in  an attem pt to  develop 
an a lte rna tive  pu rifica tio n  strategy. However, quantifica tion o f jg - 
adrenergic receptors fo llow ing 16-BAG PAGE was no t possible, and 
therefore the technique was no t used fo r receptor pu rifica tio n .
3) The jg-adrenergic receptor o f sheep om ental adipose tissue possessed
n
high a ffin ity  fo r the non-subtype selective radioligands [ H]DHA (K ^ -  
3.23 + 0.38 nM (n=4)) and [^% ]iodocynaopsindolol ([^^^I]IC YP) (K ^ -  53.5 
pM ). For [% ]D H A  binding, B ^ ^  varied between 370 and 600 fm ol/m g 
membrane protein. The rank order o f potencies o f jS-adrenergic agonists 
fo r com petition o f [ H]DHA-bdnding sites was (-)-isop ro te reno l > ( - ) -  
adrenaline > ( - ) -noradrenaline. For subtype selective jS -adrenergic
antagonists the order was IG I 118,551 (P2)»CGP 20712A (j?^)>atenolol 
<& )• These potencies are ind ica tive  o f ^ “ adrenergic receptors.
4) The a ffin itie s  o f jg-adrenergic receptor preparations from  d iffe re n t 
depots from  sheep and ra ts were compared. Displacement o f [^^^ijLC YP- 
binding w ith  ICE 118,551 and CGP 20712A from  sheep adipose tissue 
membranes prepared from  three depots, revealed heterogeneity in  jS - 
adrenergic receptor a ffin itie s . Analysis o f log^Q-transform ed results 
gave an order o f jg2~c i^aracter ° f subcutaneous = pop litea l > om ental 
(P<0.01). S im ilar studies w ith  ra t adipose tissue revealed the presence 
o f and a typ ica l (Le. neither {Sy- nor jS2-subtypes) jg-adrenergic
receptors in  both lum bar and param etria! depots. The param etria l depot
possessed a higher percentage (o f to ta l receptor binding) o f a typ ica l 
(S-adrenergic receptors compared to  the lum bar depot.
5) |g-Adrenergic receptor a ffin itie s  fo r IC I 118,551 and CGP 20712A 
were unaffected by la cta tion . However, la c ta tio n  increased ^-adrenergic 
receptor ligand binding in  om ental (P<0.01) and subcutaneous (P<0.02) 
depots.
6) Polyclonal antisera were raised in  mice against three d iffe re n t 
immunogens containing ^-adrenergic receptors from  sheep om ental adipose 
tissue. Some antisera displaced [ ^ “IJCYP binding to  sheep adipose 
tissue membranes. However, the antisera were non-specific w ith  regards 
to  j$-receptors, recognising many proteins on immunoblots. Production o f 
monoclonal antibodies against the ^-adrenergic receptor o f sheep adipose 
tissue was unsuccessful. However, the polyclonal antiserum CM 13, 
directed against the ham ster lung ^ 2“ a(^ rener§?JC- receptor, recognised 61 
and 59 kDa proteins on immunoblots o f sheep om ental adipose tissue 
membranes.
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CHAPTER ONE 
INTRODUCTION
1CHAPTER ONE -  INTRODUCTION
1.1. Adrenergic mechanisms
1.1.1. Catechola mines
The physiologically re levant catecholamines which exert th e ir 
e ffects via  adrenergic receptors are the hormone adrenaline, and the 
neurotransm itter noradrenaline. Catecholamines are synthesised from  the 
amino acid 1-tyrosine (Barrand & Callingham, 1983). Adrenaline is  
synthesised and released exclusively from  the adrenal medulla (Barrand & 
Callingham, 1983), w hilst noradrenaline is  released from  synaptic nerve 
endings upon sym pathetic stim ulation (Landsberg & Young, 1985). The 
h a lf-life  o f catecholamines in  the blood is  about 20 s (Vane, 1969), 
p rim a rily  due to  uptake by body tissues (iversen, 1975). They are 
inactiva ted by m ethylation o f the 3-hydroxyl group o f the catechol ring  
by catecho l-0 -m ethyl transferase, o r oxidative rem oval o f th e ir amino 
group by monoamine oxidase (S tryer, 1981; Barrand & Callingham, 1983). 
Generally, catecholamines are released during stress o r shock in  order to  
increase the supply o f m etabolic fuels (Von Euler, 1964).
1.1.2. Adrenergic receptor subtypes
Catecholamines such as adrenaline and noradrenaline regulate 
physiological processes via  th e ir interactions w ith  a va rie ty o f 
receptors located in  the plasma membrane (Lefkow itz & Caron, 1988). 
Ahlquist (1948) o rig ina lly classified these receptors as o£- and /5 -  
adrenergic receptors, on the basis o f the re la tive  potencies o f various 
agonists in  stim ulating responses through these receptors. Further 
studies suggested th a t a t least two major subtypes o f both ^C- and /5 -  
adrenergic receptors existed. Using a va rie ty o f pharm acological 
c rite ria , and -  adrenergic receptors were distinguished (Langer,
21974; Berthelsen & Pettinger, 1977), as were |3 and 2“ adrenergic 
receptors (Lands e t aL, 1967).
I.I.2 .I. QC-p Adrenergic receptors
Binding o f agonists to  ^C^-adrenergic receptors leads to  signal 
transduction across the membrane, resulting in  the activa tion  o f a 
phosphatidylm osdfol-4,5-bisphosphate-specif ic phospholipase C (reviewed 
in  Berridge, 1984; Graham & Lanier, 1986). This transmembrane signalling 
process is  thought to  involve an as ye t uncharacterised G protein 
(Goodhardt a t aL, 1982; Boyer e t aL, 1984; Terman e t aL, 1987; Im & 
Graham, 1989). A ctiva tion  o f phospholipase C leads to  the generation o f 
in o s ito l-1 ,4,5-triphosphate (IP3) and d iacylg lycero l, which a ct as second 
messengers (Am bler e t aL, 1984). IP3 mobilises in tra ce llu la r stores o f 
calcium  (M ichell* 1975; Graham & Lanier, 1986; Putney, 1987), and 
diacylg lycero l activates protein kinase C (Nishizuka, 1984). O ther 
studies have im plicated addditional transduction mechanisms including 
activa tion  o f phosphatidylcholine-specific phopholipase D (Irv ing  & Exton,
1987) and activa tion o f phospholipase A2 (Burch e t aL, 1986; S livka & 
Insel, 1987).
The -^-adrenergic class o f receptors has been subdivided 
pharm acologically in to  two subtypes, namely an^ ( Morrow aL, 
1985; Han e t aL, 1987; Hinneman e t aL, 1988). This heterogeneity has 
been corroborated by the cloning o f the CX-^-adrenergic receptor 
(Cotecchia e t aL, 1988). Also a novel °C^-adrenergic receptor subtype 
has been cloned and expressed which, although i t  resembles the O 
subtype, displays some unique pharm acological characteristics (Schwinn e t 
aL, 1990). This suggests th a t more 0^ -adrenergic receptor subtypes may 
exist than those id e n tifie d  by pharm acological c rite ria .
3I . I . 2.2. (X.2 ~Adrenergic receptors
A ctiva tion  o f oC2-adrenergic receptors e lic its  a va rie ty  o f 
inh iM tory and stim ulatory responses a t e ffe c to r ce lls in  the cen tra l 
nervous system and peripheral tissues (Graham & Lanier, 1986). In  
several tissues, the signal transduction mechanism u tilised  by th is 
receptor is  poorly defined (Isom & Lim bird, 1988; Bylund, 1988). 
A ctiva tion  o f -adrenergic receptors can in h ib it the stim ulation o f 
adenylate cyclase and lim it in tra ce llu la r cAMP concentrations (Bums & 
Langley, 1975; Jacobs e t aL, 1976; Cooper e t aL, 1979), and hence 
antagonise |3 -adrenergic receptor action (see 1.1.2.3). This e ffe c t is  
mediated by the G prote in , G  ^ (Bokoch e t aL, 1984; Katada e t aL, 
1984a,b,c). However th is pathway does not account fo r receptor-m ediated 
in h ib itio n  o f insu lin release (U llric h  & W ollheim, 1984; Nilsson e t aL, 
1988), depolarisation-induced neurotransm itter release (H irn in g  e t aL,
1988), o r smooth muscle contraction (Timmermans & van Zweiten, 1982; 
Graham & Lanier , 1986) produced by O ^-adrenergic receptor agonists. 
A lte rnative  transduction pathways have thus been proposed such as 
coupling to  an ion channel (H irn in g  e t aL, 1988) or activa tion  o f the 
Na+/H + exchanger (Sweatt e t aL, 1985; Isom e t aL, 1987; C antiallo & 
Lanier, 1989).
lik e  the OC ^ -adrenergic receptors, the O ^-adrenergic receptor 
class has been found to  possess subtypes. A t least three and possibly 
fou r O ^-adrenergic receptor subtypes are thought to  exist (c<2a>°^2B»
0C2q) based on pharm acological data, and the genes fo r th e G ^ - andO ^g- 
adrenergic receptors have been cloned (reviewed by Bylund, 1988).
f3 -  Adrenergic receptor stim ulation o f the membrane-bound enzyme
4adenylate cyclase is  w e ll established in  many tissues including the
heart (Murad e t aL, 1962), adipose tissue (Bimbaumer e t aL, 1969),
liv e r (M a rin e tti e t aL, 1969), lung (Benovic e t aL, 1984), and lym phoid
cells (Makman, 1971). There is  also evidence fo r yS -^-adrenergic receptor 
2+stim ulation o f Ca channels in  both the heart (Yatarri. e t aL, 1987) and 
ske le ta l muscle (Yatani e t aL, 1988). jS -Adrenergic receptors have 
become model systems fo r researchers studying the nature and regulation 
o f plasma membrane hormone and drug receptors, prim arily because they 
are present in  v irtu a lly  a ll mammalian tissues, and th e ir in tim a te  
coupling to  adenylate cyclase. Indeed, the y8 -adrenergic receptor- 
dependent adenylate cyclase was the firs t transmembrane signalling 
system to  be resolved in to  its  components and fu lly  reconstitu ted 
(reviewed in  Levitzki, 1985, 1988). Gg is  the G protein involved in  th is 
pathway (G ilm an, 1984, 1987). The activa tion  o f the Gs-adenylate cyclase 
system by agonist-occupied y8 -adrenergic receptor is  a ca ta ly tic  event, 
and the receptor is  no t perm anently associated w ith  the Gs-adenylate 
cyclase complex (Levitzki, 1988). Furtherm ore, f3 -adrenergic receptor 
activa tion  o f Gg does not appear to  require the presence o f adenylate 
cyclase (Levitzki, 1988).
Currently, three j3  -adrenergic receptor subtypes have been 
conclusively defined. £ l "  and j3 2-adrenergic receptors were o rig ina lly  
distinguished by Lands e t aL (1967). However, more recent studies 
suggest th a t yS-adrenergic receptors w ith  a typ ica l characteristics Le. 
no t conform ing to  theyS^- and ^ “ receptor classification, exist in  some 
tissues. In  the firs t instance, white (W ilson e t aL, 1984; Bojanic e t 
aL, 1985; Hollenga & Zaagsma, 1990) and brown (A rch e t aL, 1984) 
adipocytes were shown to  possess a typ ica l jS -adrenergic receptors.
5A -adrenergic receptors have also been proposed to  transduce
catecholam ine con tro l o f several m etabolic processes in  colon (McLaughlin 
& MacDonald, 1989) and ileum  (Blue e t aL, 1988; Bond & Clarke, 1988) 
smooth muscle, ske le ta l muscle (Challiss e t aL, 1988), and the heart 
(Kaumann, 1989). The existence o f a ^ -a d re n e rg ic  receptor subtype has 
been confirm ed w ith  the iso la tion  o f a human gene th a t encodes a th ird  
fS -adrenergic receptor (Emorine e t aL, 1989). The human ^ -a d re n e rg ic  
receptor shares some characteristics w ith  the ra t white adipocyte
adrenergic receptor, but appears not to  be id e n tica l (Zaagsma & Nahorski, 
1990). Therefore i t  is  very probable th a t m ore |8  -adrenergic receptor 
subtypes aw ait discovery.
Signal transduction in  th is system involves the sequential
due to  its  relevancy to  adipose tissue metabolism. Gg in te ractio n  w ith
I.I.3 .I. G proteins
About 80% o f a ll known hormones and neurotransm itters, as w e ll 
as many neuromodulators, autocrine and paracrine factors th a t regulate 
ce llu la r in teractions, are known to  e lic it ce llu la r responses by binding 
to  specific receptors which are coupled to  e ffe c to r systems by G 
proteins (reviewed by Graziano & Gilman, 1987; Bimbaumer e t aL, 1990). 
A ll G proteins are heterotrim ers composed ofC(> j8  and % subunits, which
Northup e t aL, 1980; H ildebrandt e t aL, 1984). I t  is  the G(-subunits 
Which bind and hydrolyse GTP, and define the receptor and e ffe c to r
1.1.3. 6 -Adrenergic receptor signal transduction
interactions o f -adrenergic receptor, Gg and adenylate cyclase and/or 
2+Ca channels. Only adenylate cyclase stim ulation w ill be discussed here
2+Car channels is  extensively reviewed in  Bimbaumer e t aL (1990).
dissociate upon activa tion in to  C(-suburiits
6sp e c ific ity  o f a G protein (Manning & Gilman, 1983). The stim ulatory 
e ffe c t o f Gs on adenylate cyclase is  mediated d ire c tly , and th is capacity 
is  thought to  reside in  GgoC (G ilm an, 1987). However, in te raction  o f j3 tf -  
dim ers w ith  e ffe c to r systems has no t been ru led out. Indeed a d ire c t 
in h ib ito ry  in te raction  o f -dim ers w ith  adenylate cyclase has been 
proposed (Katada e t aL, 1986); however th is  is  controversial (S m igel, 
1986; Bimbaumer e t aL, 1990). Therefore the active species is  presumed 
to  be GsoC.GTP.adenylate cyclase. This complex is  re la tive ly  long-lived  
(about 15 s), because o f the very slow ra te  o f GTP hydrolysis catalysed 
by the GgoC subunits (G ilm an, 1987). Upon GTP hydrolysis to  GDP, the 
complex dissociates and adenylate cyclase a c tiv ity  ceases (G ilm an, 1987). 
GSoc «GDP t i^en ^associates w ith  a jS ^-d im er to  form  a holo-G g prote in 
(H ildebrandt e t aL, 1984; Gilman, 1984). Ggoc subunits are also 
substrates fo r AD P-ribosylation by cholera toxin , which leads to  th e ir 
activa tion . ADP-ribosylation is  thought to  occur a t an arginine residue 
(Van Dop e t aL, 1984).
I.I.3 .2 . Adenylate cyclase
The prim ary mechanism fo r regulation o f the in tra ce llu la r 
concentration o f the second messenger adenosine 31,51 - monophosphate 
(cAMP) is  by modulation o f the a c tiv ity  o f adenylate cyclase. This 
enzyme catalyses the form ation o f cAMP from  in tra ce llu la r adenosine 
triphosphate (Sutherland e t aL, 1968). Adenylate cyclase has been shown 
to  exist in  m ultip le form s ranging in  m olecular weights from  120 kDa to  
150 kDa (P feu ffe r e t aL, 1985; Smigel, 1986). Recently, cDNAs encoding 
an adenylate cyclase were isolated (KrupdnskL e t aL, 1989). Analysis o f 
the deduced amino acid sequence reveals tw o a lternating sets o f 
hydrophobic and hydrophilic domains. Each o f the hydrophobic domains
7appears to  contain six transmembrane Ok-helices. The hydrophilic domains 
contain a sequence th a t is  homologous to  a single cytoplasm ic domain o f 
several guanylate cyclases, possibly a nucleotide binding a te . The 
predicted topography resembles th a t o f various plasma membrane ion  
channels and transporters. Therefore i t  is  possible th a t adenylate 
cyclase no t only synthesises cAMP, bu t also transports i t  from  the c e ll 
(Davoren, 1963). This process is  known to  occur in  the slim e mold 
D ictyostelium  discoideum, which synthesises cAMP and then exports i t  as 
an extrace llu la r signal fo r chemotaxis, aggregation and d iffe re n tia tio n  
(Gerisch, 1987). A ro le  fo r th is possible function o f adenylate cyclase 
in  higher eukaryotes is  no t obvious.
1.1.4. Physiological e ffects o f|8 -adrenergic receptor stim ulation
As stated ea rlie r, adrenergic receptors are found on most c e ll 
types. Therefore e ffects o f released adrenaline and noradrenaline are 
no t re stric ted  to  a specific tissue w ith in  the body (reviewed by 
Lefkow itz e t aL, 1984; Smigel e t aL, 1984). M ajor e ffects mediated by 
fS -adrenergic receptor stim ulation are: i)  stim ula tion o f adipocyte 
lipo lysis; ii)  stim ulation o f the ra te  and force o f cardiac contraction; 
i i i)  re laxation o f smooth muscle in  bronchi, blood vessels, and genito­
urinary and gastro intestinal tra cts ; iv ) increased glycogenolysis in  liv e r 
and muscle. In  contrast, O ^-adrenergic receptor activa tion antagonises 
many o f th e -a d re n e rg ic  receptor responses (Table 1.1). The number o f 
systems regulated by ^ -ad rene rg ic receptors causes many problems during 
the development o f therapeutic drugs acting via  adrenergic receptors. 
Major considerations in  the design o f such compounds are adrenergic 
receptor and tissue sp e c ific ity , because these factors are lik e ly  to  
determ ine the number o f unwanted side-effects.
81.2. P urifica tion  o fp  -adrenergic receptors
1.2.1. ligand-binding studies
Study o f the biochem ical properties o f any membrane-bound 
hormone o r drug receptor requires the a b ility  to  measure the receptor in  
membranes and solubilised o r pu rified  fractions. Successful measurement 
o f j3  -adrenergic receptors using d ire c t radioligand binding methods was 
achieved only in  1974. The in itia l ligands used were ( - ) -  
[^H ]dihydroalprenolol (Lefkow itz e t aL, 1974), ( ± ) - [ ^ ^ J i o d o h y d r o x y -  
benzylpindolol (Aurbach e t aL, 1974), and (+ )[^H ]propranolol (A tlas e t 
aL, 1974). Many more agonist and antagonist radioligands have
subsequently been developed (Burgisser & Lefkow itz, 1982). Since 1981, 
the preferred ligand has been (-)-[^% ]iodocyanop indo lo l because i t  
exhibits higher a ffin ity  and specific ra d io a ctiv ity  than the e a rlie r 
radioligands (Engel e t aL, 1981). These compounds are non-seiectLve in  
th e ir a ffin itie s  fo r jB 3-  and 2-adrenergic receptors (S tiles e t aL, 
1984b; Hussain e t aL, 1987). However, by displacing the binding o f 
such radioligands w ith  f$  -adrenergic antagonists, whose binding is  
specific fo r e ither j3  y  o r ^ 2 “ a<3rener§ ic receptors, i t  is  possible to 
quantify the number o f each ^ -adrenerg ic receptor subtype present in  a 
tissue (Minneman e t aL, 1981; De Lean e t aL, 1982). Such experim ents 
reveal th a t j2  and j3  2*-receptors often co -exist in  the same tissue 
(Minneman e t aL, 1981; Moore & W hifsett, 1981).
Some o f the radioligands have been m odified by addition o f a 
highly reactive azide m oieties, which upon irra d ia tio n  form  highly 
reactive nitrenes th a t can react covalently w ith  a va rie ty o f chem ical 
groups (Bayley & Staros, 1984). The resulting compounds are potent 
ph o to a ffin ity  labels fo r the B -adrenergic receptor, and have been used
9extensively to  id e n tify  receptors in  many tissues (Lefkow itz e t aL, 
1983; Burgerm eister e t aL, 1983).
1.2.2. P urifica tion  o f the -adrenergic, receptor
Successful pu rifica tio n  o f 3^ -adrenergic receptors from  several 
sources has been accomplished. These include receptors from  avian
(Shorr e t aL, 1981, 1982; Marbach & Levitzki, 1988), amphibian (Caron e t 
aL, 1979), and mammalian (Homey e t aL, 1983; Benovic e t aL, 1984; Cubero 
& Malbon, 1984; Graziano e t aL, 1985; Bahouth & Malbon, 1987) species. 
The use o f a ffin ity  chromatography appears to  be c ritic a l, in  p a rticu la r 
the u tilisa tio n  o f Sepharose-im mobilised alprenolol (Vauquelin e t aL, 
1977; Caron e t aL, 1979). A lprenolol is  a potent (K (j'V l-10  nM) non­
subtype selective fZ-adrenergic antagonist.
Plasma membranes have generally been solubilised w ith  d ig ilo n in  
(Hubbard, 1954), a p lant s te ro l isolated from  D ig ita lis  purpurea, since 
th is  detergent solubilises jS -adrenergic receptors in  a farm  pe rm itting  
th e ir subsequent in te raction  w ith  adrenergic ligands (Caron & Lefkow itz, 
1976; Caron e t aL, 1979). A ttem pts to  solubilise the receptors w ith  
other detergents including Lubrol PX (Haga e t aL, 1977), T riton  X-100 
(Fraser & Venter, 1982), Tween, chelate, and deoxycholate (Shorr e t aL, 
1985), have led to  com plete loss o f receptor-bdnding a c tiv ity . Recently, 
the detergent dodecyl-^S- D -  m altoside has been used to  solubilise and 
p u rify  the -adrenergic receptor (Tota & Strader, 1990). This synthetic 
detergent was preferred because o f the variable qua lity o f d ig iton in  
preparations.
A ffin ity  chromatography o f digitonm -solubdlised jS -adrenergic 
receptors on Sepharose-alprenolol gels leads to  a 100-1000 fo ld  
p u rifica tio n , depending on the exact m ethod used. E lution o f the
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receptors w ith  a concentration gradient o f antagonist was found to  be 8 
tim es more e ffic ie n t than a step e lu tion w ith  a single concentration 
(Benovic e t aL, 1984).
To pu rify  the yS-adrenergic receptor to  homogeneity requires 
additional techniques. By coupling repeated a ffin ity  chromatography to 
ion exchange (Shorr e t aL, 1981) o r ge l filtra tio n  (Homey e t aL, 1983), 
o r a ffin ity  chromatography and several high performance liqu id  
chromatography steps (Shorr e t aL, 1982; Cubero & Malbon, 1984; Benovic 
e t aL, 1984; Shorr e t aL, 1985; Graziano e t aL, 1985) the jS -adrenergic 
receptors from  several sources have been pu rified  to  homogeneity. 
Hydrophobic chromatography using heptylamine-Sepharose has also been 
used during the p u rifica tio n  o f human placenta ft y  and yS 2adrenerg ic 
receptors (Bahouth & Malbon, 1987). Im portantly, the pu rified  y3 -  
adrenergic receptors re ta in  the a ffin itie s  and specific ities o f 1 na tive ' 
receptors s t ill embedded in  plasma membranes (Shorr e t aL, 1981; Cubero 
& Malbon, 1984; Benovic e t aL, 1984; Graziano e t aL, 1985).
1.2.3. R econstitutional studies o f yff-adrenergic receptors
To study the a b ility  o f pu rified  y8  -adrenergic receptor to  
activa te  b io log ica l processes requires a reconstitu tion assay. The 
requirem ent fo r a lip id  membrane in  which the components o f the yS-  
adrenergic receptor-coupled adenylate cyclase system can in te ra c t is  
mandatory. In  fa c t, restoration o f the in te raction  between delipidated 
^-adrenerg ic receptor and Gs requires the addition o f a t least three 
specific phospholipids (B en-A rie e t aL, 1988). I t  is  lik e ly  th a t these 
added phospholipids substitute fo r the g lyco lip id  tig h tly  associated w ith  
the y3 -adrenergic receptor in  turkey erythrocytes (B ar-S inai e t aL, 1986). 
The coupling between the receptor and adenylate cyclase is  sensitive to
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detergent, and is  inh ib ited  a t detergent concentrations th a t are one- 
tenth o f those required to  in h ib it Gg and adenylate cyclase in te raction  
(Keenan e t aL, 1982). I t  remains to  be established whether gLycolipids 
play a ro le  in  the functiona l coupling between -adrenergic receptors 
and the components o f adenylate cyclase, o r have another ro le  such as 
receptor stab ilisa tion and maintainance w ith in  the lipid b ilayer. 
P alm itoylation o f cyste in e^^ residue in  human |3 2“ a^renerS^ c  receptor 
has been reported (0*Dowd e t aL, 1989). A non-palm itoylated form  o f the 
same receptor possessed drastica lly reduced ability to  mediate 
isoproterenol-stim ulation o f adenylate cyclase (O 'Dowd e t aL, 1980). 
Insertion o f the p a lm itic  acid in to  a lip id  b ilaye r may therefore be 
cru c ia l fo r norm al coupling.
Schramm e t aL (1977) pioneered reconstitu tion studies using 
re la tive ly  crude preparations o f j3 -adrenergic receptor, Gs and adenylate 
cyclase. Although some agonist-stim ulated accum ulation o f cyc lic  AMP 
was achieved, i t  was s t ill possible th a t im purites in  the preparations 
were involved in  signal transduction. Cerione e t aL (1984) were also 
plagued by im pure preparations o f adenylate cyclase, since they had to  
use an extract o f ra t brain. Later, reconstitu tion o f pure proteins in to  
unilam ellar vesicles showed th a t these three proteins are su ffic ie n t fo r 
the expression o f horm one-stim ulated adenylate cyclase (May e t aL, 
1985). U tilisa tion  o f such systems allows d ire c t evaluation o f the 
stoichiom etry and kinetics o f the reactions leading to  adenylate cyclase 
activa tion  follow ing hormone binding. Furtherm ore, such an approach 
allows de fin ition  o f the ro le  th a t the lip id  b ilaye r plays in  prom oting 
and modulating these in teractions.
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1.3. Properties o f the ^ -adrene rg ic receptor
1.3.1. Determ ination o f ^ -adrenerg ic receptor m olecular weights
The apparent m olecular weight o f f£ -adrenergic receptors has 
generally been measured using denaturing SDS PAGE, and appropriate 
protein standards. The m olecular weights o f pu rified  -receptor from  
many sources have been reported including those o f human placenta 
(1^=67 kDa)(Bahouth & Malbon, 1987); ra t adipocytes (Mr=67 kDa)(Cubero & 
Malbon, 1984); ham ster lung (Mr=64 kDa)(Benovic e t aL, 1984); ra t liv e r 
(Mr =67 kDa)(Graziano e t aL, 1985); guinea-pig lung (Mr=67 kDa)(Drake & 
Perkins, 1984), and S49 mouse lymphoma ce lls (Mr=67 kDa)(George & 
Malbon, 1985). The canine lung ^ 2“ a<^ renerg^ c  receptor has a m olecular 
weight o f 52-53 kDa (Homey e t aL, 1983), and appears to  be sm aller than 
most mammalianyS-adrenergic receptors, as is  the frog e ryth rocyte^ 2“  
adrenergic receptor (Mr =58 kDa)(Shorr e t aL, 1982).
The nature o f j5  -adrenergic receptors investigated by 
pho toa ffin ity-labe lling  in  mammalian lung is  even more diverse. /3 -  
Adrenergic receptors studied using th is technique have suggested 
m olecular weights o f 64 kDa in  ham ster lung (Benovic e t aL, 1983); 50- 
55 kDa in  canine lung (Homey e t aL, 1983); 59 kDa in  bovine lung (Fraser 
& Venter, 1982); 64 kDa in  sheep and pig lung (J. L. Benovic, personal 
com m unication), and 64 kDa, 53 kDa and 44 kDa in  ra t lung (Rashibaigi e t 
aL, 1983). Other ^-adrenerg ic receptors characterised by p h o to a ffin ity - 
labeUing include those o f human placenta (Mrs=65-67 kDa)(Bahouth & 
Malbon, 1987; Emorine e t aL, 1989); human A431 ce lls (Mr =65 kD a)(Kaveri. 
e t aL, 1987); S49 mouse lymphoma cells (Mr =65 kDa and 55 kDa)(Rashibaigi 
e t aL, 1983), (Mr =67 kDa)(Cubero e t aL, 1983); human, canine, porcine, 
ra b b it, frog , and ra t ven tric le  (Mr =62 kD a)(S tiles e t aL, 1983). There
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appears to  be lit t le  d ifference in  the m olecular weights o f the three 
human^S-adrenergic receptor subtypes (Bahouth & Malbon, 1987; Emorine e t 
aL, 1989).
P hotoaffim ty-labelling o f avian erythrocyte /3  ^ -adrenergic 
receptors id e n tifie d  receptors w ith  m olecular weights o f 48 kDa and 45 
kDa in  duck (Dickinson & Nahorski, 1981; Rashibaigi & Ruoho, 1982); 52 
kDa and 45 kDa in  pigeon (RashibaigL & Ruoho, 1982); 45 kDa and 40 kDa 
in  turkey (Lavin e t aL, 1981; Shorr e t aL, 1982). The turkey 
erythrocyte ^-adrenerg ic receptor consists o f two d is tin c t form s, which 
although d iffe rin g  in  m olecular weight, show v irtu a lly  id e n tica l ligand- 
binding properties typ ica l o f a ^ -a d re n e rg ic  receptor (Shorr e t aL, 
1982). In  contrast, m olecular heterogeneity sometimes observed during 
pho toa ffin ity-labe lling  o f other /S -adrenergic receptors is  due 
predom inantly to  proteolysis, pa rticu la rly  by metal-dependent proteases 
(Benovic e t aL, 1984b).
A dditional studies perform ed using less invasive techniques have 
suggested th a t -adrenergic receptors may dim erise in  membranes. 
Target-size inactiva tion  studies o ff!$-adrenergic receptors in  mammalian 
lung indicates a functiona l m olecular weight fo r the binding m oiety in  
s itu  o f about 110 kDa (Fraser & Venter, 1982). The pu rified  
adrenergic receptor from  ra t liv e r and the -adrenergic receptor from  
ra t adipocyte both m igrate on s te ric  exclusion HPLC in  two discrete 
form s, w ith  molecular weights o f 140 kDa and 67 kDa (Graziano e t aL, 
1985). Also, studies o f the hydrodynamic properties o f fS -adrenergic 
receptors in  extracts from  dig itonin-solubilised membranes suggest a 
native receptor m olecular weight ranging from  130 kDa-160 kDa (Homey e t 
aL, 1983; Haga e t aL, 1977; Caron & Lefkow itz, 1976). However, Shorr e t
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aL (1984) concluded th a t i t  is  not the dim er bu t the monomeric form  o f 
the £ -adrenergic receptor which demonstrates specific ligand binding.
Im munoblottdng against membranes using antisera specific fo r ^ S- 
adrenergic receptors has confirm ed the m olecular weights fo r many 
receptors. These include the jS-adrenergic receptors from  human placenta 
(Mr =67 kDa)(Bahouth & Malbon, 1987); human A431 ce lls ^£ *6 5  kD a)(Kaveri 
e t aL, 1987), (55 kDa)(G uil1et e t aL, 1985); S49 mouse lymphoma ce lls 
(Mr “ 65 kDa)(Wang e t aL, 1989<^;rat adipocyte (Mr ss67 kDa)(Moxham & 
Malbon, 1985; Moxham e t aL, 1986); and turkey erythrocyte (Mr as42 
kDa)(Chapot e t aL, 1989). Therefore the apparent m olecular weight o f jS - 
adrenergic receptors determ ined by SDS PAGE appears to  be unaffected by 
ph o toa ffin ity-labe lling .
1.3.2. S tructure o f the jS -adrenergic receptor
I.3 .2 .I. Cloning o f -adrenergic receptors
The ^ -a d re n e rg ic  receptor cDNA and/or gene from  ham ster (D ixon 
e t aL, 1986), human (Kobdlka e t aL, 1987a; Emodne e t aL, 1987), and 
mouse (Nakada e t'a L ,' 1989), the human {2^-adrenergic receptor cDNA 
(Frdelle e t aL, 1987), the ra t jg^-adrenergic receptor gene (M achida e t 
aL, 1990), and the human ^-a d re n e rg ic  receptor (Emodne e t aL, 1989) 
have been cloned and sequenced. In  addition, ^ S-adrenergic receptor cD N As 
which have no t been expressed and characterised, have been isolated from  
turkey erythrocyte (Yarden e t aL, 1986), human brain (Chung e t aL,
1987), and ra t heart (Gocayne e t aL, 1987). Data from  genomic Southern 
b lo t and gene dosage analyses indicates th a t jS -adrenergic receptor genes 
are single copy genes w ith in the genome. The chromosomal organisation 
o f the genes encoding adrenergic receptors has also been determ ined. 
Human 0(2*  and ^ -a d re n e rg ic  receptor genes are located on chromosome
15
10, while 0( j-  and ^ 2“ a^rener^ c receptor genes are on chromosome 5 
(Yang-Feng e t aL, 1990).
While the genes encoding these ft -adrenergic receptors are 
d is tin c t and intronless, they are quite homologous and are members o f 
the growing fam ily  o f cloned G protein-coupled receptors, which share 
many s tru ctu ra l features (DoKLman e t aL, 1987b). This fam ily  also 
contains the oc-j-adrenergic receptor (Cotecchia e t aL, 1988), °^2~
adrenergic receptor (Kobdlka e t aL, 1987b; Regan e t aL, 1988; Lomasney 
e t aL, 1990), muscarinic cholinergic (Kubo e t aL, 1986a,b; Peralta e t aL, 
1987; Bonner e t aL, 1987), serotonin (Julius e t aL, 1988; Fargin e t aL,
1988), angiotensin H  (Jackson e t aL, 1988), substance K (Masu e t aL, 
1987), lutropdn-choriogonadotropin and thyrotrop in  (Lomasney e t aL, 
1990), and dopaminergic (G iros e t aL, 1989; Monsma, J r e t aL, 1989) 
receptors, as w e ll as the opsins (Nathans e t aL, 1986).
I.3 .2 .2 . Topography o f the jS -adrenergic receptor
The recent cloning o f the genes o r cDNAs encoding the three /§ - 
adrenergic receptor subtypes has revealed the prim ary structure o f these 
G -protein-linked receptors. Perhaps the most s trik ing  s im ila rity  in  the 
topography o f a ll these receptor proteins is  th a t each contains seven 
regions o f 20-28 hydrophobic amino acids, postulated to be membrane- 
spanning oC-helices. Hydropathdcity analysis o f the prim ary amino acid 
sequence using the method o f Kyte & D oo little  (1982) yields rem arkably 
s im ila r p ro files (Kubo e t aL, 1986a,b; Dohlman e t aL, 1987b). Each o f 
the transmembrane oC-helices is  proposed to  be linked w ith  hydrophilic 
loops exposed (a lte rna te ly) in tra ce llu la rly  and extracelM ady (Dohlman 
e t aL, 1987b). This arrangement bears great s tru c tu ra l homology to  the 
model o rig ina lly proposed fo r bacteriorhodopsin, the purple membrane
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prote in o f Halobacterium halobmm. The presence o f a bundle o f
transmembrane helices in  th is protein has been established by high 
resolution electron d iffra c tio n  (Henderson & Unwin, 1975). An analogous 
arrangement in  the photoreceptor pigm ent rhodopsin is  supported by a 
va rie ty  o f spectroscopic techniques (Applebury & Hargrave, 1987).
Receptor subtypes exh ib it the greatest degree o f homology w ith in  
the proposed transmembrane regions, w ith  the hydrophilic loop regions 
being more divergent (D ixon e t aL, 1986; Dohlman e t aL, 1987b). The 
am ino-term inal region is  exposed on the extrace llu la r face o f the
membrane, w hilst the carboxyl te rm ina l region is  cytoplasm ic. Studies 
using site -d irected  anti-peptide antibodies support th is hypothetica l 
topography (Wang e t aL, 1989c). Average m olecular weights fo r 
polypeptides encoded by the cloned genes o f -adrenergic receptor
subtypes are 51 kDa (466-483 amino acids), 46 kDa (413-421 amino 
acids) and 43 kDa (402 amino acids) fo r and f t 3  adrenergic
receptors, respectively. ^-adrenergic receptors are therefore composed 
o f la rger polypeptide chains compared to  ^ 2"  an<^  ^ 3-adrenergic 
receptors, p rim arily  due to  the presence o f a la rger th ird  in tra ce llu la r 
loop and longer cytoplasm ic ta il (c f. Kobdlka e t aL, 1987b; F rie lle  e t 
aL, 1988).
Note: In  the fo llow ing sections, reference to  results obtained using the
technique o f s ite -d irected mutagenesis w ill be made. I t  should be made 
clear th a t although the specific changes made to  the prim ary amino acid 
sequence o f f$-adrenergic receptors using th is technique are o ften sm all, 
they can a ffe c t protein tra ffic k in g  and fo ld ing. Therefore the presence 
o f a rtifa c ts  in  the resu lts obtained cannot be ruled out due to  non­
specific e ffects o f the mutations.
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I.3 .2 .3 . G lycosylation
G -p ro te in -linked receptors are glycoproteins, w ith  the jS -  
adrenergic receptor in  pa rticu la r containing both complex and high 
mannose type oligosaccharides (Boege e t aL, 1988), accounting fo r about 
quarter o f its  native m olecular weight. A ll o f these receptors whose 
prim ary amino acid sequence is  known, possess 1-3 concensus sites fo r 
N -linked glycosylation (v ia  asparagine residues) near the extrace llu la r 
am ino-term inal (Dohlman e t aL, 1987b). S ite-d irected mutagenesis o f the 
5^-adrenergic receptor has demonstrated th a t these am ino-term inal sites 
are glycosylated in  the w ild -type  receptor (Rands e t aL, 1990).
This glycosylation causes anomalous m igration o f jS -adrenergic 
receptors on polyacrylam ide gels (Benovic e t aL, 1984), w h ils t 
agLycoprotein receptors resolve w e ll w ith  reduced m olecular weights 
(Boege e t aL, 1988). G lycosylation o f the -adrenergic receptor does 
no t appear to  be essential fo r ligand bonding. When pu rified  ^5- 
adrenergic receptor was treated w ith  endogLycosidases to  remove the 
sugar residues, no changes in  the ligand banding properties o f the 
receptor were noted (S tiles e t aL, 1984b; Dohlman e t aL, 1987a; Benovic 
e t aL, 1987d). In  ce lls treated w ith  turdcam ycin, a glycosylation 
in h ib ito r, a low ering o f coupling e ffic iency o f the £ -adrenergic receptor 
to  Gs was seen, bu t no e ffe c t on yS-adrenergic receptor expression a t the 
c e ll surface was observed (George e t aL, 1986; Boege e t aL, 1988). In  
contast, Rands e t aL (1990) found th a t in  ^3-adrenergic receptor mutants 
(created by site -d irected  mutagenesis) lacking concensus sites fo r 
glycosylation, and hence lacking oligosaccharides, were fu lly  capable o f 
coupling to  Gs and stim ulating adenylate cyclase. In  additio n , they 
found th a t glycosylation was im portant fo r co rrect tra ffic k in g  o f the jg -
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adrenergic receptor through the c e ll to  the plasma membrane. I t  is  
therefore passible th a t the e ffects o f tunica my cin were not mediated by 
in h ib itio n  o f glycosylation o f the receptor.
I.3 .2 .4 . ligand  binding domain
Many studies have suggested th a t the ligand binding domain o f 
the ^-adrenerg ic receptor is  located w ith in  a protein domain embedded in  
the phospholipid b ilayer, and involves parts o f the seven putative 
transmembrane ©C-helices. S ite-d irected mutagenesis o f cloned /3 -
adrenergic receptor genes has been used extensively to  id e n tify  
sequences and amino acid residues required fo r ligand binding. Deletion 
o f any o f the transmembrane helices o r o f regions predicted to  form  
junctions between trans membrane helices and extrace llu la r loops results 
in  a ltered protein fo ld ing (D ixon e t aL, 1987a). However, most o f the 
hydrophilic loops o f the |8 -adrenergic receptor can be deleted w ithout 
a ffecting  the structure o r the ligand binding characteristics o f the 
receptor (D ixon e t aL, 1987a). Therefore regions in  the hydrophobic 
core o f the jg -adrenergic receptor are im plicated in  form ing the ligand 
binding domain.
Analysis o f chim e ric  c ^ /^ -a d re n e rg ic  receptors indicates th a t 
helices 1-5 influence agonist sp e c ific ity  between 0C2 and @ 2  receptors, 
bu t no t antagonist sp e c ific ity  to  any great degree (Kobdlka e t aL, 1988). 
Also he lix  7 is  the major determ inant o f o(2 and agonist and 
antagonist binding character (Kobdlka e t aL, 1988). Only helices 6 and 7 
o f the 2~ack‘energic  receptor are required to  confer binding
characteristics on the chim eric c* 2/f e ” a<^ enerS^:' receptor, however alone 
they were no t capable o f banding ligands o r activa ting  adenylate cyclase 
(Kobdlka e t aL, 1988).
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Chimeric /S a d re n e rg ic  receptors were used to  define 
structures which confer j3 -subtype-selective ligand binding properties. 
H elix 4 was found to  determ ine j3 ^ versus 2 agonist binding 
characteristics i-e . a chim eric receptor containing he lix  4 from  the f$^- 
adrenergic receptor possesses ligand binding properties, and vice 
versa (F rie lle  e t aL, 1988). In  contrast, helices 6 and 7 were found to  
be im portant fo r p± versus ^2  antagonist binding (F rie lle  e t aL, 1988).
The amino acid residue a sp a rta te *^ (A sp ^*^ w ith in  he lix  3 is  
essential fo r the binding o f both agonists and antagonists to  the jS- 
adrenergic receptor (S trader e t aL, 1987c, 1988). This negatively 
charged residue is  presumed to  band the protonated amino group o f the 
catecholam ine, as a counter-ion. Substitution o f A sp ^^ w ith  a 
glutam ate residue results in  a m utant ft  -adrenergic receptor which 
recognises several w e ll characterised jg-adrenergic antagonists as p a rtia l 
agonists (S trader e t aL, 1989a). This phenomenon requires the presence 
o f a carboxylate side-chain on the am ino-acid a t position 113, and is  
no t observed when asparagine is  situated a t th is  location (S trader e t 
aL, 1989a). These observations suggest the overlapping o f binding sites
fo r agonists and antagonists on the ^-adrenergic receptor.
79Substitution o f Asp in  he lix  2 results in  a 10-fo ld decrease in  
the a ffin ity  o f the receptor fo r agonists, bu t produced no change in  the 
antagonist binding properties o f the receptor, and may therefore be a 
specific counterion fo r agonists (Strader e t aL, 1988). Substitution o f 
the highly conserved Asp residue w ith  asparagine in  h e lix  3 results 
in  a m utant ft -adrenergic receptor w ith  norm al antagonist binding, bu t 
unusually h ig h -a ffin ity  agonist binding (Fraser e t aL, 1988). In  
addition, the m utant receptor: i)  couples to  Gg; ii)  possesses an a ffin ity
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fo r agonist which is  less sensitive to  guanine nucleotides re la tive  to 
w ild -type  ft  -adrenergic receptor; i i i)  is  unable to  mediate isoproterenol- 
stirn illa tio n  o f adenylate cyclase. This data coupled to  previous findings 
(Chung e t aL, 1988) suggests the existence o f tw o d is tin c t counterions 
fo r the amine portion o f catecholamines (Le. aspartate 79 and 130), th a t 
are associated w ith  high and low a ffin ity  agonist binding states 
adrenergic receptors.
S true tu re -activ ity  mapping o f adrenergic ligands indicates the 
necessity o f s tru c tu ra l components, other than the amino group, fo r 
op tim al receptor binding. Most im portantly, yS -adrenergic agonist 
a c tiv ity  depends on the presence o f a catechol ring , which m ight in te ra c t 
w ith  amino acid side-chams w ith in  the ligand binding domain via  
hydrogen bonding and hydrophobic in teractions (B ilezikian e t aL, 1978a,b; 
Main & Tucker, 1985). S ite-d irected mutagenesis was again used to  
investigate the m olecular basis fo r these putative in teractions. 
Substitution o f residues se rin e ^^ (S e r^^ ) and S e r^  in  he lix  5, and 
Ser319 in  he lix 7 w ith  alanine residues, a ffects agonist bu t not 
antagonist binding to  the jS -adrenergic receptor (D ixon e t aL, 1989; 
Strader e t aL, 1989a). In teresting ly, substitution o f S e r^^  resulted in  
abnorm ally folded receptor protein, whereas replacem ent o f the adjacent 
S e r^^  residue did no t (S trader e t aL, 1989a). Thus hydrogen bonding 
in teractions involving hydroxyl amino acid side-chains, may be essential 
fo r maintainance o f -adrenergic receptor secondary o r te rtia ry  
structure.
Two conserved phenylalanine residues a t positions 289 and 290 in  
h e lix  6, and also tyrosine in  he lix 7, appear to  be c ritic a l fo r 
agonist binding, possibly through hydrophobic in teractions (D ixon e t aL,
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1989). In  summary, the present data suggests th a t residues located in
helices 5, 6 and 7 are involved in  binding the catechol ring  o f agonists
to  the |3-adrenergic receptor (Strader e t aL, 1989b). In  addition, the
ligand is  anchored to  the receptor by an ion ic in te raction  between the
113carboxylate side-chain o f Asp on he lix  3 and the amino group o f the,
ligand. These findings are consistent w ith  the ligand binding domain
being located w ith in  the hydrophobic trans membrane domain o f the jS -
adrenergic receptor.
To corroborate findings from  s ite -d irected  mutagenesis studies,
ph o ta ffin ity -la b e llin g  experiments were perform ed to  determ ine sites o f
incorporation fo r various pho toa ffin ity  probes. Treatm ent o f the £ 2“
adrenergic receptor w ith  p-(bro  m oace tam M o)benzyl-l-[^^]iodocarazo lo l
results in  the labelling o f a region o f 14 amino acids located in  h e lix
2 (Dohlman e t aL, 1988). U nfortunately the m odified amino acid residue
could not be determ ined. In  a separate study, the sites o f covalent
labe lling  o f pu rified  turkey eryrthrocyte jg^-adrenergic receptor by the
p h o to a ffin ity  labels ^l}iodocy anopindolol-diazirine (ICYPD) and
[^^Jiodoazidobenzylp indolol (IABP) were determ ined (Wong e t aL, 1988).
Both labels incorporate a t two separate sites. One s ite  is  located a t 
330tryptophan JU in  the extrace llu la r h a lf o f h e lix  7, w h ilst the other was 
less w e ll defined being located in  helices 3, 4 o r 5 o r in  the firs t o r 
second extrace llu la r loop (Wong e t aL, 1988). This data suggests th a t 
the catecholam ine binding s ite  o f the f3 -adrenergic receptor is  form ed by 
juxtaposed membrane spanning helices, d istant from  each other in  the 
prim ary amino acid sequence.
The binding s ite  fo r re tin o l in  rhodopsin has been b e tte r defined 
by a com bination o f spectroscopic and biochem ical studies (fo r review
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see Findlay & Pappdn, 1986). R etinol is  covalently bound to  a ly s y l 
residue in  he lix  7 ly ing  halfw ay through the lip id  b ilayer, a position 
homologous to  Trp330 Xafoejied w ith  the ph o to a ffin ity  labels ICYP and 
IABP. Therefore some homology in  secondary and te rtia ry  structure 
appears to  exist between rhodopsin and jS-adrenergic receptors.
The arrangem ent o f the helices may be d icta ted  by 
in teractions o f various amino acid side-chains, as w e ll as the possible 
form ation o f disulphide bonds, shown to  be essential fo r ligand binding 
in  the ra t adipocyte -adrenergic receptor (Moxham & Malbon, 1985). The 
more hydrophobic residues o f these oC-helices may form  a boundary w ith  
the plasma membrane, while the less hydrophobic amino acids p ro ject 
towards the in te rio r o f the protein. Juxtaposed helices have probably 
evolved in  such a way as to  m inim ise s te ric  and e lectrosta tic forces 
between each other. The precise orthogonal arrangement o f the pu tative 
seven membrane-spanning helices in  the f t  -adrenergic receptor is  s t ill 
unclear. They may be arranged in  a c ircu la r orientation, w ith  helices 1 
and 7 being adjacent in  the membrane. A lte rn a tive ly, recent data from  
the study o f chim eric -adrenergic receptors suggests th a t the 
arrangement may be akin to  the number 6, w ith  helices 1 and 2 form ing 
the ta il (F rie lle  e t aL, 1988; Kobdlka e t aL, 1988). Spectroscopic 
analysis o f pu rified  j6 -adrenergic receptor is  probably required to  solve 
th is unknown.
I.3 .2 .5 . Interactions w ith  G proteins
A ctiva tion  o f adenylate cyclase by agonist-stim ulated j3 -  
adrenergic receptor is  mediated by the guanine nucleotide-binding 
protein , Gg (G ilm an, 1984). In teraction o f receptor and Gs presumably 
occurs a t the cytoplasm ic surface o f the plasma membrane, where Gg is
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located. A lignm ent o f available amino acid sequences fo r G p ro te in - 
linked receptors reveals s trik in g  homologies in  the regions predicted to  
be located a t the cytoplasm ic surface o f the plasma membrane (O 'Dowd e t 
aL, 1988). These regions in  tu rn , d iffe r most in  th e ir C -te rm ina l 
regions and th e ir th ird  putative in tra ce llu la r loops (D ixon e t aL, 1987). 
The in tra ce llu la r location o f these structures has been confirm ed by 
in d ire c t immunofluorescence and a CHO c e ll lin e  expressing a high le ve l 
o f ^ -a d re n e rg ic  receptor (Wang e t aL, 1989).
D eletion o f residues 239-272 in  the th ird  in tra ce llu la r loop o f 
^ “ adrenergic receptors results in  the loss o f adenylate cyclase coupling 
(D ixon e t aL, 1987). This region is  therefore c ritic a l fo r the coupling 
o f receptor to  Gs. The lack o f adenylate cyclase stim ulation may be a 
re su lt o f elim ination o f a s ite  on the receptor fo r G prote in 
in te ractio n , o r d istruption o f the receptors secondary and/or te rtia ry  
structure . Further analysis o f th is region suggests -that regions o f the 
£ -adrenergic receptor encompassing amino acids 222-229 and 258-270, are 
absolutely required fo r adenylate cyclase activa tion  to  occur (S trader e t 
aL, 1987a). This has subsequently been confirm ed in  studies using m utant 
receptors expressed in  fro g  oocytes (O 'Dowd e t aL, 1988). The ce n tra l 
region o f the th ird  in tra ce llu la r loop does no t a ffe c t receptor-adenylate 
cyclase coupling (D ixon e t aL, 1987).
The regions o f prote in encompassing these im portant deletions 
are predicted to  form  am phipathic OC-helices in  solution (Cheung e t aL, 
1989). Mastoparan, a 14-am ino acid peptide toxin  isolated from  wasp 
venom, stim ulates guanine nucleotide binding and hydrolysis by some G 
proteins (HigashLjima e t aL, 1988, 1990). Mastoparan is  predicted to  
form  an am phipathic oC-helix in  solution, and in te racts w ith  the carboxyl
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te rm ina l o f the oc subunit o f (W eingarten e t aL, 1990). I t  is  
therefore possible th a t activa tion  o f Gg by the p -adrenergic receptor 
involves a s im ila r in te raction  w ith  am phipathic helices in  the th ird  
in tra ce llu la r loop, presumably exposed upon conform ational changes 
induced by agonist binding. The analogous region in  the ^ -a d re n e rg ic  
receptor which in te racts w ith  G ,^ is  also predicted to  form  an 
am phipathic oC-helix in  which positive ly charged amino acid residues are 
conserved w ith  respect to  the ^J-adrenergic receptor, but w ith  d iffe re n t 
hydrophobic residues (Kotdlka e t aL, 1987c).
Substitution o f the amino term ina l region o f the th ird  
in tra ce llu la r loop o f the ^-adrenerg ic receptor w ith  the corresponding 
region o f the ^ -a d re n e rg ic  receptor does no t a lte r the sp e c ific ity  o f 
in te raction  w ith  G proteins (O 'Dowd e t aL, 1988), however its  deletion 
removes G protein coupling (D ixon e t aL, 1989). These findings suggest 
th a t th is  region o f the receptor is  involved w ith  G protein coupling, bu t 
th a t the spe c ific ity  o f a receptor fo r a pa rticu la r G prote in  lie s  
elsewhere in  the prim ary sequence. Replacement o f the en tire  th ird  
in tra ce llu la r loop and adjacent helices (5 and 6) o f the ^ -a d re n e rg ic  
receptor w ith  the equivalent region o f the ^ 2 " a^rener&£' receptor, 
results in  a sm all agonist-induced stim ulation o f adenylate cyclase by 
the chim eric receptor (Kotdlka e t aL, 1988). Therefore some sp e c ific ity  
o f coupling to  Gs and G  ^ appears to  be located in  th is  region.
Some single residue substitutions o f the firs t and second 
in tra ce llu la r loops re su lt in  the attenuation o f adenylate cyclase 
stim ulation by mutant -adrenergic receptors (Kotdlka e t aL, 1987b; 
O'Dowd e t aL, 1988; Fraser e t aL, 1988). In  particu la r, substitution o f 
the conserved proline a t position 138 leads to  s ign ifican t im pairm ent in
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the a b ility  o f the m utant receptor to  mediate isoproterenol stim u la tion 
o f adenylate cyclase, bu t has no e ffe c t on agonist binding properties 
(0*Dowd e t aL, 1988). I t  is  postulated th a t the unique j&ysicochem ical 
characteristics o f proline ( 8^ bend) may be c ritic a l fo r proper alignm ent 
o f other regions o f the prote in th a t pa rtic ipa te  more d ire c tly  in  
receptor-G s coupling. The second in tra ce llu la r loop does no t appear to  
confer specif ic ity o f G prote in coupling on the receptor, as substitution 
o f th is  loop by the analogous region o f the M j-m uscarinic cholinergic 
receptor, results in  fu ll stim ulation o f adenylate cyclase (D ixon e t aL,
1989). Analysis o f th is  region by deletion mutagenesis has been 
unsuccessful because o f in co rrect protein fo ld ing  caused by the 
deletions (D ixon e t aL, 1987; Kobilka e t aL, 1987h).
F ina lly, regions o f the carboxyl ta il have been im plica ted in  
in teractions between /3 -adrenergic receptors and Gs. The N -te rm ina l 
segment o f the cytoplasm ic domain a t the cytoplasm ic end o f h e lix  7 is  
c ritic a l fo r e ffic ie n t coupling o f receptors to  G proteins (HigashdjjLma 
e t aL, 1988; Dixon e t aL, 1989), and can account fo r some sp e c ific ity  o f 
in te raction  (O 'Dowd e t aL, 1988). Also substitution o f a conserved 
cysteine residue (C y s ^ -) in  the cytoplasm ic ta il, causes a marked 
im pairm ent in  the m utant receptor's a b ility  to  mediate isoproterenol 
stim ula tion o f adenylate cyclase (O 'Dowd e t aL, 1988). In  rhodopsin, 
th is cysteine residue has been shown to  be involved in  an in tram olecu lar 
disulphide bridge (A l-Saleh e t aL, 1987), although th is may be an 
experim ental a rte fa c t since disulphide bridges ra re ly  e x is t in  
in tra ce llu la r proteins due to  high concentrations o f the reducing agent 
glutathione. Also in  both rhodopsin (Ouchinnikov e t aL, 1988) and the 
human j3 2_adrenergic receptor (O 'Dowd e t aL, 1989), C y s ^ - is
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palm itoylated, again suggesting th a t th is  residue is  no t p a rt o f a 
disulphide bridge in  the native receptor. M utation o f C y s '^  to  G ly ^^  
re  moves the s ite  o f th ioeste rifica tion , and results in  a non- 
palm itoylated mutant -adrenergic receptor w ith  drastica lly reduced 
a b ility  to  mediate isoproterenol-stim uLation o f adenylate cyclase (0*Dowd 
e t aL, 1989). Therefore modif ication o f 6^ -adrenergic receptor by 
pa lm itate may play a crucia l ro le  in  the norm al coupling o f receptor to  
adenylate cyclase, perhaps via  insertion o f the pa lm itate m oiety in to  the 
plasma membrane.
1.4. Regulation o f $  -adrenergic receptor number and expression
Many factors are thought to  determ ine the |3-adrenergic receptor 
complement o f a celL Perhaps the most w idely investigated is  ^3- 
adrenergic receptor desensitisation, which w ill be discussed la te r. 
Other studies have looked a t d iffe re n t physiological states and non­
catecholam ine hormones to  see i f  they a lte r and regulate ^-adrenerg ic 
receptor densities, respectively.
1.4.1. Regulation in  adipose tissue
Lactation modifies the responsiveness o f adipocytes to  
catecholamines in  ra ts (Vernon & F inley, 1986), sheep (Guesnet e t aL, 
1987) and ca ttle  (Jaster & Wegner, 1981). In  c a ttle  (Jaster & Wegner, 
1981) and ra ts (W att e t aL, 1990b), lacta tion  produces an increase in  
the number o f ^ -adrenerg ic receptors in  adipocytes. Growth hormone has 
been im plicated in  these changes in  both sheep (W att e t aL, 1990a) and 
ra ts (W att e t aL, 1990b). Fasting also increases the number o f jS - 
adrenergic receptors in  ra t adipocytes, w ith  no change in  receptor 
a ffin ity  (G iu d ice lli e t aL, 1982).
Some steroid hormones exert profound e ffects on adipose tissue
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^-adrenergic receptor number (reviewed by GiudiceUi e t aL, 1989). 
Adrenalectomy results in  decreased lip o ly tic  responses to  catecholamines 
in  ra t adipocytes (Schonhofer e t aL, 1972; Fernandez & Saggerson, 1978), 
which is  p a rtly  due to  a decrease in  |8 -adrenergic receptor number 
(Mazancourt e t aL, 1990). Dexamethasone has been shown to  correct 
these changes in  ra ts  (Mazancourt e t aL, 1990) and have a perm issive 
action on catecholam ine-induced lipo lysis (Lacasa e t aL, 1988). 
E stradiol has no e ffe c t on yg-adrenergic receptors in  ham ster adipocytes 
(Pequery e t aL, 1986).
In  the ra t adipocyte, thyro id  hormones do no t a lte r p -adrenergic 
receptor number (Malbon e t aL, 1978). However, in  human g lu tea l 
adipocytes, hyperthyroidism  s lig h tly  increases jS -adrenergic receptor 
number, whereas hypothyroidism  results in  a 50% reduction o f -receptors 
(Richelsen & Sorensen, 1987). Thyroid hormones also exert e ffects on/S - 
adrenergic receptor density in  many other tissues including heart, liv e r, 
lung, muscle and lym phocytes (B ilezildan & Loeb, 1983).
I t  therefore appears th a t a va rie ty o f physiological processes 
govern basal -adrenergic receptor expression a t the c e ll surface.
1.4.2. D iffe re n tia l regulation o f ^ - j-  a n d ^2" a(^ ner%*c  receptors
In  lig h t o f the fa c t th a t the genes encoding f3  -adrenergic 
receptor subtypes are d is tin c t, there is  the possib ility th a t the genes 
may be d iffe re n tia lly  regulated. Indeed, d iffe re n tia l regulation o f 
and 2- adrenergic receptors by glucocorticoids (L a i e t aL, 1982; Nakada 
e t aL, 1987) and sodium butyrate (Stadel e t aL, 1987) has been shown in  
3T3-L1 preadipocytes. These effects are thought to  re su lt from  
activa tion  o f the ^ 2“ a^renerS^ c  receptor gene by these agents. A 
s im ila r phenomenon occurs in  the cen tra l nervous system where the a n ti­
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depressant desipdramine do wn-reguLates ft  ^-adrenergic receptor in  ra t 
cerebral cortex (Beer e t aL, 1987). In  the same study (±)-clenbutero l 
p re fe ren tia lly  down-regulated ft 2~adrenergic receptors. D iffe ren tia tion  
o f 3T3-L1 fibroblasts to  adipocytes is  associated w ith  a 3 -fo ld  increase 
in  ^ -a d re n e rg ic  receptor mRNA levels, while -adrenergic receptor mRNA 
levels increase up to  day 2, then decline the rea fte r (Guest e t aL, 1990). 
This e ffe c t has also been shown in  3T3-F442A ce lls (Feve e t aL, 1990). 
Therefore d iffe re n tia tio n  alone promotes the up-regulation o f the 
receptor transcripts and down-regulation o f the f t  ^ -recep tor transcrip ts 
in  th is  c e ll type. D iffe re n tia l down-regulation o f f t  ^  and ^ 2“ ac^renerS^ c 
receptor mRNAs is  also observed in  C6 gliom a ce lls (Hough & Chuang,
1990). The mechanisms involved in  th is regulation are not known.
G lucocorticoids (e.g. dexamethasone) up-reguLate the f t  2~ 
adrenergic receptor mRNA. f t 2” Adrenergic receptor expression and mRNA 
levels increase in  response to  glucocorticoids (C ollins e t aL, 1988; 
Hadcock & Malbon, 1988; Malbon & Hadcock, 1988). G lucocorticoid-response 
elements (GREs) located in  the 5* region o f the cloned f t -adrenergic 
receptor sequence have been postulated to  be the ta rge t s ite  fo r the 
glucocorticoid response (Malbon & Hadcock, 1988). Nakada e t aL (1989) 
id e n tifie d  16 GREs in  the mousef t 2 - 3LdrenergLc. receptor gene. When more 
jS -receptor genes are isolated a b e tte r understanding o f transcrip tiona l 
regulation should be achieved.
1.4.3. ^g-Adrenergic receptor desensitisation
Desensitisation is  an ubiquitous phemonenon whereby continuous 
exposure o f cells to  a stim ulus results in  the waning o f the ce llu la r 
response to  th a t stim ulus and, under some circum stances, to  other 
s tim u li as welL Prolonged exposure o f f t  -adrenergic receptors to
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agonists results in  an attenuation o f the responsiveness to  agonist 
s tim illa tio n . -  Adrenergic receptor desensitisation has been the subject 
o f numerous reviews (Sibley & Lefkow itz, 1985; Sibley e t aL, 1987; 
Benovic e t aL, 1988; Collins e t aL, 1990; Hausdorff e t aL, 1990). Two 
types o f desensitisation have been defined: homologous and heterologous 
(Su e t aL, 1982). Homologous o r 1 agonist-dependent1 desensitisation 
results in  an attenuated response only to  |8 -adrenergic receptor 
agonists. In  contast, heterologous or ‘agonist non-specific* 
desensitisation is  characterised by a dim inished responsiveness to 
additiona l hormones and occasionally to  other activa tors o f adenylate 
cyclase, including guanine nucleotides and fluo ride  ion . I t  is  generally 
accepted th a t heterologous desensitisation begins a fte r homologous 
desensitisation, and occurs w ith in  minutes to  hours o f agonist exposure.
As the mechanisms o f ^-adrene rg ic receptor desensitisation 
become b e tte r understood, three key processes have been id e n tifie d : i)  
rapid uncoupling o f /3 -adrenergic receptor from  adenylate cyclase; ii)
rapid sequestration o f the receptor away from  the c e ll surface; i i i)
down-regulation o f the receptor resulting in  a ne t decrease in  c e ll
receptor number.
Discussion o f desensitisation w ill be divided in to  homologous and 
heterologous components, although in te raction  between the mechanisms 
associated w ith  the two is  no t discounted.
I.4 .3 .I. Homologous desensitisation
Three main mechanisms have been im plicated in  th is  process;
sequestration o f receptor away from  the c e ll surface, phosphorylation 
o f the receptor by c AMP-dependent prote in kinase (PKA), and 
phosphorylation by a specific |8 -adrenergic receptor kinase (jffARK).
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W ithin a few  minutes o f agonist exposure, -adrenergic receptors 
are sequestered away from  the c e ll surface in to  membrane-associated 
vesicles (Harden, 1983). Sequestration is  a specialised form  o f 
endocytosis which does no t involve the form ation o f endosomes and 
subsequent tra ffic k in g  o f any phagocytosed m aterial to  lysosomes. In  
addition, recycling o f sequestered ^  -adrenergic receptors back to  the 
plasma membrane has been observed (These vesicles can be separated from  
the plasma membrane by u ltracen trifugation , and are devoid o f Gg, G ,^ o r 
adenylate cyclase (Waldo e t aL, 1983). Sequestered -adrenergic 
receptors are no t accessible to  hydrophilic ligands such as isoproterenol 
o r the antagonist CGP 12177, but are labelled by the hydrophobic ligand 
[12^l]pdndolol (Toews e t aL, 1984). Loss o f jS-adrenergic receptors from  
the c e ll surface is  norm ally quantified by radioligand binding 
techniques. Radioligand binding can decline by 50-60% a fte r exposure to  
agonists (Su e t aL, 1980). However, although radioligand binding
provides a means by which the number and a ffin ity  o f f t  -adrenergic
receptors can be determ ined (S tiles e t aL, 1984), receptors w ith  binding 
sites e ithe r occupied by agonist o r inaccessible to  the radioligand are 
not detected. By using antibodies to  (5 -adrenergic receptors, several 
groups have found th a t receptor sequestration may be preceded by 
agonist-induced a lte ra tion(s) in  the conform ation o f the receptor th a t 
destroys ligand binding (G irille t e t aL, 1985; Strader e t aL, 1987b;
Zemcik & Strader, 1988). However, the ^-adrenergic receptor complement, 
m igration on SDS PAGE, and ce llu la r location are largely unaffected by 
agonist stim ulation, even though receptor binding o f antagonist
radioligands is  markedly down-regulated (Wang e t aL, 1989a,b). I t  has 
been suggested th a t sequestration is  a prerequisite fo r receptor
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dephosphorylation (SibiLey e t aL, 1986) o r in itia te s  long-term  mechanisms 
o f adaption to  agonist exposure (Lohse e t aL, 1990a). The basic 
biochem ical mechanisms involved in  agonist-stim ulated sequestration are 
unknown, but i t  is  no t triggered by receptor phosphorylation by PKA or 
(3ARK (Hausdorff e t aL, 1989; Lohse e t aL, 1990a).
Functional uncoupling o f £  -adrenergic receptor from  its  e ffe c to r 
system, as p a rt o f desensitisation, occurs fa s te r than sequestration in  
many cases (Waldo e t aL, 1983). A large body o f evidence suggests th a t 
70-80% o f homologous desensitisation is  caused by, o r a t least in itia te d  
by, phosphorylation o f the receptor molecule (reviewed in  Benovic e t aL, 
1988; Lefkow itz e t aL, 1990). Two protein kinases have been im plicated. 
F irs tly , cAMP-dependent prote in kinase (PKA), which becomes activated as 
a re su lt o f rises in  in tra ce llu la r cAMP levels in  the course o f j 8 -  
adrenergic receptor activa tion  (Sibley e t aL, 1984; Benovic e t aL, 1985). 
Secondly, the recently characterised cAMP-independent |3 -adrenergic 
receptor kinase (|SARK) which phosphorylates only the agonist-occupied 
form  o f the ^ 2“ a<^ rener8?c  receptor (Benovic e t aL, 1986, 1987b). f$ARK 
was firs t id e n tifie d  in  1986 (Benovic e t aL, 1986), and la te r pu rif ied to  
>90% homogeneity from  bovine cerebralcortex (Benovic e t aL, 1987b). On 
SDS PAGE, |8ARK migrates as a single 80 kDa polypeptide (Benovic e t aL, 
1987b). The cloning o f |JARK id e n tifie d  tw o highly homologous clones 
( 85% sequence homology), suggesting the presence o f isoenzymes and 
possibly a fam ily o f receptor kinase genes (Benovic e t aL, 1989). The 
deduced sequence reveals th a t jSARK has 689 amino acids, and contains a 
ca ta ly tic  domain flanked by two other domains o f approxim ately equal 
size.
Unlike phosphorylation by PKA, |SARK a c tiv ity  is  dependent on the
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presence o f ^ -a rre s tin , a 48 kDa protein (Benovic e t aL, 1987a). In  the 
re tina , an analogous protein called arrestin binds only to  rhodopsin 
th a t has been phosphorylated by rhodopsin kinase, and thereby apparently 
s te rica lly  in terupts signal transduction from  rhodopsin to  transducin 
(W ilden e t aL, 1986). A cDNA from  a bovine brain lib ra ry  has been 
isolated which is  59% homologous to  arrestin  (Lohse e t aL, 1990b). 
Expression o f the cDNA produces a protein , term ed p -a rre s tin , th a t 
inh iM ts the function o f p AkK-phosphorylated jS-adrenergic receptors by 
more than 75 percent, bu t no t rhodopsin. I t  is  proposed th a t |5 -a rrestin  
acts in  concert w ith  p ARK to  e ffe c t homologous desensitisation o f /5 - 
adrenergic receptors. £ARK only phosphorylates agonist-occupied /S- 
adrenergic receptors (Benovic e t aL, 1986), perhaps due to  the unmasking 
o f a p  ARK-phosphorylation s ite  induced by ligand binding. The 
sp e c ific ity  o f 8^ ARK is  akin to  th a t o f rhodopsin kinase, a specific 
enzyme th a t phosphorylates rhodopsin in  a light-dependent fashion, 
serving to  uncouple rhodopsin from  transducin, and hence desensitise 
signal transduction (Kuhn & Wilden, 1987). More recently, p  ARK has been 
shown to  phosphorylate agonist-occupied ^ -a d re n e rg ic  (Benovic e t aL, 
1987c) and muscarinic cholinergic (Kw atra e t aL, 1989) receptors. /3 ARK 
also phosphorylates lig h t-a c tiva te d  rhodopsin (Benovic e t aL, 1987a). 
These results support the hypothesis th a t jSARK may be o f general 
im portance in  the regulation o f receptors coupled to  the modulation o f 
adenylate cyclase, ra the r than being 8^ -adrenergic receptor-specific.
M olecular cloning o f several p -adrenergic receptor cDNAs and 
genes has id e n tified  two clear concensus sequences fo r phosphorylation 
by PKA, located in  the putative th ird  in tra ce llu la r loop and in  the N - 
te rm ina l region o f the predicted carboxyl ta il o f the (3 -adrenergic
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receptor (Kotdlka e t aL, 1987a; F rie lle  e t aL, 1987; Emorine e t aL, 
1989). In  the case o f /SARK, the im portant sites are located in  the C- 
te rm ina l end o f the carboxyl ta il, which is  very serine- and threonine- 
ric h  (DoKLman e t aL, 1987b; Hausdorff e t aL, 1989). Deletion o f one or 
more o f these sites by s ite -d irected  mutagenesis, results in  receptors 
w ith  d iffe rin g  a b ilitie s  to  mediate changes in  sensitiv ity and losses in  
maximum responsiveness (Hausdorff e t aL, 1989). In  addition, low 
agonist concentrations p re fe ren tia lly  induce phosphorylation a t PKA sites 
and results in  desensitisation. A t higher agonist concentrations, 
phosphorylation occurs a t both f iARK and PKA sites, and 70-80% o f maxim al 
desensitisation occurs (H ausdorff e t aL, 1989). In teresting ly, the 
highest levels o f /SARK mRNA expression are found in  brain, spleen and 
heart, tissues which have high catecholamine levels Le. w ith  greatest 
levels o f innervation (Benovic e t aL, 1989). This finding coupled to  
selective activa tion  of/SARK a t high agonist concentrations is  com patible 
w ith  the notion th a t /SARK is  more abundant in  tissues containg high 
numbers o f nerve endings, which may produce high concentrations o f 
noradrenaline.
In  an elegant series o f experiments, Lohse e t aL (1990a) were 
able to  examine the re la tive  contributions o f phosphorylation o f (3 -  
adrenergic receptors by /SARK and PKA, and receptor sequestration in  
homologous desensitisation using specific inh ib ito rs. The poly anion 
heparin is  a specific and e ffective  in h ib ito r o f /SARK (Benovic e t aL, 
1989), w hile the 31-amino acid PKA in h ib ito r peptide blocks 
phosphorylation by PKA (S cott e t aL, 1986). Sequestration was prevented 
by pretreatm ent o f ce lls w ith  Concanavalin A (Waldo e t aL, 1983). When 
ind ividua l pathways are blocked e ither the PKA or /SARK mechanism alone
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appear to  re su lt in  40-50% desensltisation, whereas sequestration alone 
causes 20-30% desensitisatkm . These findings suggest th a t the 
quantita tive  contributions o f each mechanism are no t additive, ind ica ting 
some redundancy in  signal transduction regulation. Also the results 
suggest th a t an agonist-dependent concentration gradient regulates the 
degree o f desensltisation produced.
Despite the growing amount o f in form ation concerning the ro le  o f 
phosphorylation in  jB -adrenergic receptor desensitisation, lit t le  is  known 
about the enzymatic basis fo r dephosphorylation o f phosphorylated 
receptor. There is  evidence th a t receptor dephosphorylation is  catalysed 
by a phosphatase specifica lly associated w ith  light-m em brane vesicles 
(Sibley e t aL, 1986), proposed to  contain sequestered ^ “ adrenergic 
receptors (S tadel e t aL, 1983). More recently, la te n t phosphatase 2 was 
shown to  specifica lly dephosphorylate 2“ adrenergic receptors (Yang e t 
aL, 1988). However p u rifica tio n  and rigorous characterisation o f the 
endogenous 2-adrenergic receptor phosphatase w ill be required to  
demonstrate conclusively th is po ten tia l ro le  fo r la te n t phosphatase 2.
I.4 .3 .2 . Heterologous desensltisation
Heterologous desensltisation o f j6  -adrenergic receptors is  no t 
dependent on agonist-occupancy o f the receptor ligand binding s ite , and 
p rim arily  involves a functiona l uncoupling o f receptor from  Gg and 
adenylate cyclase (Sibley & Lefkow itz, 1985). This process is  
characterised by a marked reduction (dow n-regulation) in  receptor 
number, and is  demonstrable only a fte r 4-12 h o f agonist exposure. The 
estim ated h a lf-life  o f the ft -adrenergic receptor in  the plasma membrane 
is /v30 hours (Neve & M olinoff, 1986; Mahan & Insel, 1986). Considering 
th is re la tive ly  long h a lf-life , down-regulation could be achieved by a
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decrease in  receptor synthesis and/or an increase in  receptor 
degradation.
I.4 .3 .2 .I. Role o f phosphorylation
Under appropriate conditions, c AMP-dependent heterologous 
desensitisation can be e lic ite d  (Sibley e t aL, 1987). The e ffe c t can be 
mimicked by incubation w ith  dibutyryl-cAM P, 8-brom o-cAM P, and forsko lin , 
and results in  the down-regulation o f both ^ 6 -adrenergic (50% reduction) 
and prostaglandin receptors (Sibley e t aL, 1987; Bouvier e t aL, 
1989). These and other results suggest a ro le  fo r PKA (Sibley e t aL, 
1984; Benovic e t aL, 1985), and possibly protein kinase C (Sibley e t aL, 
1984; Kelleher e t aL, 1984), in  down-regulation o f receptors. They also 
demonstrated th a t cAMP alone can induce down-regulation in  the absence 
o f £  -adrenergic agonist.
As noted e a rlie r (section I.4 .3 .I.), the 2-adrenergic receptor 
contains two concensus sequences fo r PKA phosphorylation, and is  a 
substrate fo r PKA. To examine the ro le  o f PKA phosphorylation in  down- 
regula tion, these two sites in  the receptor have been disrupted by a 
s ite -d irected  mutagenesis approach. Deletion o f one or both o f these 
PKA phosphorylation sites results in  m utant receptors w ith  delayed cAMP- 
induced down-regulation (Bouvier e t aL, 1989). A fte r several hours 
however, the m utant receptors undergo dow n-regulation a t a ra te  which 
closely parallels th a t o f w ild -type receptors (Bouvier e t aL, 1989). I t  
is  clear then, th a t phosphorylation contributes to , bu t is  not the m ajor 
fa c to r involved in , y6  -adrenergic receptor down-regulation. The in itia l 
delay in  cAMP-induced down-regulation o f m utant receptors, may be due 
to  an a lte ra tion  o f phosphorylation (Collins e t aL, 1990). In te resting ly, 
short-term  exposure (30 m in) o f cells to  adrenaline o r dibutyryl-cA M P
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stim ulates the ra te  o f jS 2“ adrenergic receptor gene transcrip tion in  
DDT^MF-2 cells (C ollins e t aL, 1989).
There appears to  be some requirem ent fo r the presence o f Gs in  
down-regulation because -adrenergic receptors in  S49 lymphoma ce lls, 
lacking ocg, exh ib it l i t tle  agonist-induced down-regulation (Mahan e t aL, 
1985). In  addition, m utant receptors th a t are unable to  couple to  Gg 
also generally exh ib it im paired a b ility  to  mediate agonist-induced down- 
regulation (Cheung e t aL, 1989). However, functiona l activa tion  o f 
adenylate cyclase is  no t an essential requirem ent (Mahan e t aL, 1985).
I.4 .3 .2 .2 . Regulation o f jg-adrenergic receptor messenger RNA (mRNA)
In  contrast to  short-term  exposure (30 m in), long-term  exposure 
(>24 h) o f ce lls to  a -adrenergic agonist results in  a >50% reduction 
in  -adrenergic receptor mRNA (Hadcock e t aL, 1988; Collins e t aL, 
1989). The down-regulation o f f t -adrenergic receptor mRNA displays a 
prom inent cAMP-dependent component. Agents th a t increase in tra ce llu la r 
cAMP via  receptors o r non-receptor pathways (such as fo rsko lin  and 
cholera toxin ) stim ulate a sharp decline in  -adrenergic receptor mRNA 
levels (Hadcock e t aL, 1988). The decline in  mRNA levels appears to  
involve destabilista tion o f mRNA (agonist/cAMP induced), ra th e r than a 
decrease in  the ra te  o f gene transcription (Hadcock e t aL, 1989a; Collins 
e t aL, 1989). I t  has been proposed th a t a second cAMP-independent 
signal transduction pathway also leads to  a decline in  mRNA levels 
(Hadcock e t aL, 1989b). This la tte r e ffe c t apparently requires the 
presence o f Gg and PKA, but not the elevation o f in tra ce llu la r cAMP 
levels (Hadcock e t aL, 1989b). Recently, noradenaline has been shown to  
regulate the ^ -a d re n e rg ic  receptor mRNA le ve l in  ra b b it a o rtic  smooth 
muscle cells, possibly involving destabilisation o f the mRNA and a
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co -fa c to r whose transcrip tion is  induced by noradrenaline (izzo, J r, e t 
aL, 1990).
I.4 .3 .2 .3 . Role o f endocytosis
A growing body o f evidence suggests th a t down-regulation o f £ 2“  
adrenergic receptors may involve th e ir endocytosis by way o f c la th rin - 
coated vesicles (CCVs). The in te rna lisa tion  o f the £  2**adrenergic 
receptor is  inh ib ited  by concanavalin A (W akshull e t aL, 1985), 
phenylarsine oxide (H e rte l e t aL, 1985), and reduction o f cellular ATP 
content, factors known to  perturb in te rna lisa tion by CCVs. In  addition, 
d istruption o f the form ation o f clathrin-coated p its  in h ib its  the 
in te rna lisa tion  o f ^ "a d re n e rg ic  receptors (Liao, 1990).
V aliquette e t aL (1990) have proposed th a t two tyrosine residues 
(a t positions 350 and 354) in  the cytoplasm ic ta il o f the human ^ 2”  
adrenergic receptor are involved in  down-regulation. M utation o f these 
residues dram atically reduces the a b ility  o f the ^ “ adrenergic receptor 
to  undergo isoproterenol-induced down-regulation. This e ffe c t im plicates 
CCVs since i t  is  s im ila r to  observations ind ica ting the involvem ent o f 
tyrosine residues located in  the cytoplasm ic ta ils  o f several membrane- 
bound receptors in  agonist-induced CCV-endocytosis (V aliquette e t aL, 
1990, and references c ited  there in). In  th is same study, m utation o f the 
tyrosine residues did not a ffe c t agonist-induced sequestration. There is  
evidence th a t sequestration o f ^ “ adrenergic receptors in  human A431 
cells involves non-coated vesicles (Raposo e t aL, 1989). Therefore 
down-regulation and sequestration may occur via  independent pathways o f 
in terna lisa tion.
1.5. Use o f ft -adrenergic agonists in  livestock production
Drugs acting via  adrenergic receptors are w idely used therapeutic
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agents. Perhaps the most w e ll known example o f th is class o f compounds 
are the so-called -b lockers ', used extensively to  tre a t cardiovascular 
com plaints. Recently, several -adrenergic agonists (^-agonists) have 
been id e n tifie d  th a t a lte r body com position in  many species o f animals. 
Some o f these compounds, fo r example BRL 26830A (A rch e t aL, 1984) and 
LY 104119 (Yen e t aL, 1984) reduce body-fa t deposition w ith  Tittlp  
a lte ra tion  o f lean-body mass accum ulation. 0 theryS-agonists cause a
're p a rtition in g  * o f nutrien ts resulting in  a reduction o f adipose tissue 
and an increase in  muscle grow th (reviewed by Hanrahan e t aL, 1986; 
Yang & M cE lligott, 1989). These e ffects have very im portant im plica tions 
fo r treatm ent o f muscle wasting diseases (e.g. muscular dystrophy) in  
humans, and m odification o f carcass com position in  the m eat-producing 
industry.
0 -Agonists curren tly under study include cim atero l (Jones e t aL, 
1985; Hu e t aL, 1988; Eadara e t aL, 1989), clenbuterol (Baker e t aL, 
1984; Ricks e t aL, 1984; Reeds e t aL, 1986), ractopam ine (Anderson e t 
aL, 1987; Hausman e t aL, 1989), and L-644,969 (Convey e t aL, 1987; 
Kretchm ar e t aL, 1989). Much o f the early work to  characterise the 
e ffects o f £ -agonists has been documented in  a g ricu ltu ra l an im d 
studies. However, in form ation concerning th e ir e ffects in  ra ts  is  
available (M a ltin  e t aL, 1986a,b, 1987, 1989a; M cE lligott e t aL, 1987; 
Eadara e t aL, 1989; Hausman e t aL, 1989; MacLennan & Edwards, 1989).
1.5.1. E ffects on skeleta l muscle
-Agonists are the most potent agents th a t can prom ote norm d 
ske le td  muscle growth (see Yang & M cE lligott, 1989). Current research 
is  aimed a t elucidating the mechanisms responsible fo r th is e ffe c t, but 
early findings suggest roles fo r both d ire c t and in d ire c t actions on
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muscle. One o f the d ire c t e ffects o f |5 -agonists on muscle is  
stim u la tion o f grow th (Beerman e t aL, 1987; Claeys e t aL, 1989; 
M acLennan & Edwards, 1989; MaMn e t aL, 1989a). This has been 
a ttribu ted  to  an in h ib itio n  o f protein degradation (M cE lligo tt e t aL, 
1987; Bergen e t aL, 1989; Kretchm ar e t aL, 1989), and increased protein 
synthesis (Emery e t aL, 1984; H elferich e t aL, 1988; Bergen e t aL, 
1989). However, the e ffects on muscle prote in metabolism are no t 
d e fin itive  as ye t, and therefore greater knowledge o f the biochem ical 
processes underlying these gross effects is  needed.
The ^8 -adrenergic receptor subtype on muscle has been shown to  be 
predom inantly £ 2  (Apperly e t aL, 1976; Iig g e t e t aL, 1988). Evidence 
fo r /S-adrenergic receptor-m ediation o f clenbuterol-induced muscle 
hypertrophy in  ra ts has been presented (M acLennan & Edwards, 1989). 
Propranolol was found to  attenuate clenbuterol e ffects on muscle grow th 
thus im plica ting  j8 -adrenergic receptors. This contrasts w ith  work by 
M a llin  and co-workers who found th a t propranolol addition to  
clenbuterol-supplem ented diets did not attenuate hypertrophy in  
innervated (M a ltin  e t aL, 1987b) o r denervated (M a ltin  e t aL, 1989b) 
soleus muscle, induced by clenbuteroL The la tte r findings are 
questionable since fu ll antagonism by propranolol o f the -adrenergic 
e ffects o f clenbuterol was not demonstrated. This d ire c t e ffe c t is  no t 
suprising as clenbuterol shows high a ffin ity  towards both and /$2"  
adrenergic receptors, w ith se le c tiv ity  towards 2“ a<^renerS*c  receptors 
(Cohen e t aL, 1982). However, infusion o f clenbuterol causes a sm all 
increase in  plasma noradrenaline, so th a t some effects o f clenbuterol 
may be a ttribu tab le  to  release o f endogenous noradrenaline (Mersmann,
1989).
40
{5 -agonists in te ra c t w ith  many endocrine systems and tissues in  
the body, and therefore in d ire c t mechanisms may have an im portant ro le  
in  jS -agonist-induced hypertrophy. Possible in d ire c t actions include: 
in te raction  w ith  insu lin  o r grow th hormone; increased blood flow  to  
muscle providing additional nutrients; increased a va ila b ility  o f lip ids 
fo r energy production to  the muscle, resulting from  increased adipose 
tissue lipo lysis and concom itant elevation o f plasma fre e  fa tty  acid 
concentration (see Yang & M cElligo tt, 1989 fo r fu ll discussion).
In  summary, more research is  required to  determ ine precisely the 
mode o f action o f jS -agonists on muscle metabolism. In  addition, the 
e ffects o f other /8 -agonists must be characterised before a concensus 
sequence o f events leading to  muscle hypertrophy can be established.
1.5.2. E ffects on adipose tissue
I t  is  now quite c lea r th a t chronic f t  -agonist treatm ent decreases 
to ta l carcass fa t in  m eat-producing animals and laboratory rodents. 
Evidence exists which establishes a d ire c t ro le  fo r -agonists in  the 
con tro l o f lipo lysis and lipogenesis in  adipose tissue (Fain & G arcia- 
Sainz, 1983). The plasma concentration o f fre e  fa tty  acids increases in  
dieep (Beerman e t aL, 1986) and pigs (Mersmann, 1987; Mersmann e t aL, 
1987, 1989) given ft  -agonists, suggesting increased lip id  tra ffic k in g . 
However, as noted fo r e ffects on muscle, stim u la tion o f noradrenaline 
release b y/6 -agonists may have a ro le  (Mersmann e t aL, 1989). h i v itro , 
ractopam ine (M erkel e t aL, 1987) and L-644,969 ( liu  e t aL, 1988), bu t 
no t clenbuterol (M erkel e t aL, 1987) increase lipo lysis in  pig adipose 
tissue. S tim ulation o f adipose tissue lipo lysis in  y ifm  is  also 
evidenced w ith  cim atero l in  sheep (Hu e t aL, 1988) and ra ts  (Eadara e t 
aL, 1989), clenbuterol in  sheep (Thornton e t aL, 1985), and ractopam ine
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in  ra ts (Hausman e t aL, 1989), Data re la ting  to  broilers is  inconclusive 
(Yang & M cE lligott, 1989).
E ffects o f chronic ^ -a g o n is t adm inistration on lipogenesis in  
adipose tissue in  v itro  are ill-d e fin e d . In  ra ts , cim atero l does no t 
influence de novo fa tty  acid synthesis in  e ith e r adipose tissue or liv e r 
(Eadara e t aL, 1989). Ractopamine on the other hand inh ib its  basal 
lipogenesis in  ra t adipocytes, and is  more potent in  the presence o f low 
media concentrations o f insu lin  (Hausman e t aL, 1989), C im aterol 
feeding increases lipogenesis in  sheep adipose tissue (although the 
e ffe c t is  no t s ta tis tica lly  sign ificant)(H u e t aL, 1988), while 
clenbuterol Inh ib its lipogerric enzymes in  c a ttle , showing a s ite -sp e c ific  
e ffe c t on adipose tissue (Sm ith e t aL, 1987). Also ractopam ine has been 
shown to  be antL-lipogerric in  pig adipose tissue (M erkel e t aL, 1987; 
L iu e t aL, 1988). Suprisingly, cim atero l increased lipogenesis in  lambs 
(Hu e t aL, 1987). Whether these inconsistences are due to  species, 
adipose depot, j8 -agonist o r experim ental differences is  no t ye t clear.
1.5.3. N ovel f t  -agonists
@ -Adrenergic receptors are present on alm ost every c e ll type, and 
regulate many physiological systems (see Table 1.1). Several novel /S-  
agonists have been developed which exh ib it se le c tiv ity  towards adipose 
tissue (A rch e t aL, 1984; Wilson e t aL, 1984; Yen e t aL, 1984). 
Compounds th a t selectively stim ulate brown adipocyte jS -adrenergic 
receptors may become potent thermogenic an ti-obesity drugs (A rch e t aL, 
1984), while those specific fo r white adipose tissue are a ttra c tive  
repartition ing  agents. The se le ctiv ity  o f these novel £ -agonists appears 
to  be a re su lt o f a typ ica l -adrenergic receptors being present on 
adipocytes (discussed in  section 1.1.2.3). The advantage o f using such
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drugs as repartitianm g agents is  th a t th e ir e ffects may be lim ite d  to  
adipose tissue, thus negating any concerns about cardiovascular side- 
e ffects. As more -adrenergic receptor subtypes are id e n tifie d  
pharm acologically and by d ire c t gene iso la tion , tissue-specific e ffects 
o f /3-agonists in  many tissues may become a therapeutic re a lity .
1.6. Objectives
The aim o f th is study was to  characterise the £  -adrenergic 
receptors present in  sheep adipose tissues. Its  purpose was to  look fo r 
possible species and adipose tissue depot differences in  the 
characteristics o f adipose tissue 3^ -adrenergic receptors, and to  
determ ine whether sheep adipose tissue possessed an a typ ica l ^ 3-  
receptor, as observed in  the ra t. Achievement o f these goals involved 
the p u rifica tio n  o f the/S -adrenergic receptor from  sheep adipose tissues, 
and subsequent investigation using radioligand binding and 
pho toa ffin ity-labe lling . The production o f antibodies directed against 
the /3-adrenergic receptor was also a key aim , as such antibodies would 
be useful fo r probing receptor structure and also fo r development o f an 
im m unological a lte rna tive to  the use o f 0 -agonists in  livestock 
production.
Table 1.1. Physiological responses o f adrenergic receptor subtypes
og-A drenerg ic receptors
1. Smooth muscle contraction in  blood vessels and genitourinary tra c t
2. A ctiva tion  o f glycogenolysis (liv e r)
0(2 -  A drenergic receptors
1. Smooth muscle re laxation inge/vcfourinary tra c t
2. Smooth muscle contraction in  selected vascular beds
3. Inh ib ition  o f noradrenaline release from  sym pathetic nerve endings
4. Increased grow th hormone secretion by the p itu ita ry
5. Inh ib ition  o f lipo lysis in  adipose tissue (species specific)
6. P la te le t aggregation (species specific)
7. Inh ib ition  o f insu lin release by the pancreas
8. S tim ulation o f potassium and w ater secretion by salivary glands
9. Inh ib ition  o f renin release by juxtaglom erular ce lls in  the kidney
Adrenergic receptors
1. S tim ulation o f ra te  and force o f cardiac contraction
2. S tim ulation o f lipo lysis
3. S tim ulation o f amylase secretion by salivary glands
4. Smooth muscle re laxation in  bronchi, blood vessels, and 
genitourinary and gastro in testinal tra cts
5. F a c ilita tio n  o f noradrenaline release
6. Increased glycogenolysis and gluconeogenesis in  liv e r
7. Increased glycogenolysis in  muscle
8. Increased insulin and glucagon secretion by pancreatic ce lls
9. Decreased grow th hormone secretion by the p itu ita ry
10. S tim ulation o f reran release by juxtaglom ular ce lls in  the kidney
Adapted from  Lefkow itz e t aL (1984).
Fig. 1.1. Adrenergic con tro l o f lip id  metabolism in  the adipocyte
/8 -  and ^ -a d re n e rg ic  receptor responses in te ra c t v ia  th e ir
respective G proteins and adenylate cyclase, and modulate the
in tra ce llu la r cAMP concentration. E levation o f cAMP levels increases 
protein kinase A a c tiv ity  which phosphorylates both horm one-sensitive 
lipase (stim ulato ry) and ace ty l Co A carboxylase (in h ib ito ry ). The net 
re su lt is  an increase in  the ra te  o f lipo lysis and a reduction in  de
novo fa tty  acid synthesis. H denotes /8 -agonist, c^-a g o n is t, /S-AR
£ -adrenergic receptor, c^-A R  ©Co-adrenergic receptor, ocs GgoC subunit, 
* i  subunit, &  G protean subunits, AC adenylate cyclase, ATP
adenosine triphosphate, PPL pyrophosphate, GTP guanosdne triphosphate.
E X T R A C E L L U L A R
ATP cAMP + PPi
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Fig. 1.2. Model illu s tra tin g  the amino acid sequence and presum ptive
membrane architecture o f the human 2~adrener%ic receptor
The amino acid sequence was determ ined from  a cDNA encoding the 
hu m an |5 2” ac^ renerSic receptor. The arrangement o f the polype tide  chain 
was predicted using hydropath icity analysis. Taken from  Kobilka e t aL 
(1987). ’
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CHAPTER TWO -  MATERIALS AND METHODS
2.1. Reagents
CGP 20712A was generously given by Drs Schroter and S chla ib li o f 
C3BA-GEIGY A.G. (Basel, Sw itzerland). I d  118,551 was a g ift from  I d  
Pharmaceuticals (A lderley Park, M acclesfield, Cheshire, U .K .). Polyclonal 
antiserum CM 13 was a generous g ift from  Dr Craig Malbon (S tate 
U niversity o f New York, Stony Brook, New York, U.S.A.). Monoclonal 
antibody BRK2 was a g ift from  Professor A. D. Strosberg (Pasteur 
In s titu te , Pads, France). A ll radiochem icals were purchased from  
Amersham In ternationa l p ic (Amersham, Bucks, U .K .). 1,4-Butanediol 
d ig lycydylether was purchased from  A ldrich (G illingham , Dorset, U .K .). 
Tissue cu ltu re reagents were purchased from  Northum bria B iologicals L td  
(C ram lington, Northumberland, U .K .). A ll other reagents were obtained 
from  Sigma Chemical Company (Poole, Dorset, U .K .) o r BDH (Poole, Dorset, 
U .K .).
2.2. Animals
2.2.1. Sheep
Sheep were a ll Finn x Dorset Horn cross-breds. The animals were 
given hay and w ater ad lib itum  plus 400 g/day o f a cereal m ix, fo r a t 
least 4 weeks before slaughter. Both wether lambs (6-9 months o ld) and 
3-4-year old ewes were used. LactatLng ewes received 1400 g/day o f a 
cereal m ix, possessed 2-3 lambs, and were used 18 days post partum . 
Sheep were anaesthetised w ith  an in tra jugu la r in jectio n  o f 20-30 m l o f 
Sagatal (May & Baker, Dagenham, Essex, U .K .), given by D r R. G. Vernon. 
The animals were exsanguinated when unconscious and adipose tissue 
removed as quickly as possible.
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2.2,2. Rats
W istar fem ale v irg in  ra ts (160-180 g) from  A. Tuck & Son 
(Rayleigh, Essex, U .K .) were given Labsure irrad ia ted  CRM d ie t (Labsure, 
Poole, Dorset, U .K .) and w ater ad lib itu m . Rats were k ille d  by ce rv ica l 
dislocation and adipose tissue removed as quickly as possible.
2.3. Preparation o f membrane fractions
2.3.1. Preparation o f sheep adipocyte membranes
Adipose tissue (20-80 g) was removed from  the required fa t-de po t 
and transported to  the laboratory in  0.9% (w /v) saline a t 39°C. 
Adipocytes were prepared by collagenase digestion using the method o f 
Rodbell (1964). Adipose tissue (about 20 g) was minced in  a pe tri-d ish  
using scissors, and digested in  sealed p lastic flasks containing 10 m l o f 
gassed (95% O2, 5% CO2) Krebs Ringer bicarbonate (1.2 mM CaC^) b u ffe r, 
containing 25 mM Hepes (pH 7.3), 2 mM Na acetate, 0.3 m g/m l D-glucose, 
1.5 m g/m l collagenase (Type IE (Cat. No. C 6885), Sigma) and 40 m g/m l BSA 
(dialysed and fa tty  acid fre e ), fo r 1 h  a t 37°C in  a shaking w ater bath. 
The digest was passed through a p lastic stra iner, and the flo a tin g  
adipocytes washed three tim es w ith  10 m l o f gassed (95% O2, 5% CO2) 
Krebs Ringer bicarbonate bu ffe r, containing 25 mM Hepes (pH 7.3), 2 mM 
Na acetate, 0.3 m g/m l D-glucose, 10 m g/m l BSA a t 37°C.
Adipocytes were lysed by addition o f 10 m l o f 10 mM T ris-H C l 
(pH 7.4), 20 mM EDTA, 0.2 M sucrose containing 0.1 m g/m l bacitracin , 17.5 
jig /m l benzamidine HC1, 5 jig /m l soybean trypsin in h ib ito r, 0.2 mM PMSF a t 
37°C. The suspension was vortexed fo r 2 min, transferred to  a 50 m l 
p lastic centrifuge tube, and quickly centrifuged a t 36,900xg (SS34 ro to r; 
S orvall RC-5B, DuPont, U.S.A.) fo r 20 min a t 37°C. The fa t and 
in frana tan t were poured o ff and the tubes plunged in to  ice . The p e lle t
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was gently resuspended in  5 m l o f ice -co ld  10 mM Tris-HCL (pH 7.4), 90 
mM NaGL using a glass homogeniser. Pellets from  other digestions were 
pooled a t th is  stage and centrifuged a t lOOOxg (M inifuge T, Hereaus) fo r 
10 min a t 4°C, in  order to  remove residual c e ll debris and connective 
tissue. The supernatant was recovered and recentrifuged a t 36,900xg 
(SS34 ro to r; Sorvall RC-5B) fo r 20 min a t 4°C. The resulting membrane 
p e lle t was resuspended in  10 mM Tris-H C l (pH 7.4), 90 mM NaCland stored 
in  liq u id  nitrogen.
2.3.2. Preparation o f sheep adipose tissue membranes
Adipose tissue (1 kg) was collected from  the om ental fa t-de po t 
and placed in  0.9% (w /v) saline a t 39°C. 100 g aliquots were mixed w ith  
200 m l o f 10 mM T ris-H C l (pH 7.4), 20 mM EDTA, 0.2 M sucrose containing 
0.1 m g/m l bacitracin , 17.5 jJg/m l benzamidine HC1, 5 jig /m l soybean trypsin 
in h ib ito r, 0.2 mM PMSF a t 40°C, and homogenised in  a warm blender 
(W aring, U.S.A.) a t high speed fo r 35 sec. The homogenate was quickly 
centrifuged a t 2,800xg (M inifuge T, Hereaus) fo r 5 min a t 40°C. The 
sample was cooled on ice  u n til the fa t so lid ifie d , and the in frana tan t 
removed and centrifuged a t 40,000xg (6 x 100 m l ro to r; Prepspdn 50, MSE) 
fo r 20 min a t 4°C. The p e lle t was resuspended in  10 m l o f ice -co ld  10 
mM T ris-H C l (pH 7.4), 90 mM NaGL using six strokes o f a large-bore glass 
homogeniser fitte d  w ith  a Teflon pestle. The suspension was centrifuged 
a t lOOOxg (M inifuge T, Hereaus) fo r 10 min a t 4°C. The supernatant was 
recovered and recentrifuged a t 36,900xg (SS34 ro to r; Sorvall RC-5B) fo r 
20 min a t 4°C. The resulting membrane p e lle t was resuspended in  10 mM 
T ris-H C l (pH 7.4), 90 mM NaCl, and stored in  liq u id  nitrogen.
2.4. Preparation o f ra t adipocyte membranes
Rat adipose tissue was removed and transported to  the laboratory
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in  0.9% (w /v) saline a t 37°C. Adipocyte membranes were prepared as 
described previously fo r siheep adipose tissue (section 2.3.1), except th a t 
10 g o f adipose tissue was placed in  each digestion flask and sodium 
acetate was om itted from  the digestion bu ffe r.
2.5. Assay o f ^ -adrenerg ic receptors
2.5.1. Assay o f -adrenergic receptors in  membranes
^-A d renerg ic receptors in  membranes were assayed using the 
method o f Malbon e t aL (1978), w ith  some m odifications. Membranes (100 
jig  prote in) were incubated w ith  10 nM [ H ](-)-d ihydroa lpreno lo l 
( [3H]DHA>, 50 mM T ris-H C l (pH 7.4), 10 mM M gC^, 0.1 mM ascorbate in  a 
to ta l volume o f 200 jil,  fo r 10 min a t 37°C. The reaction was quenched 
by addition o f 5 m l o f ice -co ld  50 mM T ris-H C l (pH 7.4), 10 mM MgC^, 
and the incubation m ixture filte re d  rap id ly through a single 2.5 cm 
Whatman GF/C filte r  disc. The filte r  was washed tw ice w ith  5 m l o f ic e - 
cold 50 mM Tris-H C l (pH 7.4), 10 mM MgCL.2 and added to  10 m l o f 
sc in tilla tio n  flu id  (E m ulsifie r Safe, Packard). The ra d io a ctiv ity  trapped 
on the filte rs  was counted using a LKB 1215 Packbeta liq u id  
sc in tilla tio n  counter. N on-specific binding was defined as the 
radioligand binding rem aining a fte r incubation in  the presence o f 100 jiM  
(-)-isoproterenoL
When [^^E ]-iodocyanopindolol was used instead o f [^H ]D H A , a 
radioligand concentration o f 75 pM was used, and samples were incubated 
fo r 60 min a t room tem perature. Also the amount o f membranes was 
reduced to  15 jig  protein/assay tube.
2.5.2. Assay o f soluble jg -adrenergic receptors
Solubilised |6 -adrenergic receptors were assayed using the two 
methods o f Vauquelin e t aL (1979) w ith  m odifications.
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2.5.2.1. Gel filtra tio n  method
The soluble sample (100 jig  protein) was incubated w ith  10 nM 
[% ]D H A  in  a b u ffe r composed o f 10 m M T ris-H C l (pH 7.4), 90 m M N ad, 0.1 
mM ascorbate fo r 15 min a t 30°C, in  a to ta l volume o f 250 jiL  Follow ing 
incubation, the sample was cooled on ice  fo r 5 min and bound ligand 
separated from  free by ge l filtra tio n  on a single 3.5 m l Sephadex G50 
column (Figure 2.1). The column was equilibrated a t 4°C w ith  3m l o f 10 
mM T ris-H C l (pH 7.4), 90 mM NaCl, 0.05% (w /v) d ig iton in , im m ediately p rio r 
to  sample loading. When the sample had entered the gel, 1 m l o f 
equilibra tion b u ffe r was passed through the column and any eluate 
dicarded. Receptor-ligand complexes were eluted d ire c tly  in to  a 
sc in tilla tio n  v ia l by fu rth e r addition o f 1.4 m l o f b u ffe r. S c in tilla tio n  
flu id  (10 m l : E m ulsifier Safe, Packard) was added and the ra d io a c tiv ity  
quantified using a LKB sc in tilla tio n  counter. N on-specific binding was 
defined as the radioligand binding rem aining in  the presence o f 100 jiM  
(-)-isoproterenoL
2.5.2.2. Polyethylene g lyco l (PEG) p recip ita tion  method
The soluble sample (100 jig  prote in) was incubated w ith  10 nM 
[% ]D H A  fo r 15 min a t 30°C as in  section 2.5.2.1 above. The sample was 
cooled on ice  fo r 1 m in, and 40^1 o f sheep im  munoglobulLn (6 m g/m l) and 
290 u l o f ice -co ld  16% (w /v) PEG 6000 (in  10 mM Tris-H C l (pH 7.4), 90 
mM NaCl) added. The sample was vortexed, and incubated on ice  fo r a 
fu rth e r 10 min. The sample was filte re d  through a single 2.5 cm 
Whatman GF/F filte r  and washed tw ice w ith  5 m l o f ice -co ld  8% (w /v) PEG 
6000, 10 mM T ris-H C l (pH 7.4), 90 mM NaCL The ra d io a c tiv ity  was 
determ ined as above. Non-specific binding was defined as the 
radioligand binding rem aining in  the presence o f 100 uM ( - ) -
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isoproterenol.
When [ 125j-]-iodocyanopindolol was used instead o f [% ]D H A , a 
radioligand concentration o f 75 pM was used, and samples were incubated 
fo r 60 min a t room tem perature. Also the amount o f membranes was 
reduced to  15 jig  protein/assay tube.
2.6. Preparation o f d ig iton in  solutions
D igitonin (99% pure; BDH lim ite d , Poole, England) was prepared as 
a 5% (w /v) solution in  10 mM Tris-H C l (pH 7.4), 90 mM NaCl by bo iling 
gently fo r 10 min. A fte r cooling to  4°C, the solution was centrifuged a t 
lOOOxg fo r 10 min, filte re d  through a 0.2 jim  syringe filte r  (Flow 
laboratories), and stored a t 4°C.
2.7. Solubilisation o f sheep adipose tissue membranes
Adipose tissue membranes were solubilised using a m odification 
o f the method o f Cubero and Malbon (1984). Isolated membranes were 
pelleted by centrifugation a t 36,900xg (SS34 ro to r; S orvall RC-5B) fo r 15 
min a t 4°C. The membrane p e lle t was resuspended in  ice -co ld  10 mM 
T ris-H C l (pH 7.4), 90 mM NaCl* 0.2 mM PMSF, 1% (w /v) d ig ilon in , using six 
strokes o f a glass homogeniser, and s tirre d  gently fo r 1.5 h  a t 4°C. The 
fin a l membrane protein concentration was 2 mg/mL The sample was 
centrifuged a t 36,900xg (SS34 ro to r; S orvall RC-5B) fo r 20 min a t 4°C, to  
remove insoluble m ateria l. The supernatant was removed and the 
concentration o f d ig ilon in  reduced to  0.5% (w /v) by addition o f 10 mM 
T ris-H C l (pH 7.4), 90 mM NaCL Solubilised plasma membranes were stored 
in  l iqu id nitrogen, and used w ith in  1 week o f preparation.
2.8. A ffin ity  chromatography o f -adrenergic receptors
2.8.1. Synthesis o f Sepharose 4B -alprenolol a ffin ity  ge l
(-)-A lp re n o lo l was linked to  sodium thiosulphate-derivatised
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Sepharose 4B as described by Caron e t aL (1979), w ith  the m odifications 
used by Shorr e t aL (1981). Also (-)-a lp re n o lo l d -ta rtra te  was used 
instead o f the hydrochloride sa lt fo r the synthesis.
2.8.2. P urifica tion  o f ^  -adrenergic receptors on Sepharose 4B -alprenolol 
£dL
A ffin ity  chromatography was perform ed essentially as described 
by Caron e t aL (1979) w ith  some m odifications. A Sepharose 4B- 
alprenolol a ffin ity  column ( O m n ifit), containing 10 m l o f ge l was used 
fo r the a ffin ity  p u rifica tio n . The ge l was washed free  o f azide w ith  20 
m l o f 10 m M Tris-H C l (pH 7.4), 100 m M NaCl, 2 m M EDTA, and equilibrated 
w ith  20 m l o f 10 mM T ris -H a  (pH 7.4), 100 mM NaCl, 2 mM EDTA, 0.2% 
(w /v) d ig iton in  a t room tem perature. D igitonin-soLibilised membranes 
were loaded onto the column a t room tem perature, a t a flo w -ra te  o f 12 
m l/h. The column was equilibrated to  4°C (20 min) and washed w ith  40 
m l o f 10 mM T ris -H a  (pH 7.4), 100 mM NaCl, 2 mM EDTA, 0.05% (w /v) 
d ig iton in  a t 4°C, a t the increased flo w -ra te  o f 20 m l/h. Follow ing 
washing, the column was placed a t room tem perature fo r 20 min. The 
bound -adrenergic receptors were subsequently eluted w ith  10 mM 
T ris -H a  (pH 7.4), 100 mM NaCl, 2 mM EDTA, 0.05% (w /v) d ig iton in , 1 mM ( -  
)-isopro tereno l a t the same flo w -ra te . A liquots o f column fractions (0.5 
m l) were desalted by ge l filtra tio n  (section 2.9), then assayed fo r the 
presence o f jS-adrenergic receptors, using the ge l filtra tio n  method 
(section 2.5.2.1). f t  -Adrenergic receptor containing fractions were stored 
in  liq u id  nitrogen.
The a ffin ity  column was regenerated w ith  20 m l o f 2 M NaO, 50 
m l o f w ater, and saturated w ith  0.02% (w /v) sodium azide fo r storage a t 
4°C.
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2.9. Removal o f ( - ) -isoproterenol from  p a rtia lly  purified |3-adrenerg ic
receptor preparations 
Separation o f fre e  (-)-isop ro te reno l and protein was achieved by 
ge l filtra tio n  a t 4°C. A 10 m l p lastic p ipette  (Costar) was taken and 
fille d  w ith  approxim ately 10 m l o f Sephadex G50 (g e l bed dimensions -  
20 x 0.8 cm ). VQ fo r the column was determ ined using Blue Dextran (0.2 
m g/m l) and found to  be 4.2 m l (Figure 2.2). The column was equilibrated 
a t 4°C w ith  10 m l o f ice -co ld  10 mM Tris-H C l (pH 7.4), 90 mM NaCl* 0.05% 
(w /v) d ig iton in . The soluble sample was loaded ca re fu lly onto the top 
o f the ge l bed using a Pasteur p ipette , and the column eluate collected. 
The sample was run through the column using more o f the same bu ffe r. 
The firs t 4.2 m l o f eluate was discarded (th is  volume represents the 
void volume o f the colum n), and the ]8 -adrenergic receptors co llected in  
the next 2.2 m l, and stored in  liqu id  nitrogen.
2.10. P hotoa ffin ity-labe lling  o f jS -adrenergic receptors
2.10.1. P hotoa ffin ity-labe lling  o f ^  -adrenergic receptors in  adipose 
tissue membranes 
P hotoaffin ity-labe lling  o f /3 -adrenergic receptors w ith  (+ )-3 - 
[^^JiodocyanopindolD l-diazirine ([^^SjjtCYPD) was perform ed as described 
by Burgerm eister e t aL. (1983), w ith  some modif i cations (see Figure 2.3 
fo r the chem ical structure o f [^^iJlC Y P D ). Adipose tissue membranes 
(600 jig  prote in) were suspended in  50 mM T ris-H C l (pH 7.4), 5 mM EDTA, 
0.1 mM ascorbic add containing 1 nM [^ ^EjECYPD in  a to ta l volume o f 
600 jjlL, under dim red lig h t in  a dark room. The sample was incubated 
fo r 1 h  a t 30°C in  the dark. Following incubation, the sample was 
transferred to  a 50 mm p lastic pe tri-d ish , and the volume increased to  6 
m l by addition o f ^ -s a tu ra te d  ice -co ld  50 mM T ris-H C l (pH 7.4), 5 mM
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EDTA. The dish was photolysed on ice  fo r 1 h w ith  long wave U.V. lig h t 
(366 nm ), using an U.V. lam p (2 x 8 W tubes, A llen) a t a distance o f 8 
cm. Samples were centrifuged im m ediately a t 20,000 rpm (SS34 ro to r; 
S orvall RC5B) fo r 10 min a t 4°G. The membrane p e lle t was washed once 
w ith  5 m l o f ice -co ld  50 mM T ris-H Q  (pH 7.4), 5 m M EDTA, resuspended in  
the required b u ffe r and stored a t -20° C. N on-specific p h o to a ffin ity  
labe lling  was determ ined by preparing an id e n tica l preparation in  the 
presence o f 100 jiM  (-)-isoproterenoL
P hotoaffin ity-labe lled preparations were no t boiled p rio r to  ge l 
electrophoresis, according to  the method o f Laem m li (1970), as th is  
results in  the form ation o f high m olecular weight aggregates (Shorr e t 
aL 1982, 1985).
2.10.2. P hotoa ffin ity-labe lling  o f soluble -adrenergic receptors
P hotoa ffin ity-labe lling  was perform ed according to  Burgerm eister 
e t aL (1983) w ith  some changes. -Adrenergic receptors were p a rtia lly  
pu rified  by a ffin ity  chromatography. P a rtia lly  pu rified  receptors were 
incubated w ith  1 nM [^^JECYPD in  50 mM T ris-H C l (pH 7.4), 5 mM EDTA, 
0.1 mM ascorbate in  a to ta l volume o f 250 jiL, fo r 2-3 h  a t room 
tem perature. The sample was loaded onto a 3.5 m l Sephadex G50 column 
(g e l bed dimensions: 12 x 0.6 cm) prequilibrated a t 4°C w ith  3 m l o f ic e - 
cold 5 mM Tris-H C l (pH 7.4), 0.05% (w /v) d ig iton in . When the sample had 
entered the gel, 1 m l o f equilhration b u ffe r was run through the column 
and the eluate discarded (represents the column void volum e). The|S - 
adrenergic receptors were eluted w ith  a fu rth e r 1.4 m l o f the same 
b u ffe r and d iluted to  a volume o f 3 m l w ith  N2“ saturated ice -co ld  5 
mM Tris-H C l (pH 7.4), and placed in  an open 50 mm pe tri-d ish  on ice . 
The sample was photolysed fo r 30 min using an U.V. lam p (2 x 8 W bulbs:
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A llen) a t a distance o f 8 cm. The photoa ffin ity-labe lled  |8 -adrenergic 
receptors were concentrated by lyophHisatLon o r using a Centricon 10 
m icro-concentrator (Am icon).
2.11. E lectrophoretic techniques
2.11.1. Sodium dodecyl sulphate polyacrylam ide ge l electrophoresis
SDS PAGE was perform ed according to  Laem m li (1970) w ith  some 
m odifications. Samples fo r electrophoresis were solubilised in  SDS 
sample b u ffe r (25 mM T ris-H C l (pH 6.5), 8% (w /v) SDS, 10% (v /v ) g lycero l, 
5% (v /v ) jS -  m ercaptoethanol, 0.001% (w /v) brom ophenolblue), and incubated 
fo r 1 h a t room tem perature. Electrophoresis was perform ed in  a Protean 
H (Bio-Rad) electrophoresis apparatus, equipped w ith  20 x 16 cm plates. 
Samples were resolved using a 2 cm, 4% stacking ge l and a 10% resolving 
ge l (fo r ge l buffers and m ixtures, see Hames, B. D ., 1981). Gels were 
run a t 120 V fo r the stacking gel, and 200 V through the resolving ge l 
u n til the dye fro n t was 1 cm from  the bottom  o f the geL Gels were 
stained using e ithe r 0.1% (w /v) Coomassae blue R250, 40% (v /v ) methanol, 
10% (v /v ) acetic acid, o r w ith  a s ilve r sta in k it (Bio-Rad) according to  
manufacturers instructions. For autoradiography, gels were stained and 
equilibrated in  7% (v /v ) acetic acid, 1% (v /v ) g lyce ro l fo r 1 h  a t room 
tem perature. Gels were dried on a Bio-Rad ge l dryer a t 80° C, and 
exposed to  F u ji X -ray film  in  an autoradiography cassette w ith  
in tensify ing  screens a t -7 0°C.
Molecular weights o f proteins were calculated from  a ca lib ra tion  
curve constructed from  the m obilities o f proteins contained in  a MW-SDS- 
6H m olecular weight marker k it (Sigma). A ca lib ra tion  curve is  shown in  
Figure 2.4. Marker proteins were: myosin (205 kD a); jS-galactosidase (116 
kDa); phosphorylase b (97.4 kDa); bovine serum album in (66 kDa); ovalbum in
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(45 kD a); carbonic anhydrase (29 kDa).
2.11.2. Isoe lectric focussing (IEF)
IEF was perform ed using the method o f O 'F a rre ll (1975), w ith  
am pholyte pH ranges o f 3-10 and 5-8. Samples were loaded a t the anode 
end o f the geL IEF was perform ed overnight a t 1 m A/gel (V max -  800 
V) a t room tem perature. Gels were stained w ith  Coomassae blue and 
sliced fo r counting, o r equilibrated and run in  a second dimension.
Iso -e le ctric  points o f proteins were calculated from  a 
ca lib ra tion  curve constructed from  the positions o f marker proteins w ith  
known ptl. A ca lib ra tion  curve is  shown in  Figure 2.5. Proteins used: 
bovine serum albumin (pl=4.9); carbonic anhydrase (pl=6.1); haemoglobin 
(pE-7.5).
2.11.3. Two-dim ensional polyacrylam ide ge l electrophoresis 
Two-dimensional PAGE was perform ed using the method o f O 'F a rre ll
(1975), w ith  some m inor m odifications.
Samples were subjected to  isoe le ctric  focussing (IE F) as 
described in  section 2.11.2. The IEF gels were equilibrated fo r 15 min 
in  50 m l o f SDS equilibration b u ffe r (62.5 m M T ris-H C l (pH 6.8), 2% (w /v) 
SDS, 2% (v /v ) P -m ercaptoethanol, 0.01% (w /v) bromophenol b lue). Gels 
were e ith e r frozen and stored a t -20°C o r run im m ediately in  a second 
dimension.
Second dimension ge l electrophoresis was perform ed according to  
Laem m li (1970). The second dimension was run in  16 x 16 cm plates 
using a 1.5 cm, 2.5% stacking ge l and a 10% resolving geL The IEF ge l 
was sealed on top o f the SDS gel using warm 1% (w /v) agarose (low  
gelling tem perature) in  62.5 mM Tris-H C l (pH 6.8), 0.1% (w /v) SDS. 
Electrophoresis was perform ed a t 80 V through the stacking gel, and
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200 V through the resolving geL Gels were stained and autoradiographed 
as decribed fo r SDS PAGE.
2.11.4. Two dim ensional benzyHLm ethyl-n-hexadecylam  m oroum chloride 
(16-BAC)/SDS PAGE 
Two dimensional electrophoresis was perform ed essentially as 
described by Macfarlane (1989), w ith  m odifications.- The firs t dimension 
(16-BAC) was run in  1.5 mm th ick  slab gels using 20 x 16 cm plates 
(Protean H, Bio-Rad). Electrophoresis was perform ed towards the cathode 
a t 30 m A/gel overnight (about 16 h ) a t room tem perature. Follow ing 
electrophoresis, gels were e ithe r stained and autoradiographed as fo r 
SDS PAGE, o r ind ividua l ge l lanes cu t out and run in  a second dimension 
using SDS PAGE. S trips (about 6 mm) were cu t from  the 16-BAC ge l and 
equilibrated (w ithou t previous drying) fo r 1 h  in  1.5 M T ris-H C l 
(pH 8.3), 4% (w /v) SDS, 10% (v /v ) g lycerol, 5% (v /v ) 2-m ercaptoethanol, 
0.01% (w /v) bromophenol blue. The ge l slice  was sealed on top o f an SDS 
polyacrylam ide ge l (2 cm 4% stacking gel, 10% resolving gel) in  20 x 16 
cm plates (Protean H, Bio-Rad) using 1% (w /v) low  gelling tem perature 
agarose in  62.5 mM T ris-H C l (pH 6.8), 0.1% (w /v) SDS. Electrophoresis 
was perform ed towards the anode a t 60 m A /ge l a t room tem perature. Gels 
were stained and autoradiographed as fo r SDS PAGE.
2.12. Production o f antibodies against the -adrenergic receptor
2.12.1. Im m unisation protoco l
Ind ividua l six-w eek-old fem ale BALB/c mice (A . Tuck & Son, 
Rayleigh, Essex, U .K.) were immunised w ith  three d iffe re n t immunogens: 
P a rtia lly  pu rified  (3-adrenergic receptors (1 pm ol) from  sheep adipose 
tissue membranes (m ice 1 -3 ); NaOH-treated sheep adipose tissue 
membranes (50 ug protein: mouse 4); 58 KDa proteins (50 ug prote in )
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electro eluted from  SDS PAGE gels o f sheep adipose tissue membranes 
(m ice 5 -8 ). Suspended immunogens were em ulsified in  tw ice th e ir volume 
o f Freund's adjuvant (1 p a rt com plete : 1 p a rt incom plete), and mice 
received in trape ritonea l in jections (300 jd ) o f the resulting emulsions. 
Animals were boosted (3 tim es) every 4 weeks w ith  the same amounts o f 
immunogen in  Freund's incom plete adjuvant (1 p a rt immunogen : 2 parts 
adjuvant), u n til a positive immune response was achieved. Three days 
p rio r to  fusion, mouse 2 was boosted in trapentonea lly w ith  2 pm ol o f 
p a rtia lly  pu rified  ^ 0-adrenergic receptor in  PBS.
2.12.2. Medium fo r fusion
Myeloma medium: RPMI 1640 medium, 10% (v /v ) FCS, 100 IU /m l p e n ic illin , 
100 jig /m l streptom ycin, 4 mM L-glutam ine.
HAT medium: Myeloma medium, 20% (v /v ) FCS, 0.1 mM hypoxanthine,
0.4 jiM  am inopterin, 16 jiM  thym idine.
HT medium: Myeloma medium, 20% (v /v ) FCS, 0.1 mM hypoxanthine,
16 jiM  thym idine.
2.12.3. Fusion protoco l
Mouse spleen ce lls were fused w ith  non-secreting mouse myeloma 
P3 X63-Ag 8.653 cells (Kearney e t aL, 1979) according to  the method o f 
G alfre & M ilstein (1981). B rie fly , 1.2 x 10® spleen cells and 1.7 x 10® 
myeloma ce lls in  the logarithm ic phase o f grow th were mixed and pelle ted < 
a t 1000 rpm fo r 10 min. The cells in  the p e lle t were fused by addition 
o f 0.8 m l prewarmed (37°C) 40% (w /v) PEG 1550 (in  RPMI 1640 medium) 
using a 1 m l syringe and 23g needle, slow ly over 1 min. The ce lls were 
allowed to  stand fo r 1 min, and 1 m l o f serum -free RPMI 1640 medium 
added slow ly over 1 min, follow ed by 20 m l o f myeloma medium over 5 
min. Cells were spun a t 1000 rpm fo r 10 min and resuspended gently in
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15 m l o f myeloma medium, 20% (v /v ) FCS, 4% (v /v ) hybridoma grow th 
fa c to r. The c e ll suspension was s p lit in to  3 x 5 m l aliquots, each 
receiving a d iffe re n t p la ting treatm ent in to  96-w e ll plates (lirib ro , Flow 
Laboratories). The ra tiona le  behind th is was to  investigate the e ffe c t 
o f HAT medium on the e ffic iency o f hybridoma production, by staggering 
the tim e a t which ce lls were exposed to  HAT medium post-fusion.
Tray 1: 50 jd/w e ll o f c e ll suspension in to  wells containing 50 jiL
o f myeloma medium, 20% (v /v ) FCS.
Tray 2: 5 m l o f 2 x HT medium (20% (v /v ) FCS) and incubated fo r 3 h  a t
37°C.Cells were spun a t 1000 rpm fo r 10 min and resuspended in  
10m l o f HAT medium, 2% (v /v ) hybridoma growth fa c to r. The 
ce lls were plated a t 100 jil/w e lL  
Tray 3: 50 ^d /w e ll o f c e ll suspension in to  wells containing 50 jil/w e ll
o f 2 x HAT medium (20% (v /v ) FCS).
The fo llow ing day, 50 ^iL o f medium was removed from  each w e ll o f 
tra y  1 and replaced w ith  50 j^lL o f 2 x HAT medium (20% (v /v ) FCS). On 
day 6 a fte r fusion, ce lls were fed w ith  100 jil/w e ll HAT medium. Three 
half-replacem ents w ith HAT medium were carried out during the next two 
weeks. Am inopterin was om itted from  the medium during expansion o f 
positive clones in to  24-w e ll plates. On days 14 and 18 a fte r the 
fusion, supernatants were assayed fo r antibodies against the jS -  
adrenergic receptor using an enzyme immunoassay (E IA ).
2.12.4 Enzyme immunoassay (E IA )
Hybridoma supernatants were in itia lly  screened fo r binding to  
sheep adipose tissue membranes, and sheep erythrocyte ghosts. Sheep 
erythrocyte ghosts were used as a negative con to l in  th is assay fo r 
antibodies against the ^-adrenerg ic receptor, since they had previously
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been shown to  be devoid o f measurable f$-adrenergic receptors. Sheep 
adipose tissue membranes and sheep erythrocyte ghosts were adsorbed 
onto 96-w e ll polystyrene plates overnight a t room tem perature, a t a 
prote in concentration o f 1 jig/w eH  in  PBS. The plates were washed three 
tim es w ith  PBS, 0.05% (v /v ) Tween 20 (PBS Tween), and blocked w ith  1% 
(w /v) BSA in  PBS fo r 1 h  a t room tem perature. Hybridoma supernatants 
(d ilu ted 1:2.5 in  RPMI 1640 medium) were transferred to  the plates and 
incubated fo r 2 h  a t room tem perature. A fte r three washings w ith  PBS 
Tween, 100 jiL  o f goat anti-m ouse IgG alkaline phosphatase conjugate 
(d ilu ted 1:1000) in  PBS Tween was added and incubated fo r 1.5 h  a t room 
tem perature. The plates were washed three tim es w ith  PBS Tween and 200 
J jl o f substrate (0.1% (w /v) 4 -iritrophenyl phosphate, 0.1 M glycine, 10 m M 
Z n d 2> ^  mM Mg&2) added, and the absorbance recorded a t 405 nm in  a 
T ite rte k  Twinreader. The assay was perform ed in  duplicate. Antisera o r 
hybridoma supernatants were classed as containing antibodies against the 
jg-adrenergic receptor when the absorbance change against sheep adipose 
tissue membranes (both plates) were s ign ifica n tly  higher than those fo r 
sheep erythrocyte ghost-coated wells (both p la tes). During the screening 
o f hybridomas, the background absorbance fo r each plate was defined as 
the mean absorbance reading fo r 10 wells devoid o f hybridomas.
2.12.5. Expansion o f positive hybridomas
Wells deemed to  possess antibodies against the -adrenergic 
receptor by EIA were expanded in to  a 24-w e ll p la te . The contents o f 
these positive wells were removed from  the 96-w e ll plates and 
transferred to  a w e ll o f a 24 -w e ll p la te (lin b ro , Flow) containing 1 m l 
o f HT medium and 10' mouse thymocytes as a feeder layer. A fte r 3 d the 
cells were fed w ith  a fu rth e r 1 m l o f HT medium and screened fo r
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antibodies against the |S-adrenergic receptor a fte r 1 week.
2.13. Com petition o f [~^~*I]ICYP binding to  sheep adipose tissue
membranes by hybridoma cultu re supernatants.
Sheep adipose tissue membranes (15 jig  prote in) were incubated 
w ith  100 jd. o f hybridoma cu ltu re  supernatant in  50 mM Tris-H C l (pH 7.4), 
10 mM MgC^, 0.1 mM ascorbate in  a to ta l volume o f 200 jd , fo r 1 h  a t 
37 °C. Follow ing incubation, [^^T]IC YP was added to  give a concentration 
o f 75 pM, and the tubes incubated fo r 1 h  a t room tem perature. The 
reaction was quenched by addition o f 5 m l o f ice -co ld  50 mM T ris-H C l 
(pH 7.4), 10 mM M gC^, and the m ixture filte re d  rap id ly on a single 2.5 
cm Whatman GF/C filte r . The filte r  was washed tw ice  w ith  5 m l o f ic e - 
cold 50 mM Tris-H C l (pH 7.4), 10 mM M gC^. [^^ I]IC Y P  bound to  the 
filte rs  was quantified using a LKB Gamma counter.
2.14. Im munoprecipitatLon o f soluble sheep adipose tissue membrane 
jg-adrenergic receptors by hybridoma cu ltu re  supernatants. 
D igitonin-solubilised sheep adipose tissue membranes (30 jig
prote in ) were incubated w ith  100 jd. o f hybridoma cu ltu re supernatant in  
10 mM T ris-H C l (pH 7.4), 10 mM N ad, 0.1 mM ascorbate in  a to ta l volume 
o f 250 jd , and incubated overnight a t 4°C. P recip ita tion o f the firs t 
antibody was achieved by addition o f e ithe r 100 jd. o f agarose-coupled 
goat anti-m ouse IgG (Sigma) o r 40 jd. o f sheep anti-m ouse IgG (SAPU). 
Tubes were vortexed and incubated fo r 2 h  a t room tem perature, and 
subsequently centrifuged a t 3000 r.p.m . fo r 30 min a t room tem perature. 
200 jd . o f supernatant was removed and the number o f -adrenergic 
receptors rem aining quantified using 75 pM [^ ^^LjECYP and PEG 
p recip ita tion , as described previously (section 2.5.2.2). N on-specific 
binding was determ ined using 100 jiM  (-)-isoproterenoL
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2.15, Im munoprecipltatlDn o f soluble photoaffira ty-labe lled sheep
adipose tissue membrane ^ -ad renerg ic receptors by hybridoma
cu ltu re  supernatants
Sheep adipose tissue membrane f t  -adrenergic receptors were 
photoaffim ty-labe lled w ith  [^ ^^iJtGYPD (section 2.10.1), and subsequently 
solubilised w ith  1% (w /v) d ig itonin (section 2.7), as described
previously. Solubilised pho toa ffin ity-labe lled  sheep adipose tissue 
membranes (120 jig  pro te in) were incubated w ith  200 j j I  o f hybridoma 
cu ltu re supernatant overnight a t 4°C. 150 jiL  o f SAC-CEL (A n ti-
m ouse/rat) was added, and the tubes vortexed and le ft a t room 
tem perature fo r 30 min. Samples were centrifuged a t 1000 xg fo r 10 min 
a t room tem perature, and the supernatant decanted. [^^ijLC YPD  in  the 
p e lle t was quantified using a LKB Gamma counter. 150 jiL  o f SDS sample 
b u ffe r (25 mM T ris-H C l (pH 6.5), 8% (w /v) SDS, 10% (v /v ) g lycero l, 5% 
(v /v ) yg- m ercaptoethanol, 0.001% (w /v) bro mophenol blue was added to  each 
sample, and the tubes vortexed and le ft a t room tem perature fo r 1 h. 
Samples were centrifuged a t 1000 xg fo r 5 min to  p e lle t the SAC-CEL 
beads. The SDS sample b u ffe r was removed and subjected to  SDS PAGE and 
autoradiography, as described previously (section 2.11.1).
2.16. Im munoblotting technique
Proteins were subjected to  SDS PAGE as described, using a M ini 
Protean H (Bio-Rad) ge l apparatus, and a running voltage o f 150 V. 
Transfer o f proteins to  nitrocellu lose membrane (Gelman Sciences; 
BioTrace NT, 0.45 jim ) was perform ed according to  Towbin e t aL (1979), 
using a Bio-Rad M ini Transblot celL E ffic ie n t transfe r was achieved a t 
100 V fo r lh in  25 mM Tris-H C l, 192 mM glycine, 20% (v /v ) methanoL The 
n itrocellu lose was rinsed once in  TBS (5 mM T ris-H C l (pH 7.6), 0.9% (w /v)
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NaCL), and saturated w ith  TBS, 1% (w /v) dried skimmed m ilk (M arvel) fo r 1 
h  a t room tem perature. The nitrocel l ulose was placed in  a 16-channel 
clam p (Biometxa) and d ilu ted antisera in  TBS, 1% (w /v) M arvel pipetted 
in to  separate channels and incubated overnight a t room tem perature. The 
firs t antibody was flushed from  the clamp w ith  TBS, and the
nitrocellu lose transferred to  a shallow tra y  and rinsed three tim es w ith  
TBS, 1% (w /v) M arvel (5 m in/rinse). Fresh TBS, 1% (w /v) M arvel 
containing horseradish peroxidase-labelled second antibody (1:100; SAPU) 
was added and incubated fo r 2 h a t room tem perature w ith  occasional 
shaking. A fte r extensive washing w ith  TBS, binding o f second antibody 
was revealed using 4-ch lo ro -l-na p tho ]/H 202 substrate.
2.17. P rotein determ ination
Protein was measured by the method o f Bradford (1976) using the 
B io-rad protein assay (C at. No. 500-0006). BSA (F raction V) was used as 
a prote in standard (1-5 pg standard curve). Assays were perform ed in  
96 -w ell m icro titre  plates, and read using a T ite rte k  MuLtiskan a t 600 
nm.
In  samples containing digitonm , the fin a l concentration o f 
detergent in  each w e ll was kept below 0.1% (w /v), so th a t the 
in terference o f d ig iton in w ith  the protein assay was m inim al (see Figure 
2.6).
2.18. Analysis o f data
Results are expressed as mean + /- S.E.M. Radioligand com petition 
curves were analysed using a four-param  e te r lo g is tic  equation (ALLFTT; 
De Lean e t aL, 1978). Analysis o f IC^q values from  com petition curves 
obtained fo r lacta ting  and non-lactating sheep was perform ed using 
analysis o f variance u tilis in g  the GEN ST AT com puter program.
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S ta tis tica l analysis o f paired o r unpaired 
using a Student*s t-te s t.
observations was perform ed
Fig. 2.1. Separation o f soluble membrane prote in (^-adrenergic 
receptor) from  free  [ 3H]DHA
Digitom n-solubdlised sheep adipocyte membranes (100 jjg  pro te in ) 
were incubated w ith  10 nM [ 3H]DHA fo r 10 min a t 30°C, in  10 mM T ris-H C l 
(pH 7.4), 90 mM NaCl, 0.1 mM ascorbate, in  a to ta l volume o f 300 j j L  The 
sample was loaded onto a pre-eqirilibrated column (5 m l p ipe tte , Costar) 
fille d  w ith  3.5 m l o f Sephadex G50 (g e l bed dimensions -  12 x 0.6 cm ). 
E lution was achieved w ith  10 mM Tris-HCL (pH 7.4), 90 mM NaCl, 0.05% 
(w /v) d ig iton in , and 0.2 m l fractions collected fo r protein (open de les) 
and [ H]DHA (closed circ les) measurement. The void volume (VQ) fo r the 
column was 1.75 m l, determ ined using Blue Dextran 2000.
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Fig. 2.2. Determ ination o f the void volume (Vo) fo r 0.8 x 12 cm
Sephadex G50 column
A 10 m l p lastic p ipe tte  (Costar) was blocked w ith  glass wool, and 
fille d  w ith  Sephadex G50 to  give a ge l bed w ith  dimensions o f 0.8 x 20 
cm. Next, 400 p i o f Bine Dextran 2000 (0.2 m g/m l) mixed w ith  3 drops o f 
g lycero l was loaded onto the column, and eluted w ith  d is tille d  w ater a t 
room tem perature. The elnate was collected, and 200 p i samples were 
read a t 540 nm using a T ite rte k  Twinreader. Vo was found to  be 4.2 m l 
(Maximum absorbance fo r Bine Dextran a t 540 nm ).
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Fig. 2.3. Chemical structure of (t)-3-r^^liodocyanopm do]ol diazirine
[ 125I]ICYPD consists o f iodocyanopdndolol linked to  a
photoreactive m oiety, which absorbs u ltra -v io le t a t 366 nm.
125i
OH CH3
i • 11
0-CH2-CH-CH2-NH-Gj-CH2-N H -C
CH3 
i 
t
l o d o c y a n o p i n d o l o l i 3 - t r i f  l u o r o m e t h y l -
3 - p h e n y l d i a z i r i n e
Fig. 2.4. Calibration curve fo r determination of molecular weights for
proteins by SDS PAGE
Proteins from  the MW-SDS-6H (Sigma) m olecular weight m arker k it 
were subjected to  SDS PAGE, using a 10% resolving geL Proteins were
visualised w ith  Coomassie blue stain, and th e ir re la tive  m obilities (R f) 
calculated. Proteins used: myosin (205 kDa); jS-galactosidase (116 kDa); 
phosphorylase b (97.4 kDa); bovine serum albumin (66 kDa); ovalbum in (45 
kD a); carbonic anhydrase (29 kDa).
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Fig. 2.5. Calibration curve for the calculation of isoelectric points
(p i) o f proteins fo llow ing IEF
Proteins w ith  known isoe lectric  points were subjected to  IEF 
using an ampholyte pH gradient o f 3-10, and localised w ith  Coomassie 
blue staining. The m obility (R f) o f the proteins was calculated re la tive  
to  the anode (Rf=0) and the cathode (R f= l) ends o f the geL Proteins 
used; bovine serum album in (pl=4.9); carbonic anhydrase (pl=6.1); 
haemoglobin (pl=7.5).
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Fig. 2.6. The effect of various levels of djgitonin on the Bradford
protein assay
BSA was quantified a t concentrations o f 0.1, 0.5, 1.0, 2.0 and 4.0 
pg/50 jiL  (w e ll), in  the presence o f 0%, 0.1% and 0.5% (w /v) d ig iton in , 
using a Bio-Rad protein assay k it, according to  the manufacturers 
instructions. The determ ined values are p lo tted  against the actua l 
protein concentrations in  each welL Each po in t represents the mean o f 
trip lic a te  readings.
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CHAPTER THREE -  PURIFICATION OF THE ^-ADRENERGIC RECEPTOR
OF SHEEP ADIPOSE TISSUE
3.1. Introduction
In  lig h t o f the key ro le  which (S -adrenergic receptors play in  
adipose tissue metabolism, i t  was decided to  attem pt the pu rifica tio n  o f 
the receptor(s) from  adipose tissue, w ith  a view to  increasing our 
knowledge o f th e ir physical characteristics and obtaining enough 
p a rtia lly -p u rifie d  receptor fo r the production o f antibodies against the 
jS-adrenergic receptor. The approach used involved a ffin ity  
chromatography o f -adrenergic receptor to  gain an in itia l pu rifica tio n . 
The success o f th is  process was monitored using SDS PAGE and 
radioligand binding. An a lte rna tive method using 16-BAC ge l 
electrophoresis was also studied, because o f its  claim ed high protein 
loading capacity and resolution, plus its  previous use fo r p u rifica tio n  
o f prote in antigens fo r the production o f monoclonal antibodies.
3.2. Experim ental procedure
D etails o f a ll methods used fo r the p u rifica tio n  o f |5-adrenergic 
receptors are contained in  Chapter 2. B rie fly , sheep adipose tissue 
membranes were isolated from  om ental adipose tissue (unless
otherwise mentioned). Subcutaneous adipose tissue was used fo r the 
preparation o f adipocyte membranes. Adipose tissue was obtained from  
e ith e r wether lambs, non-lactating ewes, o r lacta ting  ewes (as 
ind ica ted). Membranes were solubilised w ith  the plant glycoside 
d ig iton in , and the resulting preparation passed through a Sepharose 4B- 
alprenolol a ffin ity  column. A ffin ity  column eluates were analysed using 
radioligand binding assays and photoa ffin ity-labe lled  w ith  [ ^ ^ i]  
iodocyanopindolol-diazirine ([^^ijEC Y P D ).
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3.3. Results
3.3.1. Preparation o f sheep adipose tissue membranes
In itia l studies during th is work were perform ed using sheep 
subcutaneous adipocyte plasma membranes, whose preparation involved 
collagenase digestion (section 2.3.1). These membranes proved to  be a 
good source o f -adrenergic receptors, typ ica lly  containing 150 fm ol/m g 
protein o f receptors, determ ined using 10 nM [  H]DHA. However, the use 
o f collagenase lim ite d  the amount o f adipose tissue which could be 
processed a t any one tim e (typ ica lly  80 g), and yielded on average about 
10 mg o f membrane protein . I t  was therefore decided to  use a la rg e r- 
scale p u rifica tio n  method using whole adipose tissue (section 2.3.2), in  
order to  iso late the large quantities o f membranes required fo r f$- 
adrenergic receptor p u rifica tio n . This method has a high capacity (>1 
kg adipose tissue), and involves no addition o f exogenous proteases (as 
contained in  collagenase preparations) which m ight degrade ^-adrenerg ic
receptors. This method also gave a good yie ld  (although about h a lf th a t
\
obtained using collagenase digestion) o f membranes (30-50 mg/kg adipose 
tissue), w ith  high specific a c tiv itie s  o f (S-adrenergic receptors, usually 
200-400 fm ol/m g protein (Table 4.4 and Figure 4.11). However one 
disadvantage o f the method is  th a t contam ination o f the adipocyte plasma 
membrane preparation w ith  strom a-vascular membranes was unavoidable.
3.3.2. Solubilisation o f sheep adipose tissue membranes
Sheep adipose tissue membranes were solubilised using the p lan t 
glycoside d ig itonin. Typ ica lly, 35 mg o f sheep adipose tissue membrane 
protein were solubilised w ith  a protein yie ld o f 60-65%. Solubilisation 
tim es o f 1.5 h gave b e tte r protein yields compared to  1 h, and i t  was 
also very im portant to  homogenise the sheep adipose tissue membranes
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thoroughly w ith  the d ig lton in  solution. T ria ls w ith  0.3% and 1.5% 
d ig iton in solutions did not increase the yie ld  o r specific a c tiv ity  o f jS - 
adrenergic receptors in  soluble preparations, in  contrast to  th e ir 
beneficial, usage during the p u rifica tio n  o f ham ster lung ^2~a^ renex&c’ 
receptor by J. L. Benovic (personal com m unication). The yie ld  o f 
adrenergic receptors was not determ ined, bu t the ligand binding a c tiv ity  
o f receptors seemed to  be low er in  solubilised preparations than in  
membranes (see Tables 3.1 & 3.2).
3.3.3. A ffin ity  chromatography o f -adrenergic receptors
Synthesis o f the Sepharose 4B -alprenolol a ffin ity  resin was 
achieved as described in  Chapter 2. Some clumping o f the ge l occurred 
during the synthesis, and was removed by passing the suspension through 
a 10 m l p lastic syringe. Use o f a tem perature o f 40°C fo r the fin a l 
coupling o f alprenolol to  the ge l m atrix reduced aggregation.
jS-Adrenergic receptors from  sheep (w ether) om ental adipose 
tissue membranes were solubilised in  digi t onin, and subjected to  a ffin ty  
chromatography on a 10 m l Sepharose 4B -alprenolol column. During 
loading o f the preparation, greater than 95% o f the prote in passed 
through the column (Table 3.1 and Figure 3.1). This is  ra the r a high 
value fo r protein re tention on an a ffin ity  column m atrix, and re fle c ts  
the ion-exchange properties o f the covalently-bound alprenoloL Washing 
the column w ith  0.5 M NaCl did re su lt in  greater elution o f prote in , bu t 
decreased the yield o f -adrenergic receptors. The amount o f prote in 
contained in  fractions 11-14 (see Table 3.1) which were pooled fo r 
monoclonal antibody production, represents 0.6% o f the prote in loaded 
onto the column. For the th ird  pu rifica tio n , th is  figure  dropped to  0.1% 
(Table 3.2). Bound receptors were eluted w ith  a fro n t o f 1 mM ( - ) -
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isoproterenol; the peak o f receptor "bonding was detected in  fra c tio n  11 
(Table 3.1. and Figure 3.2). Fractions o f eluted receptors were subjected 
to  ge l filtra tio n  p rio r to  assay, to  remove the (-)-isoproterenoL The 
peak fra c tio n  contained 16.4 pm ol/mg o f -adrenergic receptors, 
representing a p u rifica tio n  o f 105 fo ld . The yield o f (3 -adrenergic 
receptors was 43%.
The results described represent the firs t p u rifica tio n  perform ed. 
In  subsequent purifica tions, the le ve l o f p u rifica tio n  increased markedly 
to  >300 fo ld  w ith  a 65% yie ld  (1.828 pm ol) o f receptors (Table 3.2).
3.3.4. Studies using pho toa ffin ity-labe lled  ^ -adrenerg ic receptors
3 .3 .4 .I. P hotoaffin ity-labe lling  o f -adrenergic receptors
/8-Adrenergic receptors were photoa ffin ity-labe lled  w ith  [ ^ ^ i]  
iodocyanopindolol-diazirine ([^~*I]IC YPD ), which can be labelled to  a high 
specific a c tiv ity  (^2000 C i/m m ol). Use o f 1 nM [^^ijLC YPD  fo r the 
in itia l equilibration step meant th a t saturating concentrations o f the
ligand were present (see Figure 4.3 fo r [^^IjLC Y P ), i f  one assumes
s im ila r binding characteristics fo r [-^^ijLCYPD and [l^ jE C Y P . 
Q uantification o f bound [^^ijECYPD fo llow ing p h o to a ffin ity-labe llin g  
revealed th a t f$-adrenergic receptors were labelled to  alm ost the same 
extent as w ith  [^^I]IC Y P  (results no t shown). However, when samples
were subjected to  SDS PAGE (Figure 3.3), most o f the counts loaded
migrated w ith  the dye fro n t. This indicated th a t only a few percent o f 
[125i ] ic y PD counts were covalently bound to  receptor. Two more washings 
o f the photoaffin ity-labe lled  preparations did no t reduce the number o f 
non-covalentLy bound counts. Fewer counts were located a t the dye fro n t 
when pho toa ffin ity-labe lling  was performed in  the presence o f 10 jiM  ( - ) -  
alprenolol (Figure 3.3). This was presumably due to  the blocking o f non-
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f$-adrenergic receptor binding sites (non-specific) by alprenolol.
3.3.4.2. SDS PAGE
Membrane-bound and p a rtia lly  p u rifi ed /S-adrenergic receptors 
from  sheep (w ether) subcutaneous adipocytes were photoa ffin ity-labe lled  
w ith  [12 5 i]icypd  and subjected to  SDS PAGE. According to  the method o f 
Laem m li (1970), samples are boiled fo r a few minutes p rio r to  
electrophoresis. However, boiling o f pho toa ffin ity-labe lied  samples p rio r 
to  SDS PAGE, resulted in  the form ation o f high m olecular weight 
aggregates (F igure 3.4, lanes 1 and 2). Only a specifica lly-labe lled  30 
kDa protein m igrated in to  the resolving ge l (F igure 3.4, lane 1). When 
samples were not boiled, speci f ica lly-labe lled  proteins w ith  m olecular 
weights o f 58, 42.5 and 30 kDa were seen (F igure 3.4, lane 3). Non­
specific labelling was re s tric te d  to  a 45.8 kDa protein (Figure 3.4, lane 
4). Also, the pattern o f labe lling was found to  be the same fo r om ental 
and subcutaneous adipose tissue depots, and fo r adipose tissue from  
wethers and ewes (c .f. Figures 3.4 & 3.6). The broad banding on the 
autoradiographs is  characte ristic o f glycoproteins.
SDS PAGE o f p a rtia lly -p u rifie d  photoa ffin ity-labe lled  jB - 
adrenergic receptors from  sheep (w ether) subcutaneous adipocytes, 
revealed a single 58 kDa labelled protein (F igure 3.5, lane 1). This 
labelling was inh ib ited  by 10 jiM  (-)-a lp re n o lo l (Figure 3.5, lane 2). 
Also no increase in  apparent molecular weight occurred when samples 
contained high concentrations o f the disulphide bridge reducing agents 
m ercaptoethanol and d ith io th re ito l, o r the alkylating agent N - 
ethylm aleim ide (Figure 3.5, lanes 3-5, respective ly). \
P hotoaffin ity-labe lling  o f ra t adipocyte £  -adrenergic receptors, 
prepared from  abdominal adipose tissue, revealed specific labe lling  o f a
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single 48 kDa band (Figure 3,6). N on-specific label l ing was much higher 
than fo r sheep adipocyte membranes run on the same geL
3.3.4.3. Isoe lectric focussing (IEF) and 2D PAGE
IEF o f pho toa ffin ity-labe lled  -adrenergic receptors from  sheep 
(w ether) subcutaneous adipocyte membranes revealed a single labelled 
peak (F igure 3.7a), no t present when pho toa ffin ity-labe lling  was
perform ed in  the presence o f 10 jiM  (-)-a lp re n o lo l (Figure 3.7b). On an 
am pholyte pH range o f 3-10, the peak was a t pH 6.15 (F igure 3.8a), and 
a t pH 6.25 on the narrower pH range o f 5-8, w ith  a shoulder on its  
acid ic side, ind ica ting the possible presence o f several receptor 
isoform s (Figure 3.8b). As w ith  SDS PAGE, most o f the [^^ijLC YPD  loaded 
was non-covalentLy bound and remained a t the acid ic end o f the geL
P artLa lly-p in ified photoa ffin ity-labe lled  -adrenergic receptors 
from  sheep (w ether) subcutaneous adipocytes gave d iffe re n t results. On 
a pH range o f 3-10, the peak a t pH 6.25 was seen, and also an additional 
broader peak a t pH 4.85 (F igure 3.9a). On a pH range o f 5-8, only a 
shoulder a t the acid ic end o f the ge l was observed (F igure 3.9b).
To determ ine whether the broad acid ic peak on the pH 3-10 ge l 
(F igure 3.9a) represented f i -adrenergic receptor, the separated proteins 
were run in  a second dimension using SDS PAGE. A fte r a 20 day exposure 
period, nine labelled proteins were seen, a ll having a m olecular weight 
o f 58 kDa (Figure 3.10). The autoradiograph was scanned w ith  a Bio-Rad 
video densitom eter to  give the re la tive  proportions o f these labelled 
species (F igure 3.11). Peaks 6 and 7 represent the major isoform s. No 
pho toa ffin ity-labe ll ed proteins were observed when labelling was 
perform ed in  the presence o f 100 jiM  (-)-isop ro te ren o l (results no t 
shown).
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3.3.4.4. 16-BAC PAGE
16-BAC PAGE is  an electrophoretic technique akin to  SDS PAGE, 
which u tilises the cation ic detergent 16-BAC (SDS is  anionic). I t  was 
used because i t  can accomodate higher protein loadings than SDS PAGE, 
and can also be used preparativeiy in  a two-dim ensional mode. 16-BAC 
PAGE o f photoaffinity-labelLed jS-adrenergic receptors from  sheep 
(lacta ting  ewe) adipose tissue and subsequent autoradiography, revealed 
a broad protein band about halfw ay down the ge l (Figure 3.12). This 
band was displaced by 100 jjM (-)-isoproterenoL No [^^ijLC YPD  was 
evident a t the dye fro n t. However when 1 mg o f sheep (lacta ting  ewe) 
adipose tissue membrane protein was used, and the ge l sliced and 
counted, w ell-defined peaks were obtained w ith  [^ ^^ijLCYPD appearing to  
reside a t both ends o f the ge l (Figure 3.13).
Proteins resolved using 16-BAC PAGE were subjected to  
electrophoresis in  a second dimension using SDS PAGE. Two-dim ensional 
separation o f sheep (lacta ting  ewe) adipose tissue membranes resolved 
the proteins along a diagonal lin e , ind ica ting an overiding e ffe c t o f 
m olecular weight on the resolving process (F igure 3.14). Using 
photoa ffin ity-labe lled  |S-adrenergic receptors from  sheep (lacta ting  ewe) 
adipose tissue membranes, i t  was possible to  id e n tify  several 
specifica lly labelled proteins (Figures 3.15 & 3.16). The resolution was 
much poorer than th a t obtained using IEF as the firs t dim ensional 
separation. In  a separate experim ent, a ge l slice containing the m ajor 
peak o f ph o toa ffin ity-labe lling  (slices 26-28), was cu t from  a 16-BAC 
PAGE ge l o f pho toa ffin ity-labe l! ed yS -adrenergic recqptors from  sheep 
(lacta ting  ewe) adipose tissue membrane j5-adrenergic receptors, and run 
in  a second dimension (Figure 3.17a). S licing and counting o f the SDS
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PAGE ge l resulted in  a single peak (Figure 3.17b). Simi la r results were 
obtained when the irra d ia tio n  tim e during pho toa ffin ity-labe lling  was 10 
min (data no t shown).
3.4. Discussion
Preparation o f sheep om ental adipose tissue membranes from  whole 
adipose tissue was useful fo r pu rifica tio n  o f the -adrenergic receptor. 
Although digestion o f adipose tissue w ith  collagenase was gave a good 
yie ld  o f adipocyte membranes, i t  had lim ite d  capacity. Radioligand
binding data and SDS PAGE o f pho toa ffin ity-labe lled  -adrenergic
receptors also indicated th a t use o f collagenase causes degradation o f 
some receptors. Collagenase preparations are known to  contain trypsin 
and clostripa in , which have been shown to  degrade adipocyte-specific c e ll 
surface antigens (A l-JafarL e t aL, 1986). Also as the duration o f
collagenase digestion increases, so does the damage to  c e ll surface
antigens (A l-JafarL e t aL, 1986). I t  is  therefore understandable why 
membranes no t exposed to  collagenase digestion contain more in ta c t £ -  
adrenergic receptors as found w ith  preparations o f sheep adipose tissue 
membranes.
A c ritic a l step in  the pu rifica tio n  o f a membrane bound prote in 
is  its  extraction o r solubilisation from  the phospholipid b ilayer. There 
is  a wide varie ty o f detergents available fo r solubilising membrane 
proteins, including non-ionic detergents such as Lubrol PX, T riton  X - 
100, o c ty l glucoside and digiton in , and ion ic detergents such as sodium 
cholate, CHAPS and SDS (fo r review see Hjelmeland & Chrambach, 1984). 
From the above lis t o f detergents, only d ig itonin is  capable o f 
solubilising |S-adrenergic receptors in  an active state Le. a sta te  which 
binds adrenergic ligands (Caron & Lefkow itz, 1976). As an a lte rna tive  to
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dig iton in , some workers have used dodecyl-|§-m altoside w ith  s im ila r 
results (Tota & Strader, 1990). Solubilisation o f sheep adipose tissue
membranes in  1% d ig iton in  fo r 1.5 h  was found to  be optim al. The
protein yie ld o f 65% is  comparable to  th a t achieved fo r ra t adipocyte 
plasma membranes (Cubero & Malbon, 1984).
A ffin ity  chromatography is  a useful step fo r the p u rifica tio n  o f 
the £ -adrenergic receptor, and can provide a 1000 fo ld  pu rifica tio n  and 
receptor recoveries o f 50% (Vauquelin e t aL, 1979; Graziano e t a l, 1985; 
Cubero & Malbon, 1984). The Sepharose 4B -alprenolol a ffin ity  resin 
described by Caron e t aL, 1979 was used in  lig h t o f its  extensive use 
in  many laboratories (Shorr e t aL, 1982; Cubero & Malbon, 1984; Bahouth 
& Malbon, 1987). The 304 fo ld  p u rifica tio n  achieved fo r jg-adrenergic 
receptors from  sheep om ental adipose tissue is  comparable to  th a t
obtained fo r dog lung (Homey e t aL, 1983) and frog  erythrocytes (Caron 
e t aL, 1979; Shorr e t aL, 1981). The Sepharose 4B -alprenolol a ffin ity  
column increased in  e ffic iency during successive purifica tions. The
higher specific a c tiv itie s  o f jg-adrenergic receptor which resulted may be 
explained by a decrease in  non-specific binding o f protein to  the column. 
However th is does no t explain the increase in  receptor yie ld .
The p a rtia lly -p u rifie d  preparations obtained were o f su ffic ie n t 
p u rity  fo r lim ite d  studies on receptor characteristics Le. p h o to a ffin ity - 
labe lling, SDS PAGE and IEF, and contained enough jg-adrenergic receptor 
protein to  attem pt the production o f monoclonal antibodies (Chapter 5).
1-2 pm ol o f jg-adrenergic receptor has been used fo r im m unisations 
during the production o f monoclonal antibodies directed against the 
turkey erythrocyte jg -^-adrenergic receptor (Couraud e t aL, 1985; Fraser & 
Venter, 1980), human A431 jg2~adrenergic receptor (Kaveri. e t aL, 1987),
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and c a lf ^ -a d re n e rg ic  receptor (Fraser & Venter, 1980). Therefore two 
a ffin ity  purifica tions provided su ffic ie n t jg -adrenergic receptors fo r the 
im m unisation o f three animals (Chapter 5). SDS PAGE o f p a rtia lly - 
pu rified  jg-adrenergic receptor preparations indicated the presence o f 
large varie ty o f non-jg-adrenergic receptor proteins, and hence they were
unsuitable fo r the production o f polyclonal antisera. Despite using 
about 1 kg o f sheep adipose tissue, the amount o f membranes (30-50 mg 
prote in) obtained was in su ffic ie n t to  allow recycling through a second 
a ffin ity  column, as u tilised  by other researchers to  increase the p u rity  
o f the jg-adrenergic receptor preparations (Graziano e t aL, 1985; Shorr 
e t aL, 1981; Homey e t aL, 1983). Also HFLC (Shorr e t aL, 1981, 1985; 
Cubero & Malbon, 1984; Graziano e t aL, 1985) and hydrophobic 
chromatography (Bahouth & Malbon, 1987) were unsuitable fo r the same 
reason.
P hotoaffin ity-labe lling  has proven to  be a valuable to o l in  the 
biochem ical characterisation o f the jg-adrenergic receptor. P hotoa ffin ity 
probes possess high specific a c tiv itie s  and high a ffin ity  (Kd <10” ^) fo r 
the jg-adrenergic receptor. In  th is study, ph o to a ffin ity-labe llin g  was 
used to  determ ine the m olecular size o f the receptor in  membrane 
preparations, and to  fo llow  the a ffin ity  p u rifica tio n . P h o to a ffin ity - 
labe lling  o f jg-adrenergic receptors from  both subcutaneous and om ental 
sheep adipose tissue membranes w ith  [^^iJlC Y P D , specifica lly labelled a 
protein w ith  a molecular weight o f 58 kDa on SDS PAGE. M inor proteins 
a t m olecular weights o f 42.5 kDa and 30 kDa were also present, and may 
arise from  pro teo lytic degradation o f the 58 kDa protein. Heterogeneity 
resulting from  endogenous p ro teo lytic a c tiv ity  varies among species and 
tissues, and can be lim ite d  w ith  protease inh ib ito rs and m etal-ion
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chelators such as EDTA and EGTA (Benovic e t aL, 1983; Strosberg e t aL, 
1984; S tru lo v ic i e t aL, 1984). Boiling o f samples in  SDS sample b u ffe r 
p rio r to  SDS PAGE, results in  the form ation o f high m olecular weight 
aggregates, a phenomenon which has been described previously fo r turkey 
erythrocyte ^-adrenergic receptors (Shorr e t aL, 1982). I t  is  unclear 
whether th is aggregation is  a property o f native -adrenergic receptor 
o r crosdinking o f the p h o to a ffin ity  probe. The problem was overcome by 
denaturing samples a t room tem perature fo r 1 h.
Photo a ffin ity -la b e llin g  o f the j3 -adrenergic receptors o f ra t 
adipocytes labelled a protein w ith  a m olecular weight o f 48 kDa. This 
contrasts w ith  the m olecular weight determ ined fo r pu rified  radiodinated 
ra t adipocyte jS-adrenergic receptors o f 67 kDa (Cubero & Malbon, 1984). 
In  addition, th is receptor has been shown to  m igrate on SDS PAGE as a 54 
kDa protein under non-reducing conditions, bu t as a protein o f 67 kDa in  
the presence o f high concentrations o f the disulphide bridge reducing 
agents jg-m ercaptoethanol (10% (v /v )) o r d ith io th re ito l (10 mM) (Moxham & 
Malbon, 1985). This e ffe c t is  also seen w ith  S49 mouse lymphoma cells 
which possess a homogeneous population o f ^2'~a^rener&c  receptors 
(Moxham e t aL, 1986), and human (3^- and ^ 2 “ a^rener&c  receptors 
(Bahouth & Malbon, 1987). Radio-iodinatLon is  no t the cause o f th is 
e ffe c t since id e n tica l results have been obtained using unlabelled 
pu rified  receptor and im  munoblotting techniques (Moxham e t aL, 1986). 
This find ing calls in to  question p rio r speculation th a t a m inor 55 kDa 
protein observed in  purif ied (Cubero & Malbon, 1984) and p h o to a ffin ity - 
labelled (S tiles e t aL, 1984b) preparations o f -adpenergic receptor, 
respectively, represents a p ro teo lytic fragm ent o f the 67 kDa form  o f 
the receptor. An equally plausible explanation fo r the appearance o f the
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55 kDa form  is  th a t o f incom plete reduction o f intram olecular disulphide 
bridges in  the receptor p rio r to  SDS PAGE. The reasons fo r the apparent 
lack o f a 67 kDa photoaffinity-labelLed prote in in  th is  study are 
unclear, bu t i t  m ight re fle c t in s ta b ility  o f th is  (3-adrenergic receptor 
under these conditions, o r degradation by proteases contained in  the 
collagenase used during adipocyte membrane preparation. Also, the low 
apparent m olecular weight is  unlike ly to  be a resu lt o f incom plete 
reduction o f intram olecular disulphide bridges in  the (3-adrenergic 
receptor, as high concentrations o f -  m ercap to  ethanol (10% (v /v )) were 
used.
The frog  erythrocyte ^ 2 “ ac^renerg^ c receptor has a m olecular 
weight o f 58 kDa, as id e n tifie d  by pho toa ffin ity-labe lling  and 
ph o to a ffin ity  crosslinking (Lavin e t aL, 1981, 1982), as w e ll as by 
p u rifica tio n  methods (Shorr e t aL, 1981). I t  m igrates as a broad band 
centred around molecular weight 58 kDa on SDS PAGE (Shorr e t aL, 1981). 
The reasons fo r th is apparent m icro-heterogeneity, also seen w ith  sheep 
adipose tissue ^-adrenergic receptors in  th is study are not clear, bu t i t  
may re la te  to  heterogeneity o f carbohydrate moieties present on the 
glycoprotein receptor. [^~*I]IC YPD -labelling o f other mammalian |S - 
adrenergic receptors tends to  re su lt in  labe lling o f proteins o f 
m olecular weight 62-67 kDa, whereas w ith  avian jS-adrenergic receptors 
e.g. those o f turkey, pigeon and duck, two proteins are labelled having 
m olecular weights o f 38-40 kDa and 45-50 kDa (fo r review see Lefkow itz 
e t aL, 1983). The sheep adipose tissue f$-adrenergic receptor therefore 
appears to  have a m olecular weight between these two groups.
A fte r a ffin ity  pu rifica tio n  o f ^-adrenergic receptors from  sheep 
subcutaneous adipocytes, only a 58 kDa protein was p h o to a ffin ity -
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labelled, suggesting th a t th is  protein represents the active form  o f the 
receptor, since i t  is  the only species able to  bond to  the antagonist 
alprenolol on the a ffin ity  m atrix. The apparent m olecular w eight o f 
membrane-bound or p a rtia lly -p u rifie d , pho toa ffin ity-labe lled  jg-adrenergic 
receptors from  sheep (w ether) subcutaneous adipocytes was unaffected by 
addition o f high concentrations o f jg -  m ercaptoethanol (10% (v /v )). I t  is  
therefore possible th a t th is jg-adrenergic receptor does not contain the 
disulphide bridges clea rly present in  other jg-adrenergic receptors, 
including th a t o f ra t adipocytes. However, ph o to a ffin ity-labe llin g  may 
stabilise the three-dim ensional topography o f the jg-adrenergic receptor, 
and render i t  insensitive to  unfolding a fte r disulphide bridge reduction, 
due to  auxilia ry crosslinking by the ph o to a ffin ity  probe (Moxham & 
Malbon, 1985).
The p i o f pho toa ffin ity-labe lled  jg-adrenergic receptors from  
sheep (w ether) subcutaneous adipocytes was 6.15-6.25. In  contast, IEF o f 
pho toa ffin ity-labe lled  p a rtia lly -p u rifie d  jg-adrenergic receptor 
preparations showed heterogeneity in  the form  o f nine d is tin c t labelled 
proteins o f more acidic pL This has no t been reported fo r any other jg - 
adrenergic receptor. The isoe lectric  po in t o f the ^ -a d re n e rg ic  receptor 
o f turkey erythrocytes has been reported to  be 5.5 (Charlton e t aL, 
1980), 5.26 (Fraser, 1984), and 6.0 (Shorr e t aL, 1982). The ra t 
adipocyte jg-adrenergic receptor has a p i o f 5.1 (Moxham e t aL, 1986). 
The values fo r jg 2-adrenergic receptors have been reported as 3.72 
(Soiefer & Venter, 1980) in  dog lung, 4.18 in  the c a lf lung (S oiefer & 
Venter, 1980), and 5.1 in  ra t liv e r (Moxham e t aL, 198§). In  most o f the 
observations cited above, peaks o f isoelectric-focussed labelled jg - 
adrenergic receptor were broad, again ind ica ting m icro-heterogeneity (see
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Moxham e t aL, 1986; Shorr e t aL, 1981; Venter & Fraser, 1981). The 
s h ift in  p i observed upon pur ifica tio n  o f the |S-adrenergic receptor from  
sheep subcutaneous adipocytes may be due to  additional p ro te in -p ro te in  
in te raction  during IEF, o r a function o f differences in  glycoproteins 
attached to  the receptor. The p i o f membrane-bound receptor is  higher 
than any quoted in  the lite ra tu re , and is  closest to  th a t o f 
adrenergic receptor.
W ith a view to  purify ing  the jg-adrenergic receptor by preparative 
PAGE, sheep adipose tissue membranes were analysed using the 
benzyldimethyl-n-hexadecylammonium chloride (16-BAC) ge l electrophoresis 
system, described by MacFarLane (1983). This uses the cation ic detergent 
16-BAC fo r protein solubilisation, and consists o f a discontinuous 
polyacrylam ide ge l system operating a t pH 4.0-1.5. This p a rticu la r 
method was studied since i t  has both high resolving power and high 
loading capacity (approxim ately 100 mg pro te in ). Using a two 
dimensional system involving SDS PAGE, proteins have been p u rifie d  from  
c e ll homogenates in  su ffic ie n t amounts fo r N ^ -te rm in a l sequencing and 
production o f specific polyclonal antisera (MacFarLane, 1989).
16-BAC PAGE o f pho toa ffin ify-labe lled  jS-adrenergic receptors from  
sheep om ental adipose tissue produced an in d is tin c t banding pa ttern  w ith  
autoradiography. However, when ind ividua l ge l lanes were sliced and the 
[125]Qic yp d  counted, c lea rly defined peaks o f labelled proteins were 
obtained. The d istribu tion  o f labelled proteins was sim ila r to  th a t seen 
w ith  SDS PAGE. Analysis o f sheep adipose tissue membrane proteins using 
two dimensional 16-BAC/SDS PAGE (MacFarLane, 1989) gave good separation, 
w ith the proteins distributed about a diagonal lin e . This indicates th a t 
the separation in  both dimensions is  re la ted to  the m olecular w eight o f
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the prote in . This decreases the potentia l resolution, compared to  th a t 
obtainable w ith  IEF as the firs t dimension, since separation is  based 
solely on charge (0 1 F a rre ll, 1975).
An id e n tica l separation using photoa ffin ity-labe lled  membrane- 
bound |S-adrenergic receptor revealed separation o f several sp e c ifica lly - 
labelled proteins, but the resolution was poor compared to  th a t obtained 
using IEF as the firs t dim ensional separation. Therefore i t  was decided 
to  locate the major specifica lly-labe lled  protein in  the 16-BAC ge l by 
slicing a b a rke r* lane. A horizontal slice containing the m ajor and 
highest m olecular weight prote in was cu t from  the rem ainder o f the gel, 
and run down an SDS PAGE geL Using fresh [^^ijLC YPD  p h o to a ffin ity  
probe, a single labelled protein on the SDS PAGE gel was obtained. I t  
therefore appeared th a t th is  method was suitable fo r preparative 
iso la tion o f -adrenergic receptor from  sheep adipose tissue, since 
receptor from  30 mg o f sheep adipose tissue membrane prote in could be 
* concentrated* in to  the fin a l SDS PAGE geL However, quantifica tion o f |5“  
adrenergic receptor proved to  be impossible. As w ith  SDS PAGE, most o f 
the [^^ijECYPD counts loaded were non-covalentLy bound, confounding any 
corre lation between recovery o f [^^ijLC YPD  and £ -adrenergic receptor. 
This is  most lik e ly  a ttribu tab le  to  the high a ffin ity  o f [^^ijECYPD fo r 
^-adrenergic receptors (K ^ 30-50 pM ). Indeed i t  has been possible to
subject both [^^^ijLCYP-labelled turkey -adrenergic receptors (Shorr e t 
aL, 1982) and [ ^% ]hydroxybenzylpdndolol-labe]] ed frog ^2~a(^ rener&£’ 
receptors (Shorr e t aL, 1981) to  IEF, even though both ligands bind non- 
covalently. TCA and acetone precip ita tion were employed to  reduce non- 
covalentLy bound counts, bu t w ithout success. W ith no quantifica tion  o f
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jg-adrenergic receptor possible, i t  was decided to  use a ffin ity
chromatography fo r the p u rifica tio n  o f receptor.
Table 3.1. Affinity chromatography of the ^ jg-adrenergic receptors of
sheep adipose tissue: analysis of column fractions
Digitom n-solubdlised jg-adrenergic receptors (22.3 mg prote in) 
prepared from  sheep (w ether) om ental adipose tissue were subjected to  
a ffin ity  chromatography on a 10 m l Sepharose 4B -alprenolol column. ( - ) -  
Isoproterenol was added a fte r fra c tio n  8 to  elute the jS-adrenergic 
receptors. SSATM -  solubilised sheep adipose tissue membranes. N/D -  
none detected.
Fraction Volume
(m l)
Protein
(m g/m l)
[ 3H]DHA binding 
(fm oi/m g protein)
[ 3H]DHA binding 
(fm o l)
SSATM 35.3 0.632 155.4 3465.4
1 10 0.039 36.43 14.21
2 10 0.670 34.24 229.41
3 10 0.723 28.87 208.73
4 10 0.713 21.74 155.01
5 10 0.183 31.97 58.50
6 10 0.012 N/D N/D
7 10 N/D N/D N/D
8 6 N/D N/D N/D
9 4 0.0088 N/D N/D
10 4 0.0082 N/D N/D
11 4 0.0116 16362.7 759.2
12 4 0.0097 8528.6 330.9
13 4 0.0063 6224.5 156.9
14 4 0.0045 4922.0 88.6
15 4 0.0041 3601.1 59.1
16 4 0.0036 2289.0 33.0
17 4 0.0031 3186.0 39.5
18 4 0.0027 2487.6 26.9
Table 3.2. A ffin ity  chromatography o f the jg-adrenergic receptors o f 
sheep adipose tissue: analysis o f column fractions from  
th ird  p u rifica tio n
DigLtoran-solnbOised jg-adrenergic receptors (24.7 mg prote in ) from  
sheep (w ether) om ental adipose tissue were subjected to  a ffin ity  
chromatography on a Sepharose 4B-alprenolD l column. The data represents 
the th ird  p u rifica tio n  perform ed using a newly-synthesised 10 m l column. 
The y ie ld  o f jg-adrenergic receptors was 65% and the p u rifica tio n  
achieved was 304 fo ld . Only the in itia l preparation and fractions 11-14 
were assayed. SSATM -  solubilised sheep adipose tissue membranes
Fraction Volume
(m l)
Protein
(m g/m l)
[ 3H]DHA binding 
( f  mol/mg protein)
[ 3H]DHA bb 
(fm o l)
SSATM 34.26 0.721 114.6 2831.4
11 4.0 0.0021 34858.6 812.2
12 4.0 0.0017 24598.4 509.2
13 4.0 0.0017 17571.7 363.7
14 4.0 0.0013 8008.0 143.3
Fig. 3.1. Affinity chromatography of the jg-adrenergic receptors of
sheep adipose tissue: Elution profile of protein
D igitonin-solubilised jg-adrenergic receptors (22.3 mg membrane 
prote in) prepared from  sheep (w ether) om ental adipose tissue were 
subjected to  a ffin ity  chromatography using a 10 m l Sepharose 4B- 
alprenolol column. Fractions 1-4 (10 m l) -  eluate during sample loading: 
fractions 5-8 (10 m l) -  eluate during column washing: fractions 9-18 (4 
m l) -  eluate during elution o f ^-adrenergic receptors w ith  1 mM ( - ) -  
isoproterenol (values in  parentheses in d ic ta te  volume o f each fra c tio n ). 
This data is  tabulated in  Table 3.1. Protein re tention on the column 
was <5% o f th a t loaded.
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Fig. 3.2. A ffin ity  chromatography o f the jg-adrenergic receptors o f 
sheep adipose tissue: E lution p ro file  o f jg-adrenergic 
receptors
D igitonin-solubilised /g-adrenergic receptors (22.3 mg membrane 
prote in) prepared from  sheep (w ether) om ental adipose tissue were 
subjected to  a ffin ity  chromatography using a 10 m l Sepharose 4B- 
alprenolol column. Fractions 1-4 (10 m l) -  eluate during sample loading: 
fractions 5-8 (10 m l) -  eluate during column washing: fractions 9-18 (4 
m l) -  eluate during elution o f jg-adrenergic receptors w ith  1 mM ( - ) -  
isoproterenol (values in  parenthesis ind icta te  volume o f each fra c tio n ), 
jg-Adrenergic receptors in  each fra ction  were quantified w ith  [^H ]D H A. 
Fractions 9-18 were desalted p rio r to  assay, in  order to  remove the ( - ) -  
isoproterenol used to  elute the j3-adrenergic receptors. This data is  
tabulated in  Table 3.1. The yie ld  o f jg-adrenergic receptors was 43% and 
the p u rifica tio n  achieved was 105 fo ld . Approxim ately 95% o f the 
protein loaded passed d ire c tly  through the column.
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Fig. 3.3. SDS PAGE o f pho toa ffin ity-labe lled  jg-adrenergic receptors o f
sheep adipocyte membranes
Adipocyte jg-adrenergic receptors (335 jig prote in) prepared from  
sheep (w ether) subcutaneous adipose tissue were photoa ffin ity-labe lled
w ith  [125i Jic yp d  in  the absence ( • ------ •) o r presence (o------ o) o f 10 ]iM
( - ) -a lprenolol, and subjected to  SDS PAGE. The ge l was stained, dried, 
subjected to  autoradiography, and fin a lly  sliced (2 mm slices) and 
counted. [^^I]IC Y P D  ra d io a ctiv ity  in  samples p rio r to  SDS PAGE was 
83,000 cpm and 37,500 cpm in  the absence and presence o f 10 pM ( - ) -  
alprenolol, respectively. Slice No. 1 represents the top o f the resolving
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Fig. 3.4. Autoradiograph of SDS PAGE of photoaffinily-labe3] ed
|3-adrenergic receptors o f sheep adipocyte membranes
Adipocyte jS-adrenergic receptors (335 jig  protein) prepared from  
sheep (w ether) subcutaneous adipose tissue were pho toa ffin ity-labe lled  
w ith  [125j-jicypd  and subjected to  SDS PAGE. N on-specific p h o to a ffin ity - 
labeUing was determ ined in  the presence o f 10 jjM (-)-a ip re n o lo l (Lanes 
2 and 4). Two samples were boiled fo r 3 min p rio r to  electrophoresis 
(Lanes 1 and 2). The exposure tim e fo r the autoradiograph was 42.5 h. 
The arrow indicates the d irection  o f electrophoresis. Molecular weights 
fo r markers are given in  kDa.
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Fig. 3.5. Autoradiograph of SDS PAGE of photoaffinity-labeiled partiaUy
purified  jg-adrenergic receptors o f sheep adipocyte membranes
P artia lly  pu rified  adipocyte ^-adrenergic receptors prepared from  
sheep (w ether) subcutaneous adipose tissue were photoa ffin ity-labe lled  
w ith  [^^IjECYPD, lyophilised and subjected to  SDS PAGE. N on-specific 
photo a ffin ity -la b e llin g  was determ ined in  the presence o f 10 j iM ( - ) -  
alprenolol (Lane 2). Additions were made to  some samples p rio r to  
electrophoresis: Lanes 1 and 2 -  none; lane 3 -  10% (v /v ) £ -  
mercaptoethanol; lane 4 -  10 mM d ith io th re ito l; lane 5 -  10 mM N - 
ethylm aleim ide. The exposure tim e fo r the autoradiograph was 7 days. 
The arrow indicates the d irection o f electrophoresis. M olecular weights 
fo r markers are given in  kDa.
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Fig. 3.6. Autoradiograph o f SDS PAGE o f photoaffim ty-labeUed 
^-adrenergic receptors o f sheep and ra t adipose tissue
jS-Adrenergic receptors (200 pg membrane protein) from  sheep 
(lacta ting  ewe) om ental adipose tissue and ra t abdominal adipocyte 
membranes were pho toa ffin ity-labe iled  w ith  [^ ^^EjlCYPD and subjected to  
SDS PAGE. N on-specific pho toa ffin ity-labe lling  was determ ined in  the 
presence o f 100 pM (-)-isop ro te reno l (Lanes 2 and 4). Lanes 1 and 2 -  
sheep adipose tissue membranes. Lanes 3 and 4 -  ra t adipocyte 
membranes. The exposure tim e fo r the autoradiograph was 7 days. The 
arrow indicates the d irection  o f electrophoresis. Molecular weights fo r 
markers are given in  kDa.
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Fig. 3.7. Isoelectric focussing of sheep adipocyte ^-adrenergic
receptors photoa ffin ity-labe lled  in  the presence o r absence 
o f 10 pM (-)-a jp re n o lo l
Adipocyte ^-adrenergic receptors (100 pg membrane protein) from  
sheep (w ether) subcutaneous adipose tissue were photoa ffin ity-labe lled  
w ith  [- ^ “TJlCYPD, in  the absence (A ) o r presence (B) o f 10 pM ( - ) -  
alprenolol, and subjected to  IEF (ampholyte pH range -  3-10). Gels were 
sliced (2 mm slices) and counted. Slice No. 1 represents the acid ic 
(anode) end o f the IEF geL
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Fig. 3.8. Isoelectric focussing of photoaffinity-labelled jg-adrenergic
receptors of sheep adipocytes
Adipocyte ^-adrenergic receptors (100 yg membrane prote in) from  
sheep (w ether) subcutaneous adipose tissue were photoaffm ity-labe lled 
w ith  [ 125r]ECYPD and subjected to  IEF. Gels were sliced (2 mm slices), 
and counted fo r loca lisation o f [ 12%J[CYPD. In  A, ampholyte pH range = 
3-10; 100 jig  protein. In  B, ampholyte pH range 5-8; 50 jig  prote in . 
Slice No. 1 represents the acid ic (anode) end o f the IEF geL
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Fig. 3.9. Isoelectric focussing of photoaffinity-labeHed partially
purified  ^-adrenerg ic receptors o f sheep adipocytes 
^5-Adrenergic receptors were p a rtia lly  pu rified  from  sheep 
(w ether) subcutaneous adipocytes by a ffin ity  chromatography, and 
photoa ffin ity-labe lled  w ith  [^ ^^TjECYPD. The samples were lyophilised 
and subjected to  IEF. Gels were sliced (2 mm slices), and counted. In  
A, ampholyte pH range = 3-10; In  B, ampholyte pH range = 5-8. Slice No. 
1 represents the acid ic (anode) end o f the IEF geL
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Fig, 3.10. Autoradiograph o f two-dim ensional PAGE o f p h o to a ffin ity - 
labeHed p a rtia lly  pu rified  |3-adrenergic receptors o f sheep 
adipocytes
1st dimension -  IEF. 2nd dimension -  SDS PAGE. Partia lly  
pu r ified ^-adrenergic receptors prepared from  sheep (w ether) 
subcutaneous adipocytes were photoa ffin ity-labe lled  w ith  [ ^ “TJCCYPD. 
The sample was resolved by IEF using a pH gradient o f 3-10, and 
subsequently separated in  a second dimension by SDS PAGE. The exposure 
tim e fo r the autoradiograph was 20 days. The arrows ind ica te the 
d irection  o f electrophoresis fo r each dimension. Molecular weights fo r 
markers are given in  kDa.
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Fig. 3.11. Densito metric scan of the autoradiograph showing 2D-PAGE of
photoa ffin ity-labe lled  partiaD y-purified  ^ -adrenerg ic 
receptors o f sheep adipocytes
The autoradiograph shown in  Figure 3.10 was scanned using a B io- 
Rad video densitom eter, para lle l to  the d irection  o f SDS PAGE a t an 
estim ated m olecular weight o f 58 kDa. The proteins labelled w ith  
[ 125i Jic ypd  a t the acid ic end o f the ge l were seen as nine d is tin c t 
peaks. Below the scan is  a table o f param eters, calculated fo r each 
peak.
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Fig. 3.12. Autoradiograph of 16-BAC PAGE of photoaffm ity-labelled
|S-adrenergic receptors o f sheep adipose tissue
^S-Adrenergic receptors from  sheep (lacta ting  ewe) om ental adipose 
tissue were photoaffinity-labelLed w ith  [^ ^^E]ICYPD and subjected to  16- 
BAC PAGE. N on-specific pho toa ffird iy-labe lling  was determ ined in  the 
presence o f 100 jjM  (-)-isop ro te reno l (Lanes 3 and 4). Protein loadings 
were; lanes 1 and 3 -  200 jig membrane protein , lanes 2 and 4 -  100 jig 
membrane protein. The exposure tim e fo r the autoradiograph was 14 
days. The arrow indicates the d irection o f electrophoresis.
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Fig. 3.13. 16-BAC PAGE of photoaffinity-labelled -adrenergic receptors
of sheep adipose tissue
Adrenergic receptors (1 mg membrane protein) from  sheep 
(lacta ting  ewe) om ental adipose tissue were photoa ffin ity-labe lled  w ith
[^ ■^ I^jECYPD and subjected to  16-BAC PAGE overnight a t 30 mA. The ge l 
was stained w ith  Coomassie blue, sliced (2 mm slices) and counted. Slice 
No. 1 represents the top o f the resolving geL
t* 
25
j]
 I
CY
PD
 
(C
PM
)
700
600
500
400
300
200 -
100
0 10 20 30 5040 60
GEL SLICE NUMBER
Fig. 3.14. Two dimensional 16-BAC/SDS PAGE of sheep adipose tissue
membrane proteins
1st dimension -  16-BAC PAGE. 2nd dimension -  SDS PAGE. Sheep 
(lacta ting  ewe) om ental adipose tissue membrane proteins (100 jig  
protein) were separated by 16-BAC PAGE, and fu rth e r resolved in  a second 
dimension using SDS-PAGE. Proteins were localised by Coomassie blue 
staining. The arrows ind ica te the d irection o f electrophoresis in  each 
dimension.
2ndD
Fig. 3.15. Autoradiograph of two dimensional 16-BAC/SDS PAGE of
photoaffinity-labe]]ed ^ "adrenergic receptors of sheep
adipose tissue
1st dimension -  16-BAC PAGE. 2nd dimension -  SDS PAGE. )3- 
Adrenergic receptors (400 jig  membrane prote in) from  sheep Q actating 
ewe) om ental adipose tissue were photoaffin ity-labe lled  w ith  [^^ijLC YPD  
and subjected to  16-BAC PAGE. Samples were fu rth e r resolved in  a second 
dimension using SDS PAGE. The exposure tim e fo r the autoradiograph was 
3 weeks. The arrows ind ica te the d irection o f electrophoresis in  each 
dimension.
1 stD
Fig. 3.16. Autoradiograph of two dimensional 16-EAC/SDS PAGE of
jg-adrenergic receptors o f sheep adipose tissue 
photoa ffin ity-labe lled  in  the presence o f 100 jiM  ( - ) -  
isoproterenol
Legend as fo r Figure 3.15, except pho toa ffin ity-labe lling  was perform ed 
in  the presence o f 100 jiM  (-)-isopro te reno l, to  determ ine non-specific 
labe lling  o f proteins.
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Fig. 3.17. Two dimensional 16-BAC/SDS PAGE o f pho toa ffin ity-labe lled  
sheep adipose tissue |g-adrenergic receptors: s lic ing o f gels
f$-Adrenergic receptors from  sheep (lacta ting  ewe) om ental adipose 
tissue were photoaffim ty-labe lled w ith  [^ ^^ijECYPD, using an irra d ia tio n  
tim e o f 1 h. Two id e n tica l samples (200 jig  membrane protein each) were 
run on a 16-BAC PAGE geL Following electrophoresis, one o f the lanes 
was sliced (2 mm slices) and counted fo r [^^iJlC Y P D  (Graph A ). A 6 mm 
slice, equivalent to  ge l slices 26-28 in  the counted lane (Graph A ), was 
cu t from  the second lane and run on an SDS PAGE geL This ge l was 
subsequently sliced (2 mm slices) and counted to  determ ine the position 
o f the [ 125]-j-qypD -labelled protein (Graph B). Slice 1 represents the 
orig in  o f the resolving geL
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CHAPTER FOUR -  PROPERTIES OF THEjg-ADRENERGIC RECEPTOR 
OF SHEEP ADIPOSE TISSUE
4.1. Introduction
Determ ination o f the physical properties o f receptors allows the 
comparison o f receptors from  d iffe re n t tissues and species. The
physiological e ffects mediated by the 3^-adrenergic receptors in  sheep 
adipose tissue have been w e ll studied by many laboratories (see Chapter 
1; Fain & Garcia-Sainz, 1983). However, there is  no in form ation about 
the structure and physical properties o f th is receptor, and therefore 
studies were perform ed to  characterise the jZ>-adrenergic receptors in  
d iffe re n t adipose tissue depots, in  sheep to  compare them w ith  those in  
the ra t.
4.2. Experim ental procedure
A ll sheep adipose tissue membranes used in  th is chapter were 
prepared from  whole tissue (section 2.3.2), and were used w ith in  one 
week o f preparation. The radioligands used were the antagonists [^H ]D H A 
and [ 125I]ICYP, both o f which are thought to  bind specifica lly to  and 
^ 2“ adrrerierrgic receptors in  a non-subtype selective manner (S tadel & 
Lefkow itz, 1983). Adrenergic ligands were dissolved in  1 m M ascorbate, 
and stored in  aliquots a t -20° C p rio r to  use.
Com petition curves fo r defining the subtypes o f jS -adrenergic 
receptors present in  a sample were analysed using the ALLFIT com puter 
program (De Lean e t aL, 1978). O ther methods used are described in  
Chapter 2.
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4.3. Results
4.3.1. Determ ination o f dissociation constants (K ^) and maximum landing; 
capacities (B MAX) fo r the -adrenergic receptor o f sheep 
(w ether) om ental adipose tissue
Dissociation constants (K ^) and the maxim al concentration o f 
binding sites were determ ined fo r [% ]D H A  and [*^>I]ICYP binding
to  sheep (wether) om ental adipose tissue membranes, using Scatchard 
analysis (Scatchard, 1949). [^H ]DHA had a high a ffin ity  fo r ^ “ adrenergic 
receptors in  sheep adipose tissue membranes, and bound in  rapid, specific 
and saturable manner (F igure 4.1). N on-specific binding o f the 
radioligand, determ ined in  the presence o f 100 jiM  (-)-isop ro te reno l, 
represented 15-25% o f to ta l banding a t 10 nM [^H ]D H A. A Scatchard p lo t 
o f [^H ]DHA binding data was linea r, w ith  a high corre lation co e ffic ie n t 
(r) o f -0.962 (F igure 4.2). The fo r [% ]D H A  was 3.23 + 0.38 nM (n=4). 
®MAX varied between 370 and 600 fm ol/m g membrane protein.
[125j] ic y p  bound to  sheep (w ether) om ental adipose tissue 
membranes w ith  a higher a ffin ity  than [% ]D H A . Binding was specific and 
saturable, w ith  non-specific binding representing about 9% o f to ta l 
binding a t 75 pM [^^ijLC Y P  (Figure 4.3). Analysis o f the data in  Figure 
4.3 using the 1IGAND com puter program (Rodbard & Munson, 1980), gave a 
o f 53.5 pM and B ^ ^  o f 1.048 pm d/m g membrane protein fo r [^^^EjtCYP 
binding (data no t shown). These values were from  a single experim ent, 
perform ed to  determ ine the best concentration o f [^^ijEC YP to  use in  
other experiments.
4.4.2. Determ ination o f the ^ -adrenerg ic receptor subtypes present in  
sheep adipose tissue
Characterisation o f j5*adrenergic receptor subtypes was achieved
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using £ -adrenergic agonists and antagonists. Omental adipose tissue 
from  wethers was used exclusively fo r [^H ]DHA binding. The rank order 
o f potencies o f -adrenergic agonist com petition fo r [^H ]DHA binding was 
(-)-isoproterenol>(-)-adrena]ine>(-)-noradrenaline (Figure 4.4 & Table
4.1). Com petition curves were steep w ith  no shoulders. IC^q and 
values fo r each ligand are shown in  Table 4.1. The antagonists selected 
were the p  2” sel£cti-ve Ifeand IC I 118,551, and the p  -^-selective ligands 
CGP 20712A and atenolol* Com petition curves fo r a ll antagonists were 
steep and sigm oidal (Figures 4.5 & 4.6). The rank order o f potencies fo r 
com petition o f [% ]D H A  binding was IC I 118,551»CGP 20712A>atenoloL 
IC50 and values fo r each antagonist are presented in  Table 4.1. The 
ra tios between the IC5q value fo r IC I 118,551 and those o f CGP 20712A 
and atenolo l were 635 and 2111, respectively.
Based on the above findings, i t  was decided to  determ ine the 
subtype(s) o f p -adrenergic receptor in  three adipose tissue depots in  
sheep (ewes). The depots studied were om ental, subcutaneous 
(im m ediately an terio r to  the hind lim b) and pop litea l (in ter-m uscular 
depot in  hind lim b ). The radioligand [^^iJtC Y P  was used because o f its  
high a ffin ity  fo r p  -adrenergic receptors and high specific a c tiv ity , as 
compared to  those o f [ H]DHA. Use o f th is ligand allowed the 
characterisation o f receptors in  less than 15 jig  o f membrane prote in . 
Curves fo r the com petition o f [^^iJ lC Y P  binding by IC I 118,551 and CGP 
20712A were steep and monophasic in  a ll three adipose depots (Figures 
4.7-4.9). Data from  eight sheep (4 non-lactating, 4 la c ta tin g ) was 
analysed using the ALLFIT com puter program. The rank order o f IC^q 
values fo r CGP 20712A displacement o f [^^ijLC Y P  binding was 
popliteal=subcutaneous>o mental (Table 4.2). The IC50 values fo r
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pop litea l (P<0.01) and subcutaneous (P<0.02) adipose tissue were 
s ign ifica n tly  d iffe re n t from  om ental adipose. There was no sign ificant 
e ffe c t o f lacta tion  on the IC5Q values fo r CGP 20712A (Table 4.2). The 
rank order o f IC^q values fo r IC I 118,551 com petition was 
omental>popliteal>subcutaneous (Table 4.3). The IC^q fo r subcutaneous 
adipose tissue was 45% low er than th a t in  om ental adipose (P<0.02). No 
e ffe c t o f lacta tion  was evident (Table 4.3). The ra tio  between IC^q 
values fo r I d  118,551 and CGP 20712A displacement o f [^^ijLC Y P  binding 
was determ ined fo r each depot. The higher the ra tio  (IC^q CGP 
20712AAC^q I d  118,551), the m ore 2” a<^ renerSic receptor character is  
present. Analysis o f log-^Q-transformed results gave an order o f ^ 2“  
character o f subcutaneous=popliteal>o m ental (P<0.01). Log^Q- 
transform ation o f some results was undertaken since i t  markedly reduced 
the coe ffic ie n t o f varia tion . Again there was no e ffe c t o f la c ta tio n  on 
tkis param eter.
In  a separate experim ent, adipocyte membranes and strom a- 
vascular membranes were prepared from  sheep (ewe) om ental adipose 
tissue (section 2.3.1). The jS -adrenergic receptor subtype(s) present in  
each subceHular fra c tio n  was then investigated. Both fractions 
contained ^2~a^rener&£' receptors (Figures 4.10 & 4.11). The number o f 
jS-adrenergic receptors in  adipocyte membranes and strom a-vascular 
membranes were 141.1 and 62.9 fm ol/m g membrane protein , respectively.
4.4.3. E ffe c t o f lacta tion  on jg -adrenergic receptor ligand binding in
three sheep adipose tissue depots
-Adrenergic receptor ligand binding (a t 75 pM [-^^iJtC YP) 
present in  sheep adipose tissue membranes prepared from  om ental, 
subcutaneous and pop litea l depots, was quantified in  samples from  non-
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la c ta ting  and lacta ting  sheep. Analysis o f log^Q-transform ed results 
showed th a t lacta tion  increased |S -adrenergic receptor ligand binding in  
two out o f three depots studied (Table 4.5 & Figure 4.12). The 
increases were s ign ifican t in  om ental (P<0.01) and subcutaneous (P<0.02) 
depots. Percentage increases in  -adrenergic receptor ligand binding 
during lacta tion  were 45% and 39% in  om ental and subcutaneous adipose 
tissue, respectively.
4.4.4. Determ ination o f the |3-adrenergic receptor subtype(s) present in  
ra t adipocytes
Pat adipocyte membranes were prepared from  combined abdominal 
adipose tissue depots i.e . param etria!, periovarian and lum bar. The rank 
order o f potencies o f ft -adrenergic agonist com petition fo r [% ]D H A  
binding was (-)-isoproterenol>(-)-adrenaline>(-)-noradrena]ine (F igure 
4.13). Com petition curves were s im ila r to  those obtained fo r sheep 
(w ether) om ental adipose tissue i.e . monophasic w ith  steep gradients. 
IC50 v 3^ 63 obtained from  a single experim ent were: (-)-isop ro te reno l, 
3.5 pM ; (-)-adrenaline , 27.2 pM; (-)-noradrenaline, 196.6 pM .
Com petition o f [^H ]DHA binding by antagonists gave the rank order 
o f potency I d  118,551>CGP 20712A>atenoloL Com petition curves fo r a ll 
three ligands were ra the r shallow and monophasic (Figures 4.14 & 4.15). 
IC50 v3^ 63 were: I d  118,551, 35.3 ± 9.2 nM (n=3); CGP 20712A, 2.5 + 0.2 
pM (n=3); atenolol, 38.2 pM (n = l).
To extend these studies fu rth e r, adipocyte membranes were 
prepared separately from  param etria l and lum bar adipose tissue depots. 
These experiments were perform ed because o f apparent differences 
between our data fo r com petition o f [^H ]DHA binding to  ra t adipocyte 
membranes by adrenergic antagonists and the published findings o f
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Bahouth & Malbon (1988). [^^ijEC YP binding to  |3-adrenergic receptors in  
both depots, was competed out w ith increasing concentrations o f I d
118,551 and CGP 20712A. Com petition curves fo r I d  118,551 and CGP 
20712A were bdphasic, ind ica ting the presence o f high and low a ffin ity  
binding sites (Figures 4.16 & 4.17). Simultaneous analysis o f pooled 
data from  three independent experiments w ith  a com puter operating non­
linea r ite ra tiv e  analysis (GraphPad InP lot, Ith ica  S treet Software, Inc., 
U.S.A.) revealed th a t the lum bar depot possessed a higher percentage o f 
high a ffin ity  CGP 20712A binding sites (62%; P<0.02) and a low er 
percentage o f low a ffin ity  CGP 20712A sites (38%; P<0.05) compared to 
the param etrial depot (Table 4.6). In  addition, the IC ^q o f the high 
a ffin ity  CGP 20712A site  (0.533 nM) in  the lum bar depot was greater 
(P<0.001) than the corresponding value fo r the param etria l depot (0.271 
nM )(Table 4.6). In  contrast, the param etrial depot possessed the highest 
percentage o f high a ffin ity  IC I 118,551 binding sites (62%; P<0.02) and 
the low est percentage o f low a ffin ity  sites (38%; P<0.05). Also, the 
param etrial depot possessed a high a ffin ity  s ite  w ith  an IC^q low er than 
the corresponding site  in  lum bar adipose tissue. However, the low 
a ffin ity  binding sites fo r both CGP 20712A and IC I 118,551 in  
param etria l adipose possessed the same a ffin itie s  ( IC ^ q )  as the 
corresponding values fo r the lum bar adipose tissue depot (Table 4.6).
4.4. Discussion
The dissociation constant (K ^) fo r [^H ]DHA binding to  sheep 
(wether) om ental adipose tissue membranes was 3.23 nM. Dissociation 
constants fo r -adrenergic receptors in  other species and tissues 
include: canine lung, 1.3 nM (Homey e t aL, 1983); turkey erythrocyte, 8 
nM (Vauquelin e t aL, 1979); frog erythrocyte, 2.2 nM (Caron & Lefkow itz,
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1976); ra t adipocyte, 20 nM (Cubero & Malbon, 1984), 19 nM (Malbon e t 
aL, 1978), 15 nM (W illiam s e t aL, 1976), 49 nM (ChLappe de Cingolani, 
1986) and 2.2 nM (Bahouth & Malbon, 1988). The reasons fo r the 
varia tion  in  the fo r ra t adipocyte ft -adrenergic receptor are unclear, 
and com plicate d ire c t comparison w ith  the sheep adipose tissue (3 - 
adrenergic receptor. The fo r [^^ijEC YP determ ined from  a single 
experim ent was 54 pM. Values obtained fo r other (3-adrenergic receptors 
are: ra t liv e r, 60 pM (Graziano e t aL., 1985); ra t adipocyte, 30 pM 
(Bahouth & Malbon, 1988); human j8-padrenergic receptor, 66 pM (FrieUe e t 
aL, 1987); ham ster lung, 50 pM (Engel e t aL, 1981); human ^-a d re n e rg ic  
receptor, 490 pM (Emordne e t aL, 1989). The dissociation constants fo r 
sheep adipose tissue /S-adrenergic receptor obtained fo r both 
radioligands, are therefore comparable to  those o f other f§-adrenergic 
receptors. Scatchard plots o f [% ]D H A  saturation binding data were 
linea r, ind icating the presence o f a single class o f high a ffin ity  
binding sites.
Bm a x  f or £  -adrenergic receptor density varies a t least 100 fo ld  
between species and tissues. The B ^ ^  f° r  [  H]DHA binding to  sheep 
(w ether) om ental adipose tissue membranes varied between 370 and 600 
fm ol/m g protein. This range encompasses the B ^ x  ra t adipocytes, 
namely 500 fm ol/m g membrane protein (Bahouth & Malbon, 1988). Rat liv e r 
and human placenta contain 17.7 fm ol/m g membrane protein and 1.2-2.5 
pmol/mg membrane protein o f ^-adrenergic receptors, respectively, and 
illu s tra te  the range o f values obtainable. Receptor densities o f 200- 
600 fm ol/m g plasma membrane protein are representative o f the m ajority 
o f tissues. Therefore sheep (wether) om ental adipose tissue possesses 
a standard complement o f ^-adrenerg ic receptors. However, a B ^ ^ ^  o f
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1.048 pmo]/mg membrane protein was obtained fo r [^^ ijlC Y P  binding to 
sheep (w ether) om ental adipose tissue membranes in  one experim ent. In  
contrast, using 75 pM [^^ijLC Y P  (about 70-80% o f maximum binding), 
binding o f 400 fm ol/m g membrane protein was usual which is  in  agreement 
w ith  estim ates from  [ H]DHA binding. Therefore the from  the single
experim ent is  probably not representative.
A t present, three subtypes o f £ -adrenergic receptor have been 
cloned, called 0 i _> h ~  and ^-a d re n e rg ic  receptors, respectively. 0 i -  
and jS?2“ adrenergic receptors were o rig ina lly characterised using agonists 
(Lands e t aL, 1967). Based on the classification o f Lands e t aL, i t  is  
possible to  define which subtype(s) o f ^-adrenergic receptor are present 
in  a sample. The rank order o f potencies fo r agonist com petition o f 
[^H ]DHA binding to  sheep (w ether) om ental adipose tissue was ( - ) -  
isoproterenol>(-)-adrenaline>(-)-noradrenaline, ind ica tive  o f ^ 2-character 
according to Lands e t aL (1967). Com petition curves were monophasic, 
ind ica ting th a t a homogeneous population o f ^ 2“ a<^ renerg^ c  receptors is  
present in  sheep (w ether) om ental adipose tissue. To characterise the 
receptor fu rth e r, subtype-selective f t -adrenergic antagonists were 
employed; CGP 20712A, atenolo l and IC I 118,551. CGP 20712A is  10,000 
fo ld  more selective fo r as compared w ith  /$2“ adrenergic receptors in  
tissues containing mixed populations o f f i y  and ^2~a(^ reuer&JZ receptors 
(Dooley e t aL, 1986; Bahouth & Malbon, 1987). A tenolol has a s im ila r 
se le c tiv ity  to  CGP 20712A (Strader e t aL, 1989a). In  contrast, IC I
118,551 is  a potent, highly ^ 2“ se -^ectf /e adrenergic antagonist (0 *Donnell 
& W anstall, 1979).
IC I 118,551 was the most potent ligand fo r the displacem ent o f 
[% ]D H A  binding to sheep (wether) om ental adipose tissue membranes,
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being 635 and 2111 tim es more e ffective  than CGP 20712A and atenolol, 
respectively. This re su lt clearly defines th is {$ -adrenergic receptor as 
o f the ^ “ subtype, which agrees w ith  the results obtained fo r agonists. 
Again curves were smooth w ith  no shoulders, ind icating the presence o f a 
single receptor population. Indeed the ra tio  between the IC^q values o f 
CGP 20712A and I d  118,551 o f 635 is  sim ila r to  th a t fo r the cloned 
human ^ 2” a<^ renergic receptor, which has a ra tio  between betaxolo l Q?j- 
selective) and I d  118,551 o f 518 (FrielLe e t aL, 1988). The human 
adrenergic receptor has a ra tio  (Betaxolol/LCI 118,551) o f 0.1 (FrLelle e t 
aL, 1988). The find ing th a t sheep adipose tissue possesses f%2~ 
adrenergic receptors correlates w ith  the fa c t th a t many o f the jg - 
agonists found to a lte r carcass com position in  livestock exh ib it 
p rim arily  2“ adrenergic receptor se le c tiv ity  (Cohen e t aL, 1982). I t  
therefore seems lik e ly  th a t these agents reduce adiposity by stim ulating 
the in tra ce llu la r processes controlled by ^ -a d re n e rg ic  receptors. 
Preparation o f two fractions from sheep (ewe) om ental adipose tissue, 
adipocyte membranes and strom a-vascular membranes showed th a t both 
fractions contained high a ffin ity  j32“ ac^ rener^ jC- receptors. This suggests 
th a t there is  no difference between |g-adrenergic receptor ligand binding 
in  sheep adipocyte and adipose tissue membranes.
In  many studies on adrenergic receptors, work has concentrated 
on a single tissue or depot in  the case o f adipose tissue. Results are 
then compared to those obtained fo r other tissues and species, often 
w ithout any consideration o f differences caused by the location o f the 
tissue w ith in  the body o f an animaL This is  o f pa rticu la r im portance 
when studying adipose tissue as i t  occurs in  d is tin c t depots a t 
d iffe re n t sites in  the body. Adrenergic receptors were studied in
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three separate sheep adipose tissue depots, om ental, subcutaneous and 
poplitea l. A ll three depots contained a single population o f H -  
adrenergic receptors. However there were differences in  IC^q values fo r 
CGP 20712A and IC I 118,551 com petition o f [-^^iJtCYP binding to 
membranes from  these depots. CGP 20712A (^ -s e le c tiv e ) was most potent 
in  om ental adipose tissue, w ith  an IC5Q sign ifica n tly  low er than those o f 
subcutaneous and pop litea l depots, suggesting a higher degree o f 
character in  the om ental depot. Conversely, IC I 118,551 ( ^ “ Selective) 
was most e ffective  in  subcutaneous adipose, w ith  om ental and pop litea l 
adipose tissue displaying equal a ffin itie s . Taken together, these 
results suggest th a t subcutaneous and pop litea l adipose tissue contain 
^-adrenergic receptors displaying a higher degree o f ^ 2“ c l^a ra c te r th an 
th a t o f om ental. Analysis o f the ra tio  between IC ^q's fo r CGP 20712A 
and IC I 118,551, showed th a t pop litea l and subcutaneous adipose tissue 
^-adrenergic receptors have the highest ra tios, again ind ica tive  o f @2~ 
adrenergic receptor character.
The e ffe c t o f lacta tion  on jg-adrenergic receptor properties was 
also studied because lacta tion  has been shown to  increase the number o f 
^-adrenergic receptors in  ca ttle  (Jaster & Wegner, 1981), sheep (W att e t 
aL, 1990a), and ra t (W att e t aL, 1990b) adipose tissue. In  a ll o f these 
studies only a single depot was tested. In  th is study, la c ta tio n  
increased -adrenergic receptor ligand binding in  two out o f the three 
adipose tissue depots studied, namely om ental and subcutaneous, thus i t  
therefore seems possible th a t lacta tion  modulates -adrenergic receptors 
in  a depot-specific manner. In  contrast, no e ffe c t o f lacta tion  on jg - 
adrenergic receptor a ffin itie s  was observed in  any o f the depots, even 
though depots possess f t -receptors w ith d iffe re n t ligand binding
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properties. I t  is  possible th a t these differences re su lt from 
environm ental e ffects e.g. changes in  the com position o f the lip id  
bdlayer, or conform ational changes induced in  the receptor by post- 
transla tiona l m odifications, in  pa rticu la r phosphorylation and 
glycosylation.
The f$-adrenergic receptors o f ra t adipocytes were also studied. 
In itia l experiments were performed on pooled abdominal adipose tissue 
Le. param etria l, peri ovarian and lum bar. The rank order o f potencies fo r 
agonist com petition o f [ H]DHA binding was ( - ) -isoproterenol>( - ) -  
adrenaline>(-)-noradrenaline, ind ica tive  o f 02  -character (Lands e t aL, 
1967). Characterisation w ith  CGP 20712A and IC I 118,551 was also 
ind ica tive  o f ^ 2“ characterJ but not to  the same degree as th a t seen in  
sheep adipose tissue. IC^q values fo r CGP 20712A and atenolo l were 
low er in  the ra t than in  the sheep, ind icating the presence o f more jg^- 
adrenergic receptor character. I t  therefore appeared th a t pooled 
abdominal ra t adipose tissue possessed a -adrenergic receptor o f 
predom inantly ^ “ character w ith  d iffe re n t binding characteristics from  
th a t present in  sheep adipose tissue. In  fa c t these results suggested 
th a t the ^-adrenergic receptors in  the ra t adipocyte were a typ ica l in  
nature Le. not being d e fin itive ly  or ^ “ adrenergic receptors.
The antagonist com petition data discussed above was d iffe re n t 
from  th a t obtained by Craig Malbon and co-workers (Bahouth & Malbon, 
1988). Therefore i t  was decided to  study the adrenergic receptors in  
two ra t adipose tissue depots ind ividually Le. param etria l and lum bar, 
and re fra in  from  pooling abdominal adipose tissue. Results fo r 
param etrial and lum bar adipose tissue suggested the presence o f a t least 
two £ -adrenergic receptor populations, w ith  d iffe rin g  a ffin itie s  fo r the
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subtype-selective antagonists CGP 20712A ( ^ )  and IC I 118,551 (f^ )* The 
com petition curves obtained fo r lum bar adipose tissue, resemble those 
shown fo r an id e n tica l characterisation o f param etrial f t -receptors 
(Bahouth & Malbon, 1988). The percentages o f high and low a ffin ity  
sites fo r CGP 20712A and IC I 118,551 in  both adipose tissue depots 
suggest th a t there are two populations o f receptors present in  these 
depots (Table 4.6). One receptor population appears to  possess high 
a ffin ity  fo r CGP 20712A and low a ffin ity  fo r IC I 118,551, norm ally 
associated w ith  ^-a d re n e rg ic  receptors, and is  most abundant in  the 
lum bar depot. A second population exhibits high a ffin ity  fo r IC I 118,551 
and low a ffin ity  fo r CGP 20712A, characteristics o f ^ -a d re n e rg ic  
receptors, and is  most prevalent in  param etrial. adipose tissue. Such a 
close corre lation was not evident in  the paper, Bahouth & Malbon (1988), 
and no discussion o f the presence o f the high a ffin ity  IC I 118,551 
binding s ite  which they also found, was given. However, the ra tio  
between the IC^q values fo r these two hypothetical receptor populations 
are quite d iffe re n t from  those o f typ ica l and ^ 2” a(^ renerS^ c
receptors (F rie lle  e t aL, 1988), and therefore the corre lation between 
the percentages o f each binding site  may be coincidentaL The ligand 
binding characteristics o f ^-adrenergic receptors in  sheep and ra t 
adipose tissue again serve to  distinguish the -receptors in  these 
species. On the one hand, sheep possess a homogeneous population o f 
adrenergic receptors, w hilst ra t adipose tissue contains a heterogeneous 
population o f and a typ ica l f$-adrenergic receptors.
The subtypes o f adrenergic receptor seen in  ra t adipose tissue 
in  th is study represent a controversial area fo r discussion. Lands e t 
aL (1967) orig ina lly proposed tha t the £ -adrenergic receptor mediating
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catecholam ine stim ulation o f lipo lysis in  the ra t was o f the £  -^-subtype, 
based upon the re la tive  lip o ly tic  potencies o f several ^-adrenerg ic 
agonists. This find ing has apparently been substantiated by other 
workers (W illiam s e t aL, 1976; Malbon e t aL, 1978; Cubero & Malbon, 
1984; Bahouth & Malbon, 1988). In  d ire c t contrast, Harms e t aL (1974), 
and De Vente e t aL (1980) suggested th a t a hybrid or a typ ica l type o f 
adrenergic receptor mediates lipo lysis in  ra t adipocytes, w ith  low
a ffin itie s  fo r and ^ 2” se^ec^ ve and non-selective ligands. Further
studies by other groups have shown th a t isoproterenol-stim ulated
lipo lysis in  ra t adipocytes is  mediated by a typ ica l ^-adrenerg ic
receptors (W ilson e t aL, 1984; Bojanic e t aL, 1985; Hollenga & Zaagsma, 
1989; Hollenga e t aL, 1990). The adipocyte receptor also has d iffe re n t 
ste reo-se lectiv ity ra tios fo r antagonist enantlomers compared to  typ ica l 
and ^ 2" ac^ rerierg^ c receptors (Harms e t aL, 1977). In  addition, i t  
was established tha t the a typ ica l characteristics o f antagonists was not 
due to a heterogeneous population o f both h -  and ^ 2” a<^ rener§ ^
receptors (De Vente e t aL, 1980; Bojanic e t aL, 1985).
The existence o f a typ ica l ^-adrenerg ic receptors in  ra t
adipocytes was dismissed in  a controversial paper by Bahouth & Malbon 
(1988). In  th is report extensive radioligand binding assays were 
perform ed using fou r d iffe re n t radioligands. Their conclusion was th a t 
ra t adipocytes contain solely ^ -a d re n e rg ic  receptors. This paper has 
recently been challenged by a proposal th a t the ra t adipocyte £ -  
adrenergic receptor is  a form  o f the recently cloned a typ ica l human jgg- 
adrenergic receptor (Zaagsma & Nahorski, 1990). They dismiss Bahouth 
and Malbonfs conclusions because o f a lack o f corre lation between
in h ib ition  constants fo r radioligand binding data, w ith  those fo r
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functiona l studies on inh ib ition  o f isoproterenol-stim  ulated lipo lysis by 
IC I 118,551 and CGP 20712A. Also i t  has been demonstrated tha t 
isoproterenol-stim ulated lipo lysis in  ra t white adipose tissue is 
mediated predom inantly by a typ ica l |S-adrenergic receptors, whereas 
typ ica l ^ -a d re n e rg ic  receptors play a sm all subordinate ro le  (Hollenga 
& Zaagsma, 1989). In  a previous study from  the same laboratory, i t  was 
suggested th a t the a typ ica l @ -adrenergic receptor was coupled to 
adenylate cyclase (Bojanic e t aL, 1985). The existence o f a typ ica l jS -  
adrenergic receptors in  sheep adipose tissue cannot be ruled out as yet. 
The results from radioligand binding assays detailed in  th is thesis, must 
be shown to  correlate w ith  functiona l studies on lipo lysis in  adipocytes, 
before the presence o f a typ ica l f t -adrenergic receptors can be dismissed.
A review o f some key papers on the ra t adipocyte reveals th a t 
the adipose tissue depot used varies between laboratories and includes 
param etrial (Cubero & Malbon, 1984; Bahouth & Malbon, 1988) and 
epididym al (Lands e t aL, 1967; Wilson e t aL, 1984; Bojanic e t aL, 1985; 
Hollenga & Zaagsma, 1989; Hollenga e t aL, 1990) adipose tissue. In  lig h t 
o f the findings o f th is study, i t  would appear th a t some o f the 
con flic ting  reports could be the re su lt o f the use o f d iffe re n t adipose 
tissue depots, and animals o f d iffe re n t sex. Indeed, how re a l are 
apparent published discrepancies in  lip o ly tic  a c tiv ity  induced by |3 -  
adrenergic agonists in  human and ra t adipocytes, when the human adipose 
tissue was subcutaneous and ra t adipose tissue was epididym al (Hollenga 
e t aL, 1990)? In  the same study, the human subjects were predom inately 
fem ale (14 fem ale : 5 male), w hilst ra ts were a ll male. Obviously, 
detailed investigation in to  sex differences in  ft -adrenergic receptor 
subtype characteristics in  adipose tissue is  required.
Table 4.1. Displacement of [^H]DHA binding to sheep omental adipose
tissue membranes by adrenergic agonists and antagonists
Com petition curves fo r displacement o f 4 nM [^H ]DHA binding to 
sheep (w ether) om ental adipose tissue membranes were analysed using the 
ALLFIT com puter program. Inh ib ition  contants (K j) fo r the ligands were 
calculated from  the resulting IC^q values using the equation 
K;j=IC5q /(1+ I/K cj) , where L is  the concentration o f [% ]D H A  used (Cheng & 
Prussoff, 1973). A o f 3.23 nM was used in  the calculations. Results 
are expressed as the mean + S.E.M. n = number o f experiments.
Ligand IC50 (nM) K± (nM) n
Agonists
(-)-Isopro tereno l 
(-)-A drena line  
( - ) -  N oradrenaline 
Antagonists 
IC I 118,551 
CGP 20712A 
A tenolol
869 + 122 
10764 + 709 
24913 +2913
24.4 ±  4.7 
15499 + 5976 
51517 + 12583
299 + 90 
3583 ± 743 
8534 + 1680
12.2 + 2.1 
7844 + 2119 
24043 + 6287
Table 4.2. Displace merit of [^%]ICYP binding to sheep adipose tissue
membranes from  three depots by CGP 20712A 
IC50 values fo r com petition o f [-^^ijECYP binding to  sheep 
adipose tissue membranes by CGP 20712A were obtained by analysis o f 
com petition curves, using the ALLOT com puter program. [^^ijLC Y P  (75 
pM) banding was measured a t eight d iffe re n t concentrations o f CGP 
20712A (10“  ^ -1 0 ” ^ M). Results are the means o f data from  eight 
animals (4 non-lactating & 4 lacta ting  ewes), analysed by analysis o f 
variance.
i)  Depot differences
Depot IC 50 (jiM )
Omental 1.60"
Subcutaneous 2.99
P opliteal 3.55
s.e.d. 0.472
*  value s ign ifican tly  d iffe re n t from  those fo r subcutaneous (P<0.02) and 
pop litea l (P<0.01) depots.
i i)  E ffe c t o f lacta tion
IC50
Depot N on-lactating Lactating
Omental 1.47 1.72
Subcutaneous 3.09 2.90
Popliteal 2.99 4.11
S.e.d. between depots w ith  the same physiological state = 0.667; s.e.d. 
fo r the e ffe c t o f lacta tion  fo r each depot = 1.004. No s ign ifica n t 
e ffe c t o f lacta tion .
Table 4.3. Displacement of [^^ijlCYP binding; to sheep adipose tissue
membranes from  three depots by IC I 118,551
IC 50 values fo r com petition o f [^^ijEC YP binding to  sheep 
adipose tissue membranes by IC I 118,551 were obtained by analysis o f 
com petition curves using the ALLFTT com puter program. [-^^ijECYP (75 
pM) binding was measured a t eight d iffe re n t concentrations o f IC I
118,551 (10“ 10-10“3 M). Results are means o f data from  eight animals 
(4 non-lactating & 4 lacta ting  ewes), analysed by analysis o f variance.
i)  Depot differences
Depot IC5Q (nM)
Omental 9.37"
Subcutaneous 5.14
P opliteal 6.82
s.e.d. 1.516
*  value s ign ifican tly d iffe re n t from  th a t fo r subcutaneous depot 
(P<0.02).
ii)  E ffe c t o f lacta tion
IC 50 (nM)
Depot N on-lactating Lactating
Omental 9.37 9.25
Subcutaneous 3.76 6.51
P opliteal 7.77 5.88
S.e.d. between depots w ith  the same physiological state = 2.144; s.e.d. 
fo r the e ffe c t o f lacta tion  fo r each depot = 2.655. No s ign ifica n t 
e ffe c t o f lacta tion .
Table 4.4. Displacement of [-^^iJlCYP binding; to sheep adipose tissue
membranes from  three depots by CGP 20712A and IC I 118,551
-  ra tio  o f IC 50 values
o f
and
IC5Q ra t^°s (CGP 20712A/ECI 118,551) fo r displacement 
[lz P ijic Y irla n d in g  to  sheep adipose tissue membranes, by CGP 20712A 
IC I 118,551, were obtained frq.m .analysis o f com petition curves, using the 
ALLOT com puter program. [ ^[JiCYP (75 pM) binding was measured a t 
e ight d iffe re n t concentrations o f antagonist (10 -10 M). Results
are means o f data from  eight animals (4 non-lactating & 4 lacta ting  
ewes), analysed by analysis o f variance using log^o transform ed data to  
reduce the co e ffic ie n t o f varia tion .
i)  Depot differences
Depot 
Omental 
Subcutaneous 
P opliteal 
Log^Q s.e.d.
IC5Q (CGP/ECI) 
mean log^Q o f mean
266.3
706.8
641.8
2.226"
2.692
2.743
0.1245
*  value s ign ifican tly d iffe re n t from  those fo r subcutaneous (P<0.01) and 
pop litea l (P<0.01) depots,
i i)  E ffe c t o f lacta tion
IC50 (CGP/ECI)
N on-lactating Lactating
Depot mean log-LQ o f mean mean logjLo o f mean
Omental 254.9 2.126 277.6 2.327
Subcutaneous 778.6 2.792 635.0 2.591
P opliteal 473.0 2.617 810.4 2.868
LogjLQ s.e.d. between depots w ith  the same physiological state = 0.1761; 
log^Q s.e.d. fo r the e ffe c t o f lacta tion  fo r each depot = 0.2838. No 
s ign ifican t e ffe c t o f lacta tion .
Table 4.5, Effect of lactation on adrenergic receptor ligand binding
in three sheep adipose tissue depots
Sheep adipose tissue membranes (15 pg protein) from om ental, 
subcutaneous and pop litea l depots were incubated w ith 75 pM [ ^[]ICYP 
fo r 60 min a t .22 C, in  the absence or presence o f 100 pM ( - ) -  
isoproterenol. [ ljECYP binding displaced by isoproterenol was assumed 
to  represent specific binding to  {$ -adrenergic receptors. Results are 
means o f data from  eight animals (4 non-lactating & 4 lacta ting  ewes), 
analysed by analysis o f variance.
i)  E ffe c t o f lacta tion
[125i J[CYP bound (fm ol/m g protein)
mean log^Q ° f  mean
N on-lactating 175.3 2.225
Lactating 280.8 2.434"
Log^Q s.e.d. 0.0689
*  value s ign ifican tly d iffe re n t from  th a t fo r non-lactating sheep 
(P<0.02).
ii)  Depot differences
[ 125r]lCYP bound (fm ol/m g protein)
N on-lactating Lactating
Depot mean logj^ Q o f mean mean log^Lo o f mean
Omental 164.2 2.192 300.1 2.466**
Subcutaneous 190.8 2.264 311.9 2.484*
P opliteal 170.9 2.219 230.5 2.352
* , * * , value s ign ifican tly d iffe re n t, P<0.02 and P<0.01, respectively, 
compared to  the corresponding value fo r non-lactating sheep. Log-j^  
s.e.d. between depots w ith  the same physiological state = 0.0743; log^Q 
s.e.d fo r the e ffe c t o f lacta tion  fo r each depot = 0.0918
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Fig. 4.1. [^H]DHA binding; to sheep omental adipose tissue membranes
Sheep (w ether) om ental adipose tissue membranes (100 jig  protein) 
were incubated fo r 10 min a t 37°C, w ith  the indicated concentrations o f 
[^H ]D H A, in  the absence (closed circ les) o r presence (open c irc les) o f 100 
jiM  (-)-isoproterenoL Specific binding (h a lf-fille d  circles) was defined 
as binding sensitive to  com petition by isoproterenoL Each po in t is  
the mean o f trip lic a te  determ inations from  a angle representative 
experim ent.
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Fig. 4.2. Scatchard analysis o f [~%]DHA binding to  sheep om ental adipose 
tissue membranes
For assay conditions see Figure 4.1. The data is  a Scatchard 
p lo t o f the data presented in  Figure 4.1. The corre lation co e ffic ie n t o f 
regression (r) fo r the transform ed data was -0.962. In  th is experim ent 
the dissociation constant fo r [% ]D H A  was 3.603 nM while the maximum 
binding was 607.5 fm ol/m g membrane protein.
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Fig. 4.3. [125jjicYP binding to sheep omental adipose tissue membranes
Sheep (w ether) om ental adipose tissue membranes (15 jig  protein) 
were incubated fo r 1 h a t 22°C, w ith  the indicated concentrations o f 
[ 125I]ICYP, in  the absence (closed circles) o r presence (open c irc les) o f 
100 pM (-)-isoproterenoL Specific banding (h a lf-fille d  c irc les) was 
defined as binding sensitive to  com petition by isoproterenoL Each po in t 
is  the mean o f trip lic a te  determ inations from  a single experim ent.
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Fig, 4.4. Competition of [%]DHA binding; to sheep omental adipose tissue
membranes by isoproterenol, adrenaline and noradrenaline
Sheep (w ether) om ental adipose tissue membranes (100 jig  prote in) 
were incubated w ith  4 nM [^H ]DHA fo r 10 min a t 37°C, in  the presence o f 
the indicated concentrations o f the agonists ( -  ) -isoproterenol (open 
squares), (-)-adrena3ine (closed squares) and (-)-noradrenaline (open 
c ir cles). T o ta l bonding represents [^H ]DHA bound in  the absence o f 
competing agonist. Curves were analysed using the AILFTT com puter 
program. This is  a representative experim ent, which was perform ed three 
tim es w ith  s im ila r results. Each po in t represents the mean o f trip lic a te  
observations.
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Fig. 4.5. Competition o f [% ]D H A  binding to  sheep om ental adipose tissue 
membranes by IC I 118,551 and CGP 20712A
Sheep (w ether) om ental adipose tissue membranes (100 jig  prote in) 
were incubated w ith 4 nM [ H]DHA fo r 10 min a t 37°C, in  the presence o f 
the indicated concentrations o f the antagonists IC I 118,551 (closed 
squares) and CGP 20712A (open squares). T o ta l binding represents
[^H ]DHA bound in  the absence o f antagonist. Curves were analysed using 
the ALLFIT com puter program. This is  a representative experim ent, which 
was perform ed three tim es w ith  s im ila r results. Each po in t represents 
the mean o f trip lic a te  observations.
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Fig. 4.6. Competition of [%]DHA binding to sheep omental adipose tissue
membranes by IC I 118,551 and atenolol
Sheep (w ether) om ental adipose tissue membranes (100 jig  prote in) 
were incubated w ith 4 nM [^H ]DHA fo r 10 min a t 37°C, in  the presence o f 
the indicated concentrations o f the antagonists IC I 118,551 (open 
squares) and atenolol (closed squares). T o ta l binding represents [^H ]DHA 
bound in  the absence o f antagonist. Curves were analysed using the 
ALLFIT com puter program. This is  a representative experim ent, which was 
perform ed three tim es w ith  s im ila r results. Each po in t represents the 
mean o f trip lic a te  observations.
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Fig. 4.7. Competition of [-^ ~*L]ICYP 'bonding to sheep omental adipose
tissue membranes by CGP 20712A and ICE 118,551
Omental adipose tissue membranes (15 pg prote in) from  3-4-year 
old ewes were incubated w ith  75 pM [^% ]IC Y P  fo r 60 min a t 22°C, in  the 
presence o f the indicated concentrations o f the antagonists CGP 20712A 
(open squares) and I d  118,551 (closed squares). T o ta l binding 
represents [^^tjEC YP bound in  the absence o f any antagonist. Curves 
were analysed using the ALLFTT com puter program. IC^q values fo r CGP 
20712A and I d  118^551 were 1.6 pM (s.e.d.=0.472) and 9.37 nM 
(s.e.d.=1.516), respectively (n=8). This is  a representative experim ent 
(lacta ting  ewe), which was perform ed eight tim es w ith  preparations from  
d iffe re n t sheep (4 non-lactating & 4 la c ta tin g ) w ith  s im ila r results. 
Each po in t represents the mean o f duplicate observations.
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Fig. 4.8. Competition of [^^I]ICYP binding to sheep subcutaneous
adipose tissue membranes by CGP 20712A and IC I 118,551
Subcutaneous adipose tissue membranes (15 jig  prote in) from  3 -4 - 
year old ewes were incubated w ith  75 pM [^^^t]lC YP fo r 60 min a t 22°C, 
in  the presence o f the indicated concentrations o f the antagonists CGP 
20712A (open squares) and IC I 118,551 (closed squares). T o ta l binding 
represents [^^ijEC YP bound in  the absence o f any antagonist. Curves 
were analysed using the ALLFIT com puter program. IC^q values fo r CGP 
20712A and IC I 118,551 were 2.99 j iM (s.e.d.=0.472) and 5.14 nM 
(s.e.d.=1.516), respectively (n=8). This is  a representative experim ent 
(lacta ting  ewe), which was perform ed eight tim es w ith  preparations from  
d iffe re n t sheep (4 non-lactating & 4 la cta ting ) w ith  s im ila r results. 
Each po in t represents the mean o f duplicate observations.
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Fig. 4.9. Competition of [^^I]ICYP binding to sheep popliteal adipose
tissue membranes by CGP 20712A and ICI 118,551
P opliteal adipose tissue membranes (15 jjg  protein) from  3-4-year 
old ewes were incubated w ith  75 pM [•^ 'b jC Y P  fo r 60 min a t 22°C, in  the 
presence o f the indicated concentrations o f the antagonists CGP 20712A 
(open squares) and IC I 118,551 (closed .squares). T o ta l binding 
represents [^^E jlC YP  bound in  the absence o f any antagonist. Curves 
were analysed using the ALLFIT com puter program. IC^q values fo r CGP 
20712A and I d  118,551 were 3.55 j iM (s.e.d.=0.472) and 6.82 nM 
(s.e.d.=1.516), respectively (n=8). This is  a representative experim ent 
(lacta ting  ewe), which was perform ed e ight tim es w ith preparations from  
d iffe re n t sheep (4 non-lactating & 4 laca ting) w ith  s im ila r results. 
Each po in t represents the mean o f duplicate observations.
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Fig. 4.10. Competition of [~^^I]ICYP binding to sheep omental adipocyte
membranes
Adipocyte membranes and strom a-vascular membranes were prepared 
from  sheep (non-lactating ewe) om ental adipose tissue, by collagenase 
digestion and d iffe re n tia l centrifugation (section 2.3.1). Adipocyte 
plasma membranes (15 jig  protein) were incubated w ith 75 pM [^^ijLC Y P  
fo r 60 min a t 22° C, in  the presence o f the indicated concentrations o f 
the antagonists CGP 20712A (open squares) and IC I 118,551 (closed 
squares). T o ta l bonding represents [^^ijLC Y P  bound in  the absence o f 
antagonist. j8 -Adrenergic receptor ligand binding was 141.1 fm ol/m g 
membrane protein. This experim ent was perform ed once, and each po in t 
represents the mean o f duplicate observations.
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Fig. 4.11. Competition of [^~*I]ICYP binding to stroma-vascular
membranes from sheep omental adipose tissue
Adipocyte membranes and strx>ma-vascuLar membranes were prepared 
from  sheep (non-lactating ewe) om ental adipose tissue, by coUagenase 
digestion and d iffe re n tia l centrifugation (section 2.3.1). Strom a- 
vascular membranes (15 jig  protein) were incubated w ith  75 pM 
[ 125I]ICYP fo r 60 min a t 22°C, in  the presence o f the indicated 
concentrations o f the antagonists CGP 20712A (open squares) and IC I 
118,551 (closed squares). T o ta l binding represents [^ ^^ijECYP bound in  
the absence o f antagonist. 8^ -Adrenergic receptor ligand binding was 
62.9 fm ol/m g membrane protein . This experim ent was perform ed once, and 
each po in t represents the mean o f duplicate observations.
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Fig. 4.12. Effect of lactation on ^  -adrenergic receptor ligand binding
in three sheep adipose tissue depots
Sheep (ewes) adipose tissue membranes were prepared from  
om ental, subcutaneous and pop litea l adipose tissues (section 2.3.2). 
Membranes (15 jig  protein) were incubated w ith  75 pM [^-*I]IC Y P  fo r 60 
min a t 22°C. N on-specific binding was determ ined in  the presence o f 100 
jjM (-)-isoproterenoL Results are means o f fo u r independent 
observations in  each case, analysed by analysis o f variance. The results 
presented are tabulated in  Table 4.5. * , * * , value s ign ifica n tly
d iffe re n t, P<0.02 & P<0.01, respectively, from  corresponding value fo r 
non-lactating sheep fo r log^Q transform ed results. Log^Q s.e.d. between 
depots w ith in  the same physiological state = 0.0743; log^Q s.e.d. fo r 
the e ffe c t o f lacta tion  fo r each depot = 0.0918
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Fig. 4.13. Competition of [%]DHA binding to ra t  adipocyte membranes by
isoproterenol, adrenaline and noradrenaline
Rat adipocyte membranes (100 ytg prote in) prepared from  abdom inal 
adipose tissue were incubated w ith  4 nM [% ]D H A  fo r 10 min a t 37°C, in  
the presence o f the indicated concentrations o f the agonists ( - ) -  
ispoproterenol (open squares), ( - ) -adrenaline (closed squares) and ( - ) -  
noradrenaline (open c irc les). T o ta l binding represents [^H ]DHA bound in  
the absence o f agonist. Curves were analysed using the ALLOT com puter 
program. This data is  from  a single experim ent. Each po in t represents 
the mean o f trip lic a te  observations.
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Fig. 4.14. Competition of [^H]DHA binding: to ra t  adipocyte membranes by
ICE 118,551 and CGP 20712A
Rat adipocyte membranes (100 pg prote in) prepared from  abdominal 
adipose tissue were incubated w ith  4 nM [^H ]DHA fo r 10 min a t 37°C, in  
the presence o f the indicated concentrations o f the antagonists IC I 118, 
551 (closed squares) and CGP 20712A (open squares). T o ta l binding 
represents [ H]DHA bound in  the absence o f antagonist. Curves were 
analysed using the ALLFIT com puter program. This is  a representative 
experim ent, repeated three tim es w ith  s im ila r results. Each po in t 
represents the mean o f trip lic a te  observations.
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Fig. 4.15. Competition of [^H]DHA binding to ra t  adipocyte membranes by
ICI 118,551 and atenolol
Rat adipocyte membranes (100 jjg  prote in) prepared from  abdominal 
adipose tissue were incubated w ith  4 nM [% ]D H A  fo r 10 min a t 37°C, in  
the presence o f the indicated concentrations o f the antagonists IC I 118, 
551 (closed squares) and atenolol (open . squares). T o ta l handing 
represents [  H]DHA bound in  the absence o f antagonist. Curves were 
analysed using the ALLFIT com puter program. This data is  from  a single 
experim ent. Each po in t represents the mean o f t r ip lic ate observations.
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Fig. 4.16. Competition of [^2^I]ICYP binding to ra t  parametria!
adipocyte membranes by CGP 20712A and IC I 118,551
Rat param etria l adipocyte membranes (20 jjg  prote in) were 
incubated w ith  85 pM [ 125I]ICYP fo r 60 min a t 22°C, in  the presence o f 
the indicated concentrations o f the antagonists CGP 20712A (closed 
circ les) and IC I 118,551 (open c irc les). T o ta l binding represents 
[ 125I]ICYP bound in  the absence o f antagonist. This is  a representative 
experim ent, which was perform ed three tim es w ith  s im ila r results. Each 
po in t represents the mean o f duplicate observations.
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Fig. 4.17. Com petition o f [^ 2~TIlCYP binding to  ra t lum bar adipocyte 
membranes by CGP 20712A and IC I 118,551
Rat lum bar adipocyte membranes (20 jig  prote in) were incubated 
w ith  85 pM [ 125T]ICYP fo r 60 min a t 22° C, in  the presence o f the 
indicated concentrations o f the antagonists CGP 20712A (closed circ les) 
and IC I 118,551 (open c irc les). T o ta l binding represents [^ 2^l]lCYP bound 
in  the absence o f antagonist. This is  a representative experim ent, which 
was perform ed three tim es w ith  s im ila r results. Each po int represents 
the mean o f duplicate observations.
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CHAPTER FIVE -  IMMUNOLOGICAL STUDIES ON THEff-ADRENERGIC 
RECEPTOR OF SHEEP ADIPOSE TISSUE
5.1. Introduction
The use o f im  munologically-based techniques in  biochem istry has 
increased markedly in  the la s t decade. The sp e c ific ity  o f antibody- 
antigen in te raction  allows the id e n tifica tio n  o f both solid-phase (E IA) 
and soluble (RIA, EIA) antigens/antibodies. In  the fie ld  o f receptor 
characterisation, antibodies raised against receptors can be used to 
determ ine structu ra l and even sequence homology between receptors from 
d iffe re n t species and tissues, or between pharm acologically d is tin c t 
receptor subtypes. These studies can often provide additional 
in form ation to  fu rth e r substantiate results from  receptor p h o ta ffin ity - 
labelling and pu rifica tion . Antibodies can be used fo r quantifica tion or 
loca lisation o f receptor protein, e ither by im m unoblotting or 
im  munocytochemistry. This has the advantage over radioligand binding 
assays o f being able to  id e n tify  receptors which are incapable o f 
binding ligands e.g. proreceptors or partially-degraded receptors.
The aim o f th is work was the production o f antibodies directed 
against the jg -adrenergic receptor o f sheep adipose tissue. Collaboration 
w ith  other researchers was in itia te d  to  obtain samples o f antisera 
specific fo r £ -adrenergic receptors from  other species and tissues.
5.2. Experim ental procedure
A ll methods used in  th is study are fu lly  described in  Chapter 2. 
Membranes were prepared from  sheep om ental adipose tissue. Antiserum 
CM 13 (Wang e t aL, 1989c) was a generous g ift from  Dr Craig Malbon, 
Department o f Pharmacological Sciences, State U niversity o f New York, New 
York, U.S.A. CM 13 is  a ra bb it polyclonal antiserum raised against a
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synthetic decapeptide whose sequence is  contained in  ham ster lung 
adrenergic receptor (Wang e t aL, 1989c). Monoclonal antibody BRK2 was 
provided by Professor A. D. Strosberg, In s titu t Pasteur, Paris, France. 
BRK2 was raised against the receptor o f human A431 cells,
and recognises and ^2 “ a(i renerSic receptors in  many species (K averi 
e t aL, 1987).
5.3. Results
5.3.1. Screening o f mouse antisera fo r antibodies against the
^-adrenergic receptor
5.3.1.1. EIA
Mice were immunised as detailed in  section 2.12.1. Serum samples 
obtained were in itia lly  screened by EIA (section 2.12.4) fo r re a c tiv ity  
against sheep om ental adipose tissue membranes and sheep erythrocyte 
ghosts. Using th is assay i t  was hoped to  select mice exhib iting strong 
anti-sheep adipose tissue responses and weak a c tiv ity  towards sheep 
erythrocyte ghosts. I t  was hypothesised th a t such re a c tiv ity  may 
re fle c t the presence o f antibodies against the ^-adrenergic receptor, 
since sheep erythrocyte ghosts lack such receptors.
Sera from  a ll mice exhibited re a c tiv ity  towards sheep (lacta ting  
ewe) om ental adipose tissue membranes (Figure 5.1). Mouse 4 (immunised 
w ith NaOH-treated sheep adipose tissue membranes) was the best 
responder against both membrane preparations, ind icating a lack o f 
se le c tiv ity  towards sheep adipose tissue (Figures 5.1 & 5.2). Three mice 
immunised w ith p a rtia lly -p u rifie d  jg-adrenergic receptor exhibited 
specific binding towards sheep adipose tissue membranes, w ith  mouse 2 
having the same response as norm al mouse serum against sheep 
erythrocyte ghosts (Figures 5.1 & 5.2). W ith regards to  mice im munised
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w ith  electroelnted 58 kDa proteins from  SDS PAGE o f sheep adipose tissue 
membranes, animals 5 and 6 possessed the best antibody responses 
against sheep adipose tissue membranes (Figure 5.1). Mouse 7 did not 
respond w ell, and had alm ost id e n tica l antibody titre  against both 
membranes. High backgrounds in  the EIA were due to  non-specific binding 
o f the alkaline-phosphatase second antibody to  the plates. In  la te r 
assays, th is was s ign ifican tly  reduced by blocking the plate w ith  1% 
(w /v) BSA instead o f Tween 20.
5 .3 .I.2 . Im munoblotting
Sera from  immunised mice were screened against sheep (ewe) 
om ental adipose tissue membrane proteins by im munoblotting (section 
2.16). The monoclonal antibody BRK2 was also tested in  the same manner. 
A ll antisera except BRK2 recognised antigens in  sheep adipose tissue 
membranes (Figure 5.3). The batch o f BRK2 antibody supplied also fa ile d  
to  recognise -adrenergic receptors in  sheep adipose tissue, sheep lung, 
ra t liv e r and human placenta in  an EIA. These results are quite 
d iffe re n t from  those published (KaverL e t aL, 1987). The sample o f BRK2 
must therefore have contained an abnorm ally low concentration o f 
antibodies (Professor A. D. Strosberg, personal correspondence). No 
binding o f NMS was evident a t a d ilu tion  o f 1:50. Sera from  mice 
immunised w ith p a rtia lly -p u rifie d  ft -adrenergic receptors (AS1-3) 
recognised two major proteins, w ith  approximate molecular weights o f 55 
kDa and 100 kDa. AS4, from  a mouse immunised w ith  NaOH-treated sheep 
adipose tissue membranes, recognised a whole spectrum o f proteins, 
ind ica tive  o f a poorly selective antiserum. Mice immunised w ith  58 kDa 
electroeluted proteins bound proteins ranging in  molecular weight from  
55-75 kDa. No molecular weight markers were run on the im m unoblot in
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Figure 5.3 and therefore the molecular weights quoted are estimates 
based on R f values obtained from  la te r im  m unoblotting experiments.
5 .3 .I.3 . Inh ib ition  o f [-^ jlC Y P  binding to  sheep adipose tissue 
membranes
A fu rth e r screen fo r antibodies against the p-adrenergic receptor 
involved the com petition o f antisera fo r [^ ^^ijECYP binding sites on 
sheep om ental adipose tissue membranes. Sera from  mice immunised w ith  
p a rtia lly -p u rifie d  @ -adrenergic receptor a ll inh ib ited binding o f 
[ 125I]ICYP, w ith  AS2 inh ib iting  22-27% o f the binding obtained in  the 
presence o f NMS (Figure 5.4). In teresting ly, AS5 also competed out 
[ 125i]ic y p  as e ffic ie n tly  as AS2, and therefore th is a b ility  was produced 
by im munisation w ith  two o f the three im munogens used. A ll other 
antisera exhibited lit t le  or no com petition o f binding. The experim ent 
was only perform ed tw ice due to  the lim ite d  a va ila b ility  (amounts) o f 
antisera (20 ^d/tube). No antibodies against [^ 2~*l]lCYP were detectable 
in  the antisera using d ire c t p recip ita tion  o f the firs t antibody w ith  30% 
(w /v) PEG (data not shown).
A fte r analysing a ll the results, mouse 2 was chosen fo r 
monoclonal antibody production since its  antiserum ; i)  bound specifica lly 
to  sheep adipose tissue membrane antigens, ii)  recognised few antigens 
on immunoblots, some w ith  molecular weights close to  th a t o f the f$- 
adrenergic receptor, i i i)  inh ib ited [^ 2^I]ICYP binding to  sheep adipose 
tissue membranes, iv ) contained no antibodies against [^ 2^lJ[CYP, v ) was 
raised against an antigen which had been used successfully before, and 
was o f the greatest p u rity . Antiserum (AS2) obtained from  th is mouse 
p rio r to  fusion was screened by EIA fo r antibodies against sheep adipose 
tissue membranes. AS2 reacted very strongly against sheep adipose
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tissue membranes, even a t a dilution o f 1:10,000 (Figure 5.5a). AS2 had 
a s lig h tly  higher titre  against sheep erythrocyte ghosts compared to  
norm al mouse serum, which is  probably a function o f an increased serum 
antibody concentration in  th is im  m uno-stim ulated animaL Binding o f 
second antibody again caused an increase in  background absorbance o f 
*0 .8  units.
5.3.2. Production o f monoclonal antibodies
Splenocytes from  a mouse (mouse 2) immunised fou r tim es w ith  1 
pm ol o f p a rtia lly -p u rifie d  £ -adrenergic receptors were fused w ith  non­
secreting myeloma cells. The e ffic ie ncy o f fusion was re la tive ly  poor, 
w ith  less than a quarter o f the wells containing sustainable grow th o f 
hybridomas in  the presence o f HAT medium. The number o f wells 
containing hybridomas in  plates 1-3 were 23%, 18% and 23%, respective ly. 
Supernatants from  cultures o f fused cells were screened tw ice by EIA fo r 
the presence o f antibodies against sheep adipose tissue membranes 
(section 2.12.4). Absorbance changes fo r wells deemed positive against 
sheep adipose tissue membranes were sm all, typ ica lly  0.15-0.2. However, 
there was a good correlation between wells deemed positive by EIA and 
wells containing growing hybridomas.
Tw enty-four wells which were positive in  EIA and contained good 
grow th (61 wells possessed growth) were expanded in to  a 24 -w e ll p late 
fo r fu rth e r screening. Analysis by EIA a fte r expansion revealed th a t 11 
out o f 24 wells contained specific antibodies against sheep adipose 
tissue membranes. These wells were studied using more elaborate assays 
to detect specific antibodies against the f t -adrenergic receptor, ra the r 
than a c tiv ity  towards other sheep adipose tissue membrane antigens. 
Hybridoma culture supernatants were in itia lly  tested fo r th e ir a b ility  to
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im m unoprecipitate solubilised -adrenergic receptors (section 2.14). 
D irect measurement o f -adrenergic receptors in  supernatants fo llow ing 
im m unoprecipitation indicated th a t no precip ita tion  o f receptors was 
evident (Table 5.1). Suprisingly, more ^-adrenerg ic receptors were 
measurable in  samples containing hybridoma supernatants, re la tive  to 
those incubated w ith  conditioned HT medium alone. Culture supernatants 
also fa ile d  to in h ib it binding o f [^^^ijLCYP to  sheep adipose tissue 
membranes (Table 5.2). In  fa c t an enhancement o f binding was obtained, 
which also occurred in  the presence o f the irre levan t monoclonals 2H11 
and 2C12 raised against rGH (provided by Dr L. Q. Stevenson).
Im munoblotting w ith  supernatants against sheep om ental adipose 
tissue membranes showed th a t some wells contained hybridomas secreting 
antibodies against the 100 kDa protein recognised by antiserum 2 (AS2). 
However th is  re su lt was seen a t the detection lim it o f im  m unoblotting. 
In  order to  overcome th is problem and also th a t o f in terference o f 
culture supernatants w ith  [^ ^^ijECYP binding, pho toa ffin ity-labe lled  f$- 
adrenergic receptors were incubated w ith  hybridoma supernatants to  see 
i f  they could be im munoprecipitated (section 2.15). Analysis o f
autoradiographs fo llow ing im m unoprecipitation and SDS PAGE showed th a t 
no specific p recip ita tion  o f pho toa ffin ity-labe lled  jS -adrenergic 
receptors had occurred. However, Coomassie-blue staining o f the SDS 
PAGE gel revealed tha t proteins w ith molecular weights o f 55 kDa and 95 
kDa were im m unoprecipitated by some supernatants (Table 5.3).
5.3.3. Im munoblotting against sheep adipose tissue ^-adrenergic 
receptors w ith antiserum CM 13
CM 13 is  a ra b b it polyclonal antiserum directed against the 
peptide G ln-Asp-Asn-Leu-Ue-Pro-Lys-G lu-Val-Tyr-Cys. The firs t ten
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amino acids in  th is peptide correspond to  residues 299-308 in  the cloned 
hamster lung ^52"a<^ renerSic receptor (Figure 5.6). The antiserum was 
received as a lyophilised powder, and was resuspensed in  500 jiL  o f PBS, 
1% (w /v) M arvel w ith  no idea o f the fin a l protein concentration.
Immunoblots o f sheep adipose tissue membranes w ith  CM 13 showed 
prom inent im  m unoreactivity against fou r proteins (Figure 5.7). Staining 
comprised o f a doublet and two higher molecular weight bands. A repeat 
im m unoblot, which possessed molecular weight markers, was perform ed 
using a peroxidase anti-peroxidase am plifica tion system. On th is b lo t 
the doublet o f proteins was very clear, w ith  lit t le  im  m unoreactivity 
towards other proteins (F igure 5.8, lane 3). The doublet comprised o f 
polypeptides w ith m olecular weights o f 59 kDa and 61 kDa. No staining 
was observed w ith a 1:50 d ilu tion  o f norm al ra b b it serum (F igure 5.8, 
lane 1). The immunostaining o f AS2 against sheep adipose tissue 
membranes was greater in  Figure 5.7 than in  Figure 5.8, re la tive  to  CM 
13 a c tiv ity . The reasons behind th is s h ift in  re la tive  im m unoreactivity 
are not clear, but i t  could have resulted from  the use o f d iffe re n t 
second antibodies (i.e . AS2 -  mouse; CM 13 -  ra bb it) in  Figure 5.7, and 
d iffe re n tia l a c tiv ity  o f peroxidase anti-peroxidase and bridging 
antibodies in  Figure 5.8.
5.4. Discussion
The aim o f th is work was to  develop antibodies specific fo r the 
jS-adrenergic receptor. From the pur if ication work described in  Chapter 
3, i t  became clear th a t i t  was not possible to  pu rify  the £ -adrenergic 
receptor from  sheep adipose tissue membranes to  homogeneity using the 
available techniques, w ithout excessive loss o f receptors. To pu r ify the 
fS-adrenergic receptor to  homogeneity from  membranes requires a
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p u rifica tio n  o f about 40,000 fo ld  (Shorr e t aL, 1981; Homey e t aL, 1983; 
Benovic e t aL, 1984; Cubero & Malbon, 1984). SDS PAGE o f p a rtja lly - 
purifLed -adrenergic receptor preparatLons indicated the presence o f a 
whole spectrum o f protein contaminants. I t  was therefore decided to  use 
monoclonal antibody technology to  produce the desired antibody, since a 
polyclonal antiserum raised against th is immunogen would have been non­
specific.
Three d is tin c t immunogens were used fo r th is purpose. One group 
o f mice received 1 pm ol o f active |8 -adrenergic receptors, p a rtia lly - 
pu rified  by a ffin ity  chromatography. This amount o f receptor has been 
successfully used fo r the production o f monoclonal antibodies to  the 
turkey erythrocyte (3^-adrenergic receptor (Couraud e t aL, 1983; Chapot 
e t aL, 1989), c a lf lung ^2 “ ac^ renerS ^ receptor (Fraser & Venter, 1980) 
and human A431 f$2~a&r:ener&jZ receptor (K averi e t aL, 1987). A second 
group o f animals were immunised w ith proteins electroeluted from  SDS 
PAGE gels o f sheep adipose tissue membranes (w ith  approximate m olecular 
weights o f 58 kDa). I t  was predicted th a t the |3-adrenergic receptor 
would be contained in  th is preparation, based on the apparent m olecular 
weight o f photoaffin ity-labe lled  receptor. About a 10-fo ld p u rifica tio n  
fa c to r was also inherent in  th is method. A single mouse received NaOH- 
treated sheep om ental adipose tissue membranes, which i t  was hoped 
contained a ll the in te g ra l membrane proteins, including the -adrenergic 
receptor. NaO H-treatm ent strips o ff peripheral proteins which are non- 
covalently bound to  the membrane (M ueller & Morrison, 1981). This 
immunogen was included because o f the success o f Deckman and Shinitzky 
(1989), who raised monoclonal antibodies against the S 2-serotonin 
receptor from  ra t brain using a s im ila r method. Only 2.4% o f protein
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remained associated w ith  sheep adipose tissue membranes a fte r NaOH 
treatm ent, and represented a possible purif ication o f the f3-adrenergic 
receptor.
Antisera from  a ll mice bound to  sheep om ental adipose tissue 
membranes in  EIA, but animals immunised w ith  p a rtia lly -p u rifie d  f3- 
adrenergic receptors exhibited the greatest specific response. Two o f 
these mice fa ile d  to recognise antigens in  sheep erythrocyte ghosts, 
which is  probably due to  the re la tive ly  high pu rity  o f the immunogen 
used. Indeed, in  im m unoblotting experiments antisera from  th is group o f 
animals stained only a few proteins. Mice immunised w ith  58 kDa 
proteins produced less specif ic antisera, but nonetheless 
im m unoreactivity was lim ite d  to  a few major proteins whose m olecular 
weights centred around 58 kDa. The range o f proteins recognised was 
most lik e ly  due to  the size o f the slice cu t from  the SDS PAGE ge l (1 
cm ), and also perhaps from  binding to  precursors o f 58 kDa proteins. 
This re su lt also indicated th a t these antigens retained th e ir 
im  m unoreactivity fo llow ing electro elution and im m unisation in  the 
presence o f SDS detergent. Antiserum from  the single mouse which 
received in te g ra l membrane proteins bound equally w e ll to  sheep om ental 
adipose tissue membranes and sheep erythrocyte ghosts in  EIA, and also 
recognised a host o f proteins on immunoblots. These results indicated 
th a t th is antiserum was non-specif ic towards sheep adipose tissue 
membranes, but served to  illu s tra te  the se le c tiv ity  obtainable by EIA fo r 
sheep adipose tissue membrane antigens prepared in  a more specific 
fashion.
To select a mouse fo r the production o f monoclonal antibodies, 
two fu rth e r assay systems were employed. Antisera from a ll mice fa iled
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to  im  m unoprecipitate dig itonin-solubilised -adrenergic receptors. The 
reasons fo r th is are unclear since no positive con tro l was available to  
validate the assay protocol. However some antisera inh ib ited binding o f 
[ 125ljLCYP to  sheep om ental adipose tissue membranes. Although th is 
suggests th a t antibodies were present th a t were binding to  the f$- 
adrenergic receptor, i t  is  possible th a t [^ 2-*l]lCYP binding could have 
been reduced by stei ic  hindrance from  antibodies binding to  non-receptor 
antigens in  close proxim ity to  the receptor. However, the degree o f 
in h ib itio n  o f two antisera, AS2 and AS5, was encouraging, especially 
since AS4 from the mouse immunised w ith  NaOH-treated membranes did not 
in h ib it binding, even though i t  recognised many antigens and had the 
highest titre  in  EIA.
Screening by EIA o f hybridoma supernatants during the production 
o f monoclonals revealed th a t some antibodies were present th a t bound 
sheep adipose tissue membrane antigens. This assay system has been 
successfully used by several groups, and appeared to  be an id e a l choice 
o f firs t screen (Couraud e t aL, 1983; KaverL e t aL, 1987; Chapot e t aL, 
1989). In  re a lity  im  m unoreactivity in  EIA was poor and absorbance 
changes were smalL This was probably due to  the lim itin g  amounts o f 
proteins on the wells and the low concentrations o f antibodies in  the 
cu ltu re supernatants 1-5 jig /m l). Having been com m itted to  th is assay 
as a firs t screen, tw en ty-fou r wells w ith  s ta tis tica lly  higher titre s  
against sheep adipose tissue membranes compared to  sheep erythrocyte 
ghosts were expanded. Due to  the low e ffic iency o f fusion (^ 20% growth 
in  each plate) the choice o f wells was reduced from  a possible 288 wells 
to  only 61.
Further characterisation o f the resulting hybridomas fa ile d  to
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show the presence o f antibodies against the ^-adrenergic receptor. The 
hybridomas fa iled  to ; i)  im  m unoprecipitate dig itonin-solubilised f$- 
adrenergic receptors, di) in h ib it .[^"ijEC YP binding to  sheep adipose 
tissue membranes, ii i)  im  m unoprecipitate solubilised p h o to a ffin ity - 
labelled ^-adrenergic receptor, even though microgram quantities o f 
other antigens were precip ita ted, iv ) recognise a 58 kDa protein (o r
doublet) on immunobLots against sheep om ental adipose tissue membranes. 
However, most o f the assays fo r hybridoma characterisation used 
detergent-solubilised -adrenergic receptor, and therefore i t  is  possible 
th a t antibodies capable o f binding native receptor were present but
th e ir binding was affected by the detergent.
The fa ilu re  to  produce a monoclonal antibody specific fo r jS-  
adrenergic receptor was possibly due to  a number o f factors. F irs tly , 
the amount o f pa rti a lly -p u rifie d  -adrenergic receptor was lim itin g . 
Only three animals could be immunised, and there was in su ffic ie n t 
preparation fo r use as an antigen in  the firs t EIA screen. Secondly, the
EIA employed as a firs t screen was not su ffic ie n tly  specific fo r
antibodies against ^-adrenerg ic receptors. Because the receptor 
represented less than 1% o f protein in  the immunogen, and even less in  
the membranes coated on the EIA p late, i t  is  lik e ly  th a t any specific 
binding to  -adrenergic receptors would have been ins ign ifican t re la tive  
to im  m unoreactivity towards other major antigens. Th ird ly, the growth 
o f hybridomas post-fusion was poor. Since ^-adrenergic receptor protein 
represented <1% o f the immunogen, less than 1 in  100 hybridomas was 
lik e ly  to  secrete antibodies against th is receptor, or even less since 
the f t -adrenergic receptor is  probably poorly immunogenic due to  its  
conserved sequence. However, some wells could have contained many
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clones, and so even w ith  th is poor growth there was a chance o f 
screening out a positive clone. F inally, the accurate measurement o f |S- 
adrenergic receptors using radioligand "bonding assays was no t possible 
in  the presence o f hybridoma supernatants, because o f an enhancement o f 
binding due to  an unknown fa c to r.
A number o f improvements could be made fo r subsequent studies: 
i)  Increase the yie ld and p u rity  o f ^-adrenerg ic receptor preparations 
used fo r im m unisation, possibly by using la rger amounts o f membranes 
and a la rger a ffin ity  column, ii)  Following fusion o f splenocytes and 
myeloma cells use only 24-w ell plates (2 m l wells) fo r growing 
hybridomas, and thus allow the use o f more elaborate assays fo r the 
in itia l screens. iii)  Use the im m unoprecipitation o f p h o to a ffin ity - 
labelled ^-adrenergic receptor as a prim ary screen, since i t  involves 
d ire c t in te raction  o f antibodies w ith  ^-adrenergic receptor, and the 
analysis is  not dependent on radioligand binding assays. iv ) Perform 
more studies w ith CM 13 or BRK2 antibodies, w ith  a view to  using them 
as positive controls in  assays.
Two antibodies were provided as g ifts  from  other researchers, 
namely CM 13 (D r Craig Malbon) and BRK2 (Professor A. D. Strosberg). 
U nfortunately BRK2 fa iled  to  recognise {2-adrenergic receptors in  sheep 
adipose tissue, or membrane-bound ^-adrenergic receptors from  various 
species and tissues in  EIA which i t  had previously recognised w ith  high 
a ffin ity  (KaverL e t aL, 1987). A new sample o f BRK2 has been promised 
a t the tim e o f w riting . I t  is  probable th a t BRK2 w ill recognise the 
sheep adipose tissue ^-adrenerg ic receptor because o f its  lack o f 
sp e c ific ity  w ith  regards to  species and tissue, and ^-adrenergic receptor 
subtype (KaverL e t aL, 1987; Raposo e t aL, 1989). Rabbit polyclonal
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antiserum CM 13 is  a site -d irected  anti-peptide antiserum raised against 
the ham ster lung ^2 “ a^rener&-c receptor (Wang e t aL, 1989c). CM 13 
recognised a doublet o f proteins on immunoblots o f sheep adipose tissue 
membranes, whose m olecular weights were 59 kDa and 61 kDa. These bands 
most lik e ly  represent two isoform s o f /§-adrenergic receptor since CM 13 
has already been shown to  bind ^-adrenergic receptors in  mouse S49 
lymphoma cells, hamster lung, and both human an<^  /^-ad rene rg ic 
receptor subtypes (Wang e t aL, 1989c). In teresting ly, CM 13 displayed no 
sign ifican t im  m unoreactivity towards the ra t adipocyte /S-adrenergic 
receptor (Wang e t aL, 1989c). CM 13 recognises a decapeptide sequence 
in  the predicted exo -facia l domain linking  transmembrane helices 6 and 7 
(see Figure 5.6). I t  therefore appears th a t the f i -adrenergic receptor in  
sheep adipose tissue shares homology in  th is area w ith  /S-adrenergic 
receptors in  S49 lymphoma cells, ham ster lung, and human /8^- and ^ 2“  
adrenergic receptors, but not w ith  the ra t adipocyte /8-receptor. This 
may re fle c t a divergence o f the genes encoding these receptors during 
th e ir evolution.
Human placental /S^- (FrLelle e t aL, 1987) and /^-a d re n e rg ic  
receptors (Kobdlka e t aL, 1987a) share 2 out o f 10 and 9 out o f 10 
amino acids in  the decapeptide sequence to  which CM 13 was raised, 
respectively. Since CM 13 binds to  both these /8-adrenergic receptors on 
immunoblots, i t  appears th a t th is antiserum recognises the secondary 
structure o f th is extrace llu la r loop ra ther than the prim ary amino acid 
sequence. Studies w ith CM 13 were lim ite d  by the amount o f antiserum 
supplied. I t  would therefore be useful to  synthesise the decapeptide 
antigen 'in  house1 and produce our own antiserum . The antiserum could 
then be used fo r im munocytochemistry, im m unoblotting and fo r screening
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an expression lib ra ry  o f sheep adipose tissue proteins, w ith  a view to 
cloning the j8-adrenergic receptor. Some additional characterisation o f 
the antiserum would have to  carried out in ti a lly  to  confirm  th a t i t  
binds to  the ft -adrenergic, receptor o f sheep adipose tissue. Experiments 
could also be perform ed to  see i f  the antiserum inh ib its  binding o f 
adrenergic, ligands to  the £ -adrenergic receptor, and im munoprecdpitates 
dig itonin-solubilised ^-receptors.
In  summary, the work detailed in  th is chapter has la id  a good 
foundation fo r fu rth e r studies in  th is area, having highlighted 
pa rticu la r methodological problems. I t  appears th a t the major problem 
w ith  the production o f antibodies against the ^-adrenergic receptor is  
the low abundance o f th is protein in  c e ll plasma membranes. This 
hampers the production o f a good immune response due to  the use o f 
sm all amounts o f im pure immunogens, and re s tric ts  the type o f assays 
which can be used to  detect antibodies against a single antigen. By 
overcoming th is fundam ental problem, i t  should be possible to  raise 
antibodies against the ^-adrenergic receptor o f sheep adipose tissue 
using monoclonal antibody technology.
Table 5.1. Im m unoprecipitation o f digitonin-solublised ^3-adrenergic 
receptors by hybridoma culture supernatants
Hybridoma cultu re supernatants were tested fo r th e ir a b ility  to  
im  m unoprecipitate dig itonin-solubilised ^-adrenerg ic receptors from  sheep 
(lacta ting  ewe) om ental adipose tissue, as detailed in  section 2.14. 
Culture supernatants are from  wells containing hybridomas secreting 
antibodies against sheep om ental adipose tissue membrane antigens. 
Results are expressed as means o f trip lic a te  observations. The 
experim ent was perform ed tw ice w ith  s im ila r results.
/S-Adrenergic receptor ligand binding in  
Sample supernatants a fte r im  m unoprecipitation
[lz jjic Y p  bound specific a lly  
(CPM)
HT medium, 20% (v /v ) FCS 3164
Norm al mouse serum 3010
Polyclonal antiserum
Antiserum 2 (AS2) 3078
Hybridoma supernatants
A1 
A2 
A5 
A6 
B2 
B3 
B4 
C l 
C2 
C4 
C5
4045
3884
3736
3720
3828
3844
4333
4314
4752
4330
4539
Table 5.2. Inhibition of [~^~*I]ICYP binding to sheep adipose tissue
membranes by hybridoma culture supernatants
Hybridoma cultu re supernatants were tested fo r th e ir a b ility  to  
in h ib it binding o f 75 pM [^% ]IC Y P  to sheep (lacta ting  ewe) om ental 
adipose tissue membranes, as detailed in  section 2.13. 2H11 and 2C12 -  
anti-rG H  hybridoma cultu re supernatants (controls provided by D r L  Q. 
Stevenson). A ll other wells are culture supernatants from  wells 
containing hybridomas secreting antibodies against sheep om ental adipose 
tissue membrane antigens. Results are expressed as mean + /-' S.E.M. o f 
trip lic a te  observations. This is  a representative experim ent which was 
perform ed tw ice w ith  the same results. Binding was independent o f the 
order in  which samples were assayed.
Sample [ 1250lCYP bound
(CPM)
HT medium, 20% (v /v ) FCS 4184 + 280
Hybridoma culture supemtants
A1 4612 ± 178
A2 4383 ± 154
A5 5360 ± 395
A6 5155 ± 225
B2 5318 ± 162
B3 5163 + 274
B4 5266 + 567
C l 5212 ± 291
C2 5512 + 369
C4 4970 + 65
C5 5439 ± 368
Anti-rGH hybridomas
2H11 4899 ± 83
2C12 5289 ± 267
Table 5.3. Im munoprecipitation of sheep adipose tissue membrane
proteins w ith  hybridoma culture supernatants
Sheep (lactaring ewe) om ental adipose tissue membrane proteins 
were im munoprecipitated w ith  hybridoma supernatants during p recip ita tion  
o f digi tom n-solubilised photoa ffin ity-labe lled  adrenergic receptors 
(section 2.15). Coomassie blue staining o f the resulting SDS PAGE gel 
revealed the im  m unoprecipitation o f two separate protein species.
Hybridoma Protein im munoprecipitated
supernatant 55 kDa 95 kDa
A4 +
A6 + -
B2 + +
B6 + +
C2 -  +
C4 + +
D4 + +
tFig. 5.1. Screening of mouse antisera against sheep adipose tissue
membranes by EIA
Sheep (non-lactating ewe) om ental adipose tissue membranes were 
coated onto 96-w ell m icro titre  plates (im m iilon 2, Dynatech) overnight. 
Seria l  d ilutions o f mouse sera were incubated in  the plates, and 
antibody binding quantified by EIA (section 2.12.4). Further deta ils o f 
immunogens are given in  section 2.12.1. NMS -  Norm al mouse serum.
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Fig. 5.2. Screening of m ouse antisera against sheep erythrocyte ghosts
by EIA
Sheep erythrocyte ghosts were coated onto 96-w ell m icro titre  
plates (immuLon 2, Dynatech) overnight. Serial d ilu tions o f mouse sera 
were incubated in  the plates, and antibody binding quantified by EIA 
(section 2.12.4). Further details o f immunogens are given in  section 
2.12.1.
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Fig. 5.3. Im munoblottmg against sheep adipose tissue membranes with
mouse polyclonal antisera and BRK2 monoclonal antibody
Sheep (non-lacating ewe) om ental adipose tissue membrane 
proteins (5 yg protein/weU) were subjected to  SDS PAGE, transferred to  
n itrocellu lose, and probed w ith  antisera (section 2.16).
Lane Immunogen D ilution
1 Norm al mouse serum 1:50
2 PartiaLly-pi rri f i ed ^-adrenergic receptor "
t t5 NaOH-treated sheep adipose tissue membranes
6 E lectro eluted 58 kDa proteins 1:300
•j  h  »i i i  i i  i t
8 11 "  "  "  1:100
9 Norm al mouse serum 1:50
10 BRK2 monoclonal antibody 1:50
1 2 3 4  5 6  7 8 9  10
*
Fig. 5.4. Inhibition of [~^^I]ICYP binding to solubilised sheep adipose
tissue membranes by mouse antsera
D igjtonin-solubilised sheep (non-lactating ewe) om ental adipose 
tissue membranes (25 pg protein) were incubated w ith  mouse antisera
(1:10 fin a l d ilu tio n ) fo r 2 h a t 22°G. [^^ I]IC Y P  was added to  a fin a l 
concentration o f 75 pM, and samples incubated fo r a fu rth e r 2 h a t 22°C. 
[ 125I]ICYP binding was then quantified using the PEG precip ita tion  assay 
fo r soluble jg-adrenergic receptors. The data represents results from  
two independent experiments, and are expressed as percentage o f 
[125j]ic y p  binding in  the presence o f norm al mouse serum (NMS). Samples 
were analysed in  duplicate. See section 2.14.1 fo r fu rth e r details o f 
immunogens.
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Fig. 5.5. Screening of mouse antiserum AS2 against sheep adipose
tissue membranes and sheep erythtocyte ghosts
Sheep (lacta ting  ewe) om ental adipose tissue membranes and sheep 
erythrocyte ghosts were coated onto 96-w ell plates (Immulon 2, 
Dynatech). Serum from a pre-fusion bleed o f mouse No. 2 (fille d  c irc les) 
and NMS (open circles) were screened fo r anti-m em brane a c tiv ity  by ELA 
(section 2.12.4). In  A, sheep om ental adipose tissue membranes; B, sheep 
erythrocyte ghosts.
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Fig. 5.6. Topography of the hamster Fung A2~a^rener^ c  receptor
The prim ary amino acid sequence fo r the ham ster lung f$2 ~ 
adrenergic receptor, deduced from  the cloned cDNA, is  shown. The jS- 
adrenergic receptor is  predicted to  possess seven hydrophobic membrane- 
spanning domains. CM 1-13 define the amino acid sequences used fo r 
preparing anti-peptide antibodies.
Fig. 5.7. Immunoblotting against sheep omental adipose tissue
membranes w ith  CM 13 and AS2
Im munoblotting as described fo r Figure 5.3, except th a t the 
adipose tissue came from  a lacta ting  ewe. Key: lane 1 -  norm al mouse 
serum (1:50); lane 2 -  CM 13 (1:50); lane 3 -  CM 13 (1:1); lane 4 -  
antiserum from  mouse 2 (AS2) (1:50). D ilutions quoted fo r CM 13 
represent d ilu tion  o f the lyophilised preparation a fte r its  resuspension 
in  500 y l o f PBS, 1% (w /v) MarveL
1 2  3 4
Fig. 5.8. Im munoblotting against sheep omental adipose tissue
membranes w ith  CM 13 and AS2 -  M olecular weight 
determ ination
Im munoblotting as described fo r Figure 5.3, except th a t a 
peroxidase anti-peroxidase complex was used to  am plify the 
im  munostaining and the adipose tissue came from  a lacta ting  ewe. Key: 
lane 1 -  norm al ra bb it serum (1:50); lanes 2 and 3 -  CM13 (1:50 and 1:1 
respective ly); lane 4 -  antiserum from  mouse 2 (AS2) (1:50); lane 5 -  
norm al mouse serum (1:50). Molecular weights fo r markers (SDS-6H, 
Sigma) are in  kDa.
7 . 4 -
6 6 -
4 5 -
2 9 -
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CHAPTER SIX -  GENERAL DISCUSSION
When th is study began, nothing was known about the structure o f 
the ^-adrenerg ic receptor o f sheep adipose tissue, and lit t le  about its  
ligand binding properties. This apparent 'gap* in  the lite ra tu re  made i t  
d iffic u lt to  correlate d ire c t e ffects o f physiological state and jg -  
adrenergic ligands on adrenergic mechanisms in  sheep adipose tissue. 
Indeed there was a strong possib ility th a t sheep adipose tissue 
contained an a typ ica l ^-adrenergic receptor, in  lig h t o f the controversy 
surrounding the ra t adipocyte jg-adrenergic receptor (Bahouth & Malbon, 
1988; Zaagsma & Nahorski, 1990). Also, the current in te rest in  the use 
o f /S-agonists in  livestock production (including sheep), which act 
d ire c tly  on adipose tissue to  reduce adiposity in  carcasses, meant th a t 
characterisation o f the sheep adipose tissue (8-adrenergic receptor m ight 
lead to  a b e tte r understanding o f f t -agonist action, and possibly allow  
the development o f b e tte r and more selective drugs and/or therapies.
In itia l radioligand binding studies confirm ed the presence o f j 3 -  
adrenergjc receptors in  sheep adipose tissue, in  su ffic ie n tly  high 
numbers to  attem pt th e ir pu rifica tio n . The le ve l o f -adrenergic 
receptor expression re fle c ts  the im portance o f adrenergic regulation in  
adipose tissue metabolism. The £ -adrenergic receptor o f sheep om ental 
adipose tissue was pu rified  greater than 300 fo ld  (compared to  levels 
found in  membranes) by a ffin ity  chromatography, which allowed lim ite d  
studies on p a rtia lly -p u rifie d  receptors. The amount o f (S-adrenergic 
receptor in  these preparations meant th a t d ire c t staining o f receptor 
protein on SDS PAGE gels was not feasible. Therefore, p h o to a ffin ity - 
labelling o f the |S-adrenergic receptor was perform ed to determ ine the 
apparent molecular weight o f the receptor. As a resu lt, p h o to a ffin ity -
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labelling o f jS-adrenergic receptors in  membranes and partia l!y-purif ied 
preparations identified a 58 kDa protein, which appeared to be heavily 
glycosylated. Glycosylation is a common feature o f membrane proteins, 
the sugar moieties being added in  the Golgi apparatus p rio r to  the 
prote in ’s transport and insertion in to  the plasma membrane.
Classification o f adrenergic receptor subtypes is  a subject 
which has received much attention over the past two decades. The 
m u ltip lic ity  o f £ -adrenergic receptor 'selective1 radioligands (both 
agonists and antagonists), and the study o f many tissues, has culminated 
in  the positive identifica tion  o f three /S -adrenergic receptor subtypes, 
termed and ^-Adrenergic receptors were firs t described by
AhLquist (1948), w ith (S-^ - and ^ 2 '“a<^rener&£' receptors being 
differentiated by Lands e t aL (1967). This characterisation remained 
in ta c t u n til investigations in to  the properties o f the ra t adipocyte |S- 
adrenergic receptor revealed atypical characteristics (Grana e t aL, 1972; 
Stanton, 1972). This contrasted w ith Lands e t aL 's classification o f the 
ra t adipocyte jg-adrenergic receptor as a -subtype. Detailed study o f 
both the ligand binding and functional properties o f this f t -adrenergic 
receptor defined i t  as being a 'hybrid ' receptor Le. possessing both 
and characteristics (De Vente e t aL, 1980), and elim inated in  the 
development o f adrenergic agonists w ith selective action on adipose 
tissue (Arch e t aL, 1984; Wilson e t aL, 1984). However, the 
classification o f a jg^-adrenergic receptor was only confirmed 
unequivocally w ith the isolation o f a cDNA encoding a th ird  human |g- 
adrenergic receptor (Emorine e t aL, 1989).
Characterisation o f the properties o f the f t -adrenergic receptor 
o f sheep adipose tissue identified i t  as prim arily n0
108
^ -ch a ra c te ris tics  and w ith high a ffin ities  fo r non-subtype selective (S- 
adrenergic radioligands. Its  properties are therefore d iffe ren t from the 
ra t adipocyte |3-adrenergic receptor. As a result o f Lands e t aL’s 
classification, jg-^-adrenergic receptors became associated w ith lipolysis 
and cardiac stim ulation, whilst j§2“recePtors were proposed to mediate 
bronchodilation and vasodilation. For many years researchers regarded 
these arbitary divisions as being absolute, and were re luctant to  accept 
change. The cloning o f the human jg^-adrenergic receptor discredited the 
subtype classification, and adds weight to  proposals o f a typ ica l jg- 
adrenergic receptor properties in  other species and tissues. Indeed, 
Kaumann (1989) has proposed tha t a th ird  jg-adrenergic receptor exists in  
the heart. The finding tha t sheep adipose tissues possess mostly the 
jg2“ subtype provides fu rthe r evidence against the early proposal o f Lands 
e t aL (1967), supported by Bahouth & Malbon (1988), tha t adipocytes 
possess |S-^-adrenergic receptors.
Adipose tissue is  found in  d istinct locations throughout the body 
e.g. omental, para me tr ia l, subcutaneous, intramuscular. This d istribution 
shows lit t le  variation between mammalian species, and appears to  have 
occurred early in  mammalian evolution (Pond, 1984). There is  an 
increasing body o f evidence suggesting tha t both anatomic and metabolic 
characteristics o f adipocytes vary between adipose tissue depots. 
F irstly, adipocyte size and volume varies between d iffe ren t depots w ithin 
a species (Pond, 1984; Sinnett-Smith & Woolliams, 1987). Also, the ra te 
o f lipolysis increases w ith adipocyte size (Hood, 1982), and larger cells 
in  sheep have greater noradrenaline-stimulated lip o ly tic  rates (Vernon & 
Finley, 1985). The development and growth o f adipose depots occurs non- 
uniform ly in  sheep (Hammond et aL, 1971; Leat e t aL, 1976; Wood &
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Butler-Hogg, 1986), guinea pigs (Pond e t aL. 1986). rats (Cryer & Jones, 
1978), pigs and ca ttle  (Wood & ButLer-Hogg, 1986). Castration o f ca ttle  
results in  greater growth o f subcutaneous re la tive  to perirenal adipose 
tissue (Prescott & Lamming, 1964).
On a more biochemical theme, several metabolic activ ities vary 
between adipose depots. Lipoprotein lipase a c tiv ity  varies amongst fa t 
depots in  growing sheep (Sidhu e t aL, 1973), wether lambs (Haugebak e t
aL, 1974), and lean rats (Savard & Greenwood, 1988). Differences in
acetyl CoA carboxylase a c tiv ity  are apparent between subcutaneous
adipose depots in  sheep (Sinnett-Sm ifh & Woolliams, 1987). This 
correlates w ith earlier findings suggesting depot-differences in  the ra te  
o f fa tty  acid synthesis in  growing lambs (ingle e t aL, 1972a,b). 
UndemutrLtLon o f wether lambs results in  the preferentia l loss o f lip ids 
from subcutaneous adipose tissue depots (Vernon, 1980). In  the ra t, 
regional differences occur in  glucocorticoid action (Hauner & P fe iffe r, 
1989), glucose metabolism (Fried e t aL, 1982), and the sensitivity o f
noradrenaline-stimulated lipolysis (Hartman & Christ, 1978). In  humans, 
depot differences in  the contro l o f lipolysis (Ostman e t aL, 1979; 
Rebuffe-Scrive e t aL, 1989) and lipoprotein lipase a c tiv ity  (Rebuffe- 
ScrLve e t aL, 1989) have been shown. Thus i t  is  clear tha t a ll adipose 
tissues are not identical, and so differences in  the properties o f j6 - 
adrenergic receptors might have been predicted.
Study o f -adrenergic receptors in  d iffe ren t sheep adipose tissue 
depots revealed tha t differences in  the ir properties were present. 
Subcutaneous and popliteal depots both possessed ft -adrenergic receptors 
w ith high selectivity towards the 2“ se j^eot -^ve antagonist IC I 118,551. 
In  contrast, omental adipose tissue possessed a ^-adrenergic receptor
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w ith less B o-character. The reasons fo r these findings ere not clear.
They may represent a complex modulation o f {$-adrenergic receptor 
properties, which correlates the location o f adipose tissue w ithin the 
body w ith -adrenergic receptor function. Periods o f under-nutrition do 
not lead to uniform fa t loss from a ll depots (Vernon, 1980), and such 
differences may w all be due to differences in  ^-adrenergic receptor 
properties o f individual depots.
In the ra t, parametria! and lumbar adipose tissue depots 
possessed two £ -adrenergic receptor subtypes. One subtype exhibited 
character, whilst a second displayed atypical jg -adrenergic receptor 
characteristics. The number o f each receptor species in  the two depots 
studied was d iffe rent. This was supdsing since anatomically the 
parametria! and lumbar depots are v irtu a lly  juxtaposed in  the abdomen o f 
the ra t. Competition o f [^^ijLC YP binding to ra t lumbar adipocyte 
membranes by IC I 118,551 and CGP 20712A gave graphs sim ilar to  those 
obtained by Bahouth & Malbon (1988) in  an identica l experiment performed 
on param etria! adipose tissue. Why such profound differences should 
occur between laboratories is  not immediately apparent, but they may 
result from methodological differences during the preparation o f 
adipocyte membranes. No discussion o f the atypical binding present was 
included in  Bahouth & Malbonfs paper, and only the parametr ia! depot was 
studied. The authors also dismissed the concept o f a typ ica l -  
adrenergic receptors in  ra t adipose tissue by other groups w ithout any 
consideration o f depot and sex differences. Indeed, Zaagsma*s group, 
firm  proponents o f atypical ^-adrenergic receptors, used male ra ts and 
the epididymal adipose tissue, a depot not present in  female animals 
(Hollenga & Zaagsma, 1990). In lig h t o f this controversy, the influence
I l l
of sex on fl-adrenprcnV receptor characteristics deserves further study.
This study has revealed marked differences between the /5 -  
adrenergic receptors present in  sheep and ra t adipose tissue. The 
receptors d iffe r in  the ir structura l characteristics, notably molecular 
weight, susceptibility to reduction by disulphide reducing agents, and
possibly prim ary amino sequence, w ith respect to the binding o f the 
polyclonal antisera CM 13. Sheep possess ^g2“ a^rener^ c  receptors whilst 
ra ts have atypical and ^-a d re n e rg ic  receptors on the ir adipocytes. 
Therefore when studying ^-adrenergic mechanisms in  adipose tissue, i t  is 
not always possible to d irectly  extrapolate findings between species.
Since adipose is not a homogeneous tissue w ith many differences 
between fa t depots, i t  is  feasible tha t drugs acting on adipose tissue 
may exhibit depot-selective effects. I t  may therefore be possible to 
design -adrenergic agonists/antagonists which selectively bind and
activate ^S-adrenergic receptors in  a particu lar depot. This therapy
could be used in  humans where adiposity needs to be reduced in  a 
particu lar depot fo r medical/cosmetic reasons, assuming tha t the {$ -
adrenergic receptors in  human adipose tissue also d iffe r between depots.
I f  the study had been more successful, and monoclonal antibodies 
were raised against the £ -adrenergic receptor o f sheep adipose tissue, 
i t  might have been possible to develop immunological alternatives to 
agonists. M onoclonal antibodies have already been produced which 
possess agonist activ ity , but these were an ti-id io typ ic antibodies raised 
against monoclonal antibodies against the jS-adrenergic ligand alprenolol 
(Giiin e t e t aL, 1985). By using purified @-adrenergic receptors as an 
immunogen, i t  may be possible to raise monoclonal antibodies w ith 
selective agonist a c tiv ity  against a single adipose tissue depot. These
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antibodies would be a welcome alternative to the 5-accnists used inr '  °
livestock production, as they would not leave any potentia lly harm ful 
residues in  the animal a fte r treatm ent.
With regards to fu ture research, i t  is  im portant to correlate the 
ligand binding properties o f the yg -adrenergic receptor o f sheep adipose 
tissue w ith its  physiological function i.e . contro l o f lip id  metabolism. 
In itia l work could investigate receptor stim ulation o f lipolysis, and 
confirm tha t 2~adrenergic receptors mediate this e ffe c t in  sheep 
adipose. Also during such functional studies, the possible presence o f
an atypical yg-adrenergic receptor could be investigated using the novel 
yg-agonist BRL 37344, and the approach o f Holienga & Zaagsma (1989). By 
studying the e ffec t o f subtype selective antagonists (e.g. CGP 20712A 
and IC I 118,551) on ( - ) -isoproterenol- and BRL 37344-stLmulated
lipolysis, a clear indication o f which subtype(s) o f yg -adrenergic
receptor mediate catecholamine regulation o f lipolysis in  sheep adipose 
tissue should be attainable. These experiments could also examine 
adipose tissue depots not studied in  this work, to  determine the degree 
o f heterogeneity in  yg -adrenergic receptor properties throughout the 
entire body.
In addition, the production o f polyclonal antisera against the yS -  
adrenergic receptor o f sheep adipose tissue should continue to be a key 
aim. Such antisera are useful fo r im munoblotting and immuno- 
precipitation, and can also be used to screen cDNA expression libraries 
from sheep adipose tissue fo r yg-adrenergic receptor cDNAs. Cloning o f a 
yS-adrenergic receptor from adipose tissue would allow the generation o f 
anti-peptide antisera once the primary amino acid sequence was known. 
An alternative approach would be to obtain a suitable cDNA from another
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laboratory e.p. that encoding the hair.ster lung ^  ^ -adrenergic receptor 
(Dixon e t aL, 1986), and use i t  to screen a cDNA lib ra ry. Who knows 
what such studies w ill reveal? Perhaps sheep adipose tissue receptors 
w ill be shown to be ye t another jS -adrenergic receptor subtype!
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